Host-microbial interactions and cellular reponses associated with 'Streptococcus anginosus' group infection by Landrygan-Bakri, Janine
Host-microbial interactions and cellular responses 
associated with 'Streptococcus group
infection.
Janine Landrygan-
Submitted in accordance with the requirements of the degree 
of Doctorate of Philosophy
coleg meddygaeth
a  h
8 1
college of medicine
Department of Oral Surgery, Medicine and Pathology 
Cardiff University, Wales College of Medicine 
2007
Cardiff
U N I V E R S I T Y
P R I F Y S G O l
CAt RDYjt*)
UMI Number: U584103
All rights reserved
INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com plete manuscript 
and there are missing pages, th ese  will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U584103
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
DECLARATION
This work has not previously been accepted in substance for any degree and is not 
being concurrently submitted in candidature for any degree.
Signed... ) J :     (candidate)
Date........1 a). .* .Q.U.'.. “X-.Q .Q .3.................................................
STATEMENT 1
This thesis is the result of my own investigations, except where otherwise stated.
Other sources are acknowledged by footnotes giving explicit references. A 
bibliography is appended.
Signed... jJ.  (candidate)
Date ).^5.: .Q.U:. 2 Q Q 3 . ..................................................
STATEMENT 2
I hereby give consent for my thesis, if accepted, to be available for photocopying 
and for inter-library loan, and for the title and summary to be made available to 
outside organisations.
Signed... J .   (candidate)
Date \ 3 : .Q U .2 ( X H . . . ..................................................
ACKNOWLEDGEMENTS
Firstly, I would like to thank my supervisors Dr Melanie Wilson and Dr 
Rachel Waddington for their support and guidance during the course of this 
work.
I would also like to thank Dr David Williams, Dr Ryan Moseley, Dr Stuart 
Jones and Dr Sam Hooper for their invaluable help and advice throughout 
the PhD. I am also grateful to Mrs Wendy Rowe for her help with sample 
collections on some very cold mornings, and to Anna Koutoulaki and 
Sladjana Malic for their support in the final few months. In addition, I would 
like to acknowledge the remaining staff and students of the fourth floor for 
their helpfulness and support over the past few years.
Finally, I thank my husband Sam for helping me achieve my goal by being 
more than patient, supportive and understanding, and to my family; Mam, 
Dad, Vicki, Gerwyn and Kara, for keeping me motivated whenever I felt like 
giving up, through their endless wealth of love and affection. Without your 
guidance, encouragement and unfailing faith in me I could never have 
completed this task.
Summary
Interactions of the Streptococcus anginosus group (SAG) with the 
extracellular matrix (ECM) and subsequent effects on host connective tissue 
and bacterial cells is proposed to be important in the initial establishment of 
dentoalveolar infections. The aim of this thesis was to investigate the 
interactions of the SAG with small leucine-rich proteoglycans (SLRPs), 
decorin and biglycan, from periodontal tissues and recombinant decorin and 
biglycan. Additional aims were to investigate the subsequent effects of the 
SAG on cellular components within host tissues and the influence of ECM 
components on bacterial phenotype. Using surface plasmon resonance, this 
study indicated that both commensal and pathogenic strains of the SAG 
interact with SLRPs but there was preferential binding toward the dermatan 
sulphate-substituted decorin and biglycan present in gingival tissues. In 
addition, commensal and pathogenic SAG isolates were shown to influence 
periodontal ligament (PDL) and endothelial ECM responses, including cell 
growth and PG synthesis. The effects on the different cell types illustrates the 
complexity of disease caused by the SAG, and helps to highlight the 
complicated roles decorin and biglycan play within the ECM. This study has 
also shown that potential virulence factors of the SAG, including degradative 
enzymes, are up-regulated following exposure to ECM components derived 
from PDL cells, potentially causing destruction of the host ECM and possibly 
inhibiting remodelling of the ECM. Overall, this thesis provides valuable 
information on host-SAG interactions, highlighting complex roles for SAG 
and SLRPs in the establishment of periapical abscesses.
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CHAPTER ONE
Chapter 1
Host-microbial interactions and cellular responses associated 
with Streptococcus anginosus infection.
1.0 General introduction
Acute infections associated with the teeth and surrounding supporting 
structures often progress to dentoalveolar abscesses (Rice and Crean, 
2006). Causative agents are endogenous oral commensal bacteria, usually 
from the apex of a necrotic tooth or from the periodontal pockets, due to 
caries, exposure during cavity preparation or traumatic fractures. The 
outcome of such dentoalveolar abscesses depends upon the virulence of 
the causative microorganism, the local and systemic defence mechanisms 
of the host and the anatomical features of the region. Bacterial species 
frequently isolated from dentoalveolar abscesses are Prevotella spp., 
Porphyromonas spp., and facultative streptococci, such as the 
Streptococcus anginosus group (SAG) (Samaranayake, 2001).
Microbes that colonise or infect their mammalian hosts often exhibit both 
host and tissue tropism (Viiji, 1996). Host-microbial interactions are two- 
way processes. Factors from eukaryotic cells are able to engage with and 
change the activity of prokaryocytic cells and vice-versa, this ability is a 
crucial first step in the development of infection. The extracellular matrix 
(ECM) is a major component of healthy tissues covered by epithelial or 
endothelial cells. Therefore, under normal circumstances, the ECM is 
unavailable for binding. However, any trauma that damages host tissues 
may expose the ECM and allow microbial colonisation and invasion 
(Nallapareddy et al., 2000). Part of the defence mechanism against foreign
material and damaged tissue is to coat them with a film of various ECM 
components. However, these components can become involved in host- 
microbial interactions as receptors for colonising organisms so that the site 
of injury can be accessible for establishment of infection (Ljungh and 
Wadstrom, 1995). Gaining an insight into the interactions between matrix 
proteins and bacteria is important for understanding the mechanism of 
bacterial colonisation, a pre-requisite to infection, with a view to 
preventing or controlling infection (Holmes et al., 1997).
1.1 Structure of the periodontium
The periodontium is a complex structure that provides the support 
required to maintain teeth in adequate function. The periodontium is a 
unique organ consisting of two soft connective tissues (gingiva and 
periodontal ligament) and two calcified tissues (alveolar bone and 
cementum) (see figure 1.1a). Together, these tissues retain the tooth 
within its socket and protect both the tooth root and adjacent structures 
from the external environment (Avery, 2000).
1.1.1 Gingiva
The connective tissue of the gingiva functions to support the tissue and to 
supply nutrients and innervation to the surrounding structures 
(Bartold, 2000).
The gingival unit comprises a number o f distinct regions (see figure 
1.1b), each with unique histological and clinical features. The free 
gingiva extends coronal to the attached gingiva and forms the walls of the 
gingival sulcus. In health, this is a narrow and shallow crevice of 1 -2 mm
depth surrounding the tooth and often is not clinically obvious. The 
sulcus is lined by sulcular epithelium, which is continuous apically with the 
junctional epithelium and, although the demarcation between these two 
epithelia appears gradual clinically, it is distinct in histological sections. 
The sulcular epithelium is continuous coronally with the epithelium lining 
the oral cavity and is usually clinically demarcated from the attached 
gingiva on the oral-facing surfaces by the free gingival groove (Bartold et 
al. 2000; Clark and Loe, 2001).
The attached gingiva extends from the free gingiva and apically becomes 
continuous with the alveolar mucosa. This junction is clearly demarcated in 
health as the mucogingival junction or line. Palatal to the upper teeth, 
however, masticatory mucosa extends from the gingivae to cover the 
hard palate such that there is no alveolar mucosa and thus no 
mucogingival junction. The attached gingiva has a stratified squamous 
orthokeratinized epithelium and in health appears coral pink, firm and 
stippled, like orange peel, in contrast to the dark red and loosely bound 
alveolar mucosa to which it abuts (Clark and Loe, 2001).
Interdentally, the gingival papillary shape is determined by tooth contact. 
It is pyramidal in shape between the anterior teeth, but becomes more 
flattened in the premolar and molar regions, where approximal contact 
areas rather than contact points exist. In this region, a col (concavity) is 
formed, covered by a thin non-keratinized epithelium. This represents a 
structural weakness that may predispose to breakdown as a consequence 
of plaque-induced disease.
1.1.2 Periodontal ligament
The periodontal ligament (PDL) is a complex, vascular, and highly cellular 
soft tissue that is physically small but functionally important tissue in tooth 
support, proprioception and regulation of alveolar bone volume. It has a 
rapid turnover and an ability to adapt to alterations of mechanical loading, 
thus making it a model system to study connective tissue homeostasis and 
remodelling (McCulloch et al., 2000). The main cell type found within the 
PDL is the fibroblast. Most PDL fibroblasts are highly active cells, 
exhibiting an elongated well-polarized cytoplasm with extensive areas of 
contact to collagen fibres. These fibroblasts contain a large number of 
rough endoplasmic reticulum and well-developed golgi complexes, 
indicating a high rate of protein synthesis (Beertsen et al., 1997). 
Fibroblasts attach to the substratum of the ECM via surface receptors for 
structural matrix components such as, collagen and fibronectin. This 
attachment is essential for cell migration and organisation of the 
extracellular fibrillar matrix (Cho and Garant, 2000). Fibroblastic cells of 
the PDL are a suggested source of osteoblast-like and cementoblast-like 
cells, and are therefore suggested to be multipotent cells, or composed of 
heterogeneous cell populations that have the capacity to differentiate 
depending on the microenvironment (Roberts et al., 1982; McCulloch and 
Bordin, 1991).
1.1.3 Alveolar bone
Alveolar bone forms during root development and is synthesised by 
osteoblasts derived from the denticle follicle. It is a specialised area of the 
mandibular and maxilla bones that lines the tooth sockets, providing
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primary support for teeth (Avery, 2000). Alveolar bone can be described 
as a specialised form of connective tissue, whose mineral phase 
contributes to around two thirds of its weight with the remaining third 
attributable to the ECM (Sodek and McKee, 2000). Conversely, unlike 
other bone tissue within the body, alveolar bone is subject to continual and 
rapid remodelling associated with tooth eruption, adaptation and the 
functional demand of mastication. Considering the importance of this 
tissue, there is relatively little detailed information on its extracellular 
matrix, even though the type of ECM constituents known are thought to 
be similar for all bone types (Sodek and McKee, 2000).
1.1.4 Cementum
Cementum is a hard, calcified connective tissue covering the root dentine 
and providing the site for anchorage of PDL fibres. However, unlike 
bone, it lacks blood and lymph vessels and is not innervated or 
remodelled. Its thickness does, however, increase with age, with the rate of 
formation depending on the function of the tooth, and it contributes to repair 
if the root surface is damaged. In the cervical two-thirds of the root, it exists 
as a thin acellular tissue (primary cementum) laid down by an advancing 
front of cementoblasts. In the apical onethird of the root, cementum is 
cellular (secondary cementum) and is thus more comparable to bone. 
Sharpey's fibres are also evident (Hoag and Pawlak, 1990; Avery, 2000).
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Figure 1.1a Periodontium, showing the periodontal ligament attaching 
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Figure 1.1b Periodontal tissue anatomy with gingival fibers
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1.2 Extracellular matrix
Connective tissue serves a “connecting” function by supporting and 
binding other tissues. Unlike epithelial tissue, connective tissue typically 
has cells scattered throughout an ECM. The ECM is a complex array of 
secreted molecules including collagens, proteoglycans (PGs), 
glycosaminoglycans (GAGs) and a number of glycoproteins (Iozzo, 1998). 
This mixture of structural and functional proteins underlies all epithelia 
and endothelia and surrounds all connective tissue cells. The ECM is 
arranged into a unique, tissue-specific three-dimensional ultra-structure, 
providing a natural scaffold for tissue and organ morphogenesis, 
maintenance, and regeneration following injury (Embery et al, 2000; 
Waddington and Embery, 2001).
It has become clear that the pattern of non-collagenous and collagenous 
materials in the periodontium is similar to other soft and mineralised 
connective tissues present throughout the body (Waddington and Embery, 
2001), albeit in differing compositions. However, the ECM of the 
periodontium has a much higher turnover and responds to stimuli more 
sensitively, such as mechanical stress and pathology (McCulloch et al., 
2000; Keles et al., 2005).
1.2.1 Collagen
Collagens are the main organic constituents of the connective tissue 
matrix providing the tensile strength required by these tissues. They are 
involved in the general structural organisation of the ECM due to their
7
ability to interact with other ECM molecules and cells (Uitto and Laijava, 
1991).
Collagen contains a triple helical conformation of tropocollagen which 
form fibrils in a tightly regulated manner, with a rod-like structure, 300nm 
in length and 1.5nm in diameter. Subsequently, multiple fibrils form into 
collagen fibres (Rushikof et al. 2004).
A collagen trimer may consist of two or three different a  chains or three 
identical chains. There are at least 27 collagen types identified, with about 
42 different a  chains, and the number of members of this family is 
increasing continuously. Most collagens form supra-molecular assemblies, 
which are divided into nine distinct families: (1) fibril-forming collagens 
(types I, II, III, V, XI, XXIV, XXVII); (2) fibril-associated collagens with 
interrupted triple helices (FACITs) located on the surface of the fibrils, and 
structurally related collagens (types IX, XII, XIV, XVI, XIX, XX, XXI, 
XXII, XXVI); (3) the family of collagens VIII and X forming hexagonal 
networks; (4) the type IV collagens, located in basement membranes; (5) 
type VI collagen, forming beaded filaments; (6) type VII collagen, forming 
anchoring fibrils for basement membranes; (7) collagens containing trans­
membrane domains (types XIII, XVII, XXIII, XXV); and (8) the family of 
type XV and XVIII collagens. The modes of supra-molecular assembly of 
families 7 and 8 are so far unknown. (Myllyharju & Kivirikko, 2001).
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Collagens are the major ECM components of periodontal connective 
tissues, particularly type I collagen, providing mechanical attachment of 
the tooth to the bone and gingiva and mediate signals that regulate cell 
functions, including remodelling of the PDL and bone. Type I collagen is 
also present in bone, the sclera of the eyes, the cornea, lungs and skin 
(Glimcher, 1989; Hernandez et al, 1991; Gentle et al., 2003). Collagen 
type I may represent some 60% of the organic components within the soft 
connective tissues of PDL and gingiva, and 90% of the total organic 
matrix of mineralised tissues, such as alveolar bone (Waddington and 
Embery, 2001). Interaction with non-collagenous proteins, most notably 
PGs, helps in the assembly of the collagen matrix, in addition to a variety 
of other functions, including regulation of mineral deposition within the 
collagen fibrils.
1.2.2 Glycosaminoglycans
GAGs provide tissue hydration for fluid flow and molecular transport, 
charge repulsions and attractions for intermolecular spacing, and poly­
anionic domains for growth factor or integrin signalling, cell adhesion, 
and migration or proliferation. Due to these functions, studies of ECM 
metabolism in genetic development and tissue engineering experiments 
include analysis of GAGs (Iozzo and Murdoch, 1996; Plaas et al, 2001).
GAG chains are the hallmark of PGs. They are highly anionic, linear 
polysaccharides that entail a backbone of repeating disaccharide units, 
hexuronic acid and an «-acetyl hexosamine. Seven different GAG species 
have been generally identified; chondroitin 4- and 6- sulphate (CS),
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dermatan sulphate (DS), keratan sulphate (KS) I and II, heparan sulphate 
(HS), heparin and hyaluronan (HA) (see table 1). All GAGs are sulphated 
except hyaluronan, which is also the only GAG found non-covalently 
attached to a protein core (Hascall et al, 1995; Rostand & Esko, 1997; 
Waddington & Embery, 2001). Selective epimerisation of the hexuronic 
acid residue, within DS and HS, and selective sulphation of the hexosamine 
residue, within CS, DS, HS, heparin and KS, has permitted for a larger 
range of GAGs. This ultimately results in the production of specific 
properties (Hardingham & Fosang, 1992). Through biochemical 
characterisations and immunohistochemical studies, it has become apparent 
that the nature of GAGs varies in different tissue types (Fisher et al., 1983; 
Heinegard et al., 1985; Waddington et al., 2003).
1.2.2.1 Biosynthesis of glycosaminoglycans
Biosynthesis of GAGs is initiated by transferring the reducing end of 
xylose from UDP-xylose to the hydroxyl serine residue of the core protein 
(threonine may also accept the xylose). The reaction is catalysed by 
xylosyl transferase I (XT-I) and II (XT-II) (Sugahara et al., 1988; Cuellar 
et al., 2006; Ponighaus et al., 2006). Xylosylation is the rate-limiting 
factor in GAG biosynthesis, XT-I initiates the biosynthesis of the GAG 
linkage tetraaccharide in PGs whereas XT-II initiates the biosynthesis of 
both HS and CS GAGs (Cuellar et al., 2006; Ponighaus et al., 2006).
Subsequently, there is an addition of two galactose residues (from UDP- 
galactose), to the existing xylose, through galactosyl transferases. The 
carbohydrate backbone then forms by alternate transfer of N-
acetylhexosamine and hexuronic acid residues from the corresponding 
UDP-glycosyl donors onto the non-reducing end of the chain, linked by a 
and P chains (Roden, 1981).
The repeating disaccharide unit undergoes continuous modifications with 
the addition of sulphate by sulphotransferases, as the GAG chains elongate 
(Greiling et al., 1972). After sulphation, further changes can occur to the 
GAG chains, such as the epimerisation of the carboxyl group at position 5 
in the hexuronic acid of CS, this causes the carboxyl group within D- 
glucuronic acid to rotate and lie below the plane of the hexose ring to form 
L-iduronic acid to produce DS (Hascall and Hascall, 1981).
HA synthesis, which ultimately does not attach to a core protein, is 
different from other GAG chain synthesis. Synthesis does not occur in the 
golgi, instead it is linked to the cytoplasmic side of the plasma membrane. 
HA synthase elongates HA at the reducing end by adding UDP-N- 
acetylglucosamine or UDP-glucuronic acid (Prehm, 1984). HA is then 
successively released into the ECM without being bound to a core protein 
(Mason et al., 1982).
Due to the synthesis process and post-translational modifications, GAG 
chains display differences, such as the degree and position of sulphation 
(Neame and Kaye, 2000).
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Figure 1.2 Glycosaminoglycan structures
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1.2.3 Glycopeptide linkage and proteoglycan core protein
As mentioned, a trisaccharide sequence of xylose-galactose-galactose 
forms the linkage region for the attachment between GAGs and PG core 
proteins, where xylose covalently attaches to the serine residue on the 
protein core (Roden, 1981). CS, DS, HS and heparin all attach through the 
reducing terminal of the GAG monosaccharides and the hydroxyl groups of 
serine residues in the protein core via an O-glycosidic bond. The sulphate 
and carboxyl groups make these macromolecules highly negative under 
physiological conditions (Bartold, 1990). The molecular weight of PG core 
proteins ranges from 10 -  400kDa, and over 100 GAGs can covalently link 
to a core protein (Kreis and Vale, 1993). A wide range of protein cores 
serve as acceptors for the initiation and polymerisation of GAG chains. 
Due to advances in both biochemical and molecular techniques, there has 
been an emergence of distinct differences between PG families. Therefore, 
PGs are classified due to their core protein and relative biological function 
(Iozzo, 1998).
Figure 1.3 Glycopeptide linkage
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1.2.4 Proteoglycans
PGs represent a family o f macromolecules, ubiquitously extracellular and 
cell-surface associated. PGs surround the plasma membrane of a cell and 
constitute part of the substrate upon which the cell attaches and performs 
its major functions. They comprise some of the most complex and multi­
functional molecules of the animal kingdom (Iozzo, 1999).
PGs characteristically carry highly charged, sulphated polysaccharide 
GAGs. PG families are characterised from the amino acid sequence, the 
size of the core protein and the nature of the GAG, including its size, 
sulphation pattern and number of chains attached to the protein core 
(Iozzo and Murdoch, 1996).
Both structural features of core protein and GAG are important in 
interactions with cell and matrix components. Overall, PGs provide 
structural constraints, can function as growth-supportive or suppressive 
molecules, and possess adhesive and anti-adhesive properties. They also 
act as major biological filters, promote angiogenesis, and bind, store, and 
deliver growth factors to target cells during normal development and in 
pathologic states (Iozzo and Murdoch, 1996).
1.2.4.1 Biosynthesis of proteoglycans
Maintenance of the structural and functional organisation of ECM 
components requires the correct targeting of proteins to their destinations. 
This is achieved by the delivery of newly synthesised PGs via the 
secretory pathway. Newly synthesised proteins in the secretory pathway
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encounter several important components such as recognition elements for 
nascent protein insertion in to the endoplasmic reticulum (ER), molecular 
surveillance chaperones, endogenous enzyme for post-translational 
modifications, and routing molecules to deliver the finished protein to the 
cell exterior (Rothman, 1994).
The biosynthesis of PGs is a strict, complex, highly regulated process, 
which begins with the formation of the protein core. The biosynthesis of 
PG core proteins follows that of other proteins. The specific mRNA is 
transcribed from DNA, which is then used in polysomes as a template for 
the core protein. The majority of the core proteins are synthesised with one 
or more asparagine-X-serine (threonine) sites. These are important for the 
commencement of N-linked oligosaccharide synthesis, which are required 
for the correct folding of the protein. The N-asparagine linked 
oligosaccharide is covalently attached to the core protein by a lipid-linked 
oligosaccharide pre-cursor assembled on dolichol pyrophosphate
f
(Komfield and Komfield, 1985). This dolichol moiety is set in the rough 
endoplasmic reticulum (RER) membrane with the oligosaccharide 
protruding into the lumen. Specific enzymes (transferases) move the entire 
oligosaccharide onto the carboxyamino side chain of an asparagine residue 
in the budding core protein, providing that the asparagine-X-serine 
(threonine) recognition sequence is available. The dolichol pyrophosphate 
is released with the formation of an N-glycosylamine bond. Then, the 
entire molecule is transported through the RER to the golgi body, where it 
undergoes the addition of sialic acid residues and GAG addition 
(Lohmander et al., 1986). Those PGs whose primary sequences are known
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to contain hydrophobic, N-terminal signals, are removed co- 
translationally. However mutant proteins with abnormal confirmations 
frequently fail to pass through the secretory pathway. Therefore, 
improperly folded proteins are retained in the ER lumen until folded 
properly or they are destined for degradation (Hammond and Helenius, 
1995).
1.2.5 Proteoglycan families
There are several PG families: aggregating PGs, small leucine-rich repeat 
PGs (SLRPs), cell-surface PGs and orphans.
1.2.5.1 Aggregating proteoglycans
The aggregating PG family are also known as modular molecules 
integrating structural motifs such as an epidermal growth factor (EGF)- 
like domain, lectin-like domain, complement regulating protein-like 
domain, immunoglobulin folds and PG tandem repeats (Fosang and 
Hardingham, 1989). This family is further divided into two subfamilies; 
the hyalectans (hyaluronan- and lectin-binding PGs) comprising versican, 
aggrecan, neurocan, brevican; and the non-hyaluronan-binding PGs, 
which comprise perlecan and agrin (Iozzo and Murdoch, 1996).
One of the most studied large aggregating PGs is versican, which is 
expressed by numerous cells in a variety of connective tissues. It has been 
identified in osteoid predentine, cartilage, placenta, gingiva and tendon 
(Ruoslahti, 1989; Dours-Zimmermann and Zimmermann, 1994). This is a
large extracellular CS PG, with a molecular mass over lOOOkDa
/
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(Zimmermann and Ruoslahti, 1989; Iozzo, 1998). The structure of the 
protein core, which is around 400kDa, consists of several distinct 
domains. There are two globular domains present at the N-terminus; the 
amino-terminal globular domain (Gl) comprising an immunoglobulin-like 
domain and a PG tandem repeat form aggregates with hyaluronan. The 
selectin-like domain (G3) at the carboxy-terminus is composed of EGF- 
like, lectin-like, and complementary-regulatory protein-like domains. 
These terminal globular domains can interact with a variety of ligands, 
including other ECM proteins, as well as components of the cell surface. 
These diverse binding activities predict a central role for versican in the 
assembly of the pericellular matrix, which directly and indirectly 
participates in the regulation of cellular adhesion, proliferation, and 
migration. There are two extended regions, which bear CS chains (Neame 
and Barry, 1993), which are believed to serve an anti-adhesive function, 
and their hygroscopic properties make versican a large space-filling 
molecule (Yamagata et al., 1993).
1.2.5.2 Small-leucine rich proteoglycans
SLRPs are typically compact proteins with alternating hydrophobic and 
hydrophilic amino acid residues that harbour multiple amino acid repeats 
with conserved leucine residues (Iozzo and Murdoch, 1996). Fisher et al. 
(1983) first identified, SLRPs as small PGs in bone, which were 
subsequently found in the ECM of most tissues (Kresse et al., 1994). 
There are currently nine members of this family with multiple sequence 
alignment classifying three main groups and three subfamilies. Class I
comprise decorin and biglycan, showing the greatest amount of homology
/
18
and they are primarily involved in the maintenance and regulation of the 
ECM in tissues. Class II includes fibromodulin, lumican, keratocan, 
proline arginine-rich end leucine-rich repeat protein (PRELP), and 
osteoadherin (Sommarian et al., 1998). Opticin, osteoglycan/mimecan, and 
epiphycan comprise class III (Iozzo, 1998; Scott et al., 2004).
The molecular weight of the protein core for SLRPs ranges from 30- 
50kDa. The core protein consists of four main regions. There is an amino- 
terminal region, containing an attachment site for the negatively charged 
GAGs, a central domain with varying numbers of LRRs (7 to 24 leucine- 
rich tandem repeat pattern), which also contains consensus sites for the 
addition of 2 (for biglycan) or 3 (for decorin) N-linked oligosaccharides, 
and a carboxyl end region. Both the C- and N-terminal contain a number 
of cysteine residues, which create a loop, stabilised by intra-chain 
disulphide bonds (see figure 1.4). Variability is shown within the N- 
terminal due to the covalent attachment of GAG chains (Iozzo and 
Murdoch, 1996; Matsushima et al., 2000; Neame and Kaye, 2000).
1.2.5.2.1 Decorin and Biglycan 
Structure
Decorin and biglycan are extremely important members of the SLRP 
family, therefore they are the most widely studied. Both are widely 
distributed in connective tissues, including the periodontium (Kinsella et 
al., 2004), and both are highly homologous, suggesting their formation by 
a relatively recent gene duplication event. The genes of these closely
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Figure 1.4 General features o f small leucine-rich proteoglycans, decorin 
and biglycan (modified from Iozzo and Murdoch, 1996).
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related SLRPs are both composed of 8 exons, with highly conserved 
intron/extron transitions (Fisher et al., 1991; Danielson et al., 1993). 
Decorin and biglycan are characterised by the presence of signal peptides, 
which control intracellular trafficking by targeting the protein core into the 
ER, these signal peptides are cleaved co-translationally. There are also 
short propeptides, which are highly conserved and influence the attachment 
of GAG chains to decorin and biglycan core proteins (Hocking and 
McQuillian, 1996; Oldberg et al., 1996). Generally, the propeptides are not 
present on the mature, secreted forms of decorin and biglycan. Regardless 
of the protein sequence homology, decorin and biglycan are distinct gene 
products and, to date, their genes are situated on at least two different 
chromosomes (McBride et al., 1990; Danielson et al., 1993; Gover and 
Roughley, 1995).
Until recently, the leucine-rich repeat motif was comparable to that of the 
ribonuclease inhibitor protein. It was thought that the SLRPs folded in a 
similar horseshoe confirmation, with the inner concave face proposed to 
provide the sites for protein-protein interactions and therefore responsible 
for many of the interactions that define SLRP function. X-ray 
crystallography demonstrated the leucine-rich repeat folded via alternating 
parallel a-helices and p-sheets, with the parallel p-sheets in the inner 
concave surface (Kobe and Deisenhofer, 1993; Weber et al., 1996; 
Kinsella et al., 2004). Contrary to this, biophysical analyses of decorin 
have recognized the potential presence of a dimeric form in solution. Low 
angle X-ray scattering data has suggested that the concave structures are 
involved in dimerisation, potentially making them unavailable for ligand
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binding (Scott et al., 2003; Scott et al., 2004). However, Goldoni et al. 
(2004) disputed this, and proposed decorin is a monomer, and that 
dimerisation is artefactual. In 2006, Scott et al. reinforces the notion that 
decorin is a dimer and also provided evidence that biglycan is also a dimer 
in solution.
Decorin (also known as PG-1, PG-S1, and PG-40) is found in both 
mineralised and soft connective tissues, such as bone (Fisher et al., 1983) 
and gingiva (Bratt et al., 1992). There is one GAG attachment site at the 
fourth amino acid, serine (Fisher et al., 1983). This is invariably substituted 
with CS in mineralised tissue (Franzen and Heinegard, 1985; Waddington 
et al., 1989), or DS in non-mineralised tissue (Heinegard et al., 1985). 
Similar DS substituted decorin and biglycan have been identified in pre­
mineralised matrices of osteoid (Robey et al., 1993) and pre-dentine 
(Waddington et al., 2003). The molecular weight of the entire 
glycoconjugate is around 120kDa and the protein core is around 38-45kDa 
(Krusius and Ruoslahti, 1986).
Biglycan is enriched in bone and other non-skeletal connective tissues 
(Fisher et al, 1983). The molecular weight of the glycoconjugate 
approximately 200kDa, with a protein core of between 37-45kDa (Fisher et 
al., 1987). The core prptein comprises twelve LRR. At the N-terminus, 
biglycan has a short domain consisting of 20-30 amino acids that contain 
two GAG attachment sites, which are located on serine residues at position 
5 and 11. As with decorin, the attached GAG depends on the source of
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tissue, with CS found in mineralised tissue and DS in soft tissues (Krusius 
and Ruoslahti, 1986, Fisher et al., 1989).
Functions
Decorin and biglycan exhibit a different pattern of expression and tissue 
location, which indicates diverse biological functions within the ECM of 
connective tissues. Both the core protein and the GAG chains of these 
SLRPs play important roles in the formation and regulation of connective 
tissue (Iozzo and Murdoch, 1996). There are two principle mechanisms of 
action thought to contribute to the biological functions of decorin and 
biglycan. First, they interact with other matrix proteins, including 
collagens, fibronectin, elastin, and thrombospondin, and influence matrix 
assembly and fibrillogenesis. Second, considerable evidence suggests that 
decorin and biglycan can modify the cellular response to growth factors, 
such as transforming growth factor B (TGF-P) and EGF (Laine et al.2000; 
Kinsella et al., 2004).
Decorin
Decorin interacts with several matrix molecules, and has a role in the 
organisation and alignment of the collagen fibril scaffolding. The 
association between collagen and decorin has been demonstrated by 
immuno-staining (Pringle et al., 1990; Greve et al., 1990), and by in vitro 
binding studies (Vogel and Trotter, 1987; Sugars et al., 2002). The decorin 
protein core binds to the collagen at specific points along the fibril and the 
GAG chain regulates interfibrillar distances (Scott, 1986). Since the 
interaction between decorin and collagen type I is blocked by the reduction
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of the disulphide bonds in decorin, the disulphide-bonded loops of decorin 
appear to be required for the interaction (Scott and Haigh., 1988). 
However, the extended LRR region in the central portion of decorin is also 
required for the interaction with collagen type I (Schonherr et al., 1995).
The targeted disruption of decorin was the first in vivo demonstration of the 
importance of this SLRP for proper collagen fibrillogenesis (Danielson et 
al., 1997). Mice harbouring a decorin gene disruption were viable, but they 
had fragile skin with markedly reduced tensile strength compared to their 
wild-type counterparts. Ultra-structural analysis of these mice revealed 
abnormal collagen morphology in skin and tendon, with coarser and 
irregular fibre outlines and sizes, due to abrupt increases and decreases in 
mass along their axes. In addition to modulating the morphology of the 
collagen fibrils, decorin deficiency also induces changes in collagen 
orientation. In the absence of decorin, the collagen fibrils in the periodontal 
ligament display a random orientation instead of their usual parallel 
orientation, leading to susceptibility of infection (Hakkinen et al., 2000).
TGF-P is a principal growth factor identified in many tissues, including 
periodontal tissues (Yamaguchi et al., 1990), regulating cell proliferation in 
the PDL (Hakkinen et a l , 2000), and has important roles in bone 
remodelling. Decorin is considered a potential anti-fibrotic agent because 
this SLRP binds TGF-p and potentially sequesters the growth factor. Over­
expression of TGF-p in the rodent lung induces fibrosis that can be 
ameliorated by co-expression of decorin (Kolb et al., 2001). However, the 
situation is complex, as it has been proposed that the activation of TGF-p
can either enhance or inhibit cellular growth. This phenomenon is 
dependent on cell type and it has been reported that TGF-p can inhibit 
epithelial cell growth and enhance mesenchymal cell growth (Spom and 
Roberts, 1990).
It has been suggested that complexes between decorin and TGF-P result in 
the inactivation of this cytokine. Inactivation of TGF-p in Chinese hamster 
ovary cells resulted in the inhibition of cell growth (Yamaguchi et al., 
1990). Markmann et al. (2000) used MG-63 osteosarcoma cells to suggest 
that possible inhibitory effects of TGF-p by decorin may be due to the 
sequestration of TGF-p to the collagen matrix. An important consideration 
is whether the PG binds to a biologically active or inactive form of TGF-p. 
Hildebrand and co-workers (1994) suggested there is only an active form. 
The pro-peptide of TGF-P is cleaved prior to secretion but remains with the 
homodimer as latency associated protein (LAP), thus continuing the 
molecule in a biologically active state. This TGF-p/LAP complex can 
associate with different components within the ECM, suggested to be 
awaiting activation (Schonherr and Hausser, 2000).
Biglycan
The primary role of biglycan is similar to that of decorin, as this SLRP 
binds to a variety of ECM components and modulates cell function. 
Biglycan interacts with TGF-B, with consequent up-regulation of biglycan 
(Kahari et al., 1991), and this may be related to increases in biglycan 
expression with fibrotic responses such as, glomerulonephritis, pulmonary 
and hepatic fibrosis. Hausser et al. (1994) showed TGF-B mediated an
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increase in biglycan expression in MG-63 osteosarcoma cells, which was 
inhibited by the presence of decorin.
Despite the core protein sequence of biglycan sharing homology with 
decorin, its interaction with type I collagen is often debatable and appears 
to depend upon the ionic environment (Pogany et al., 1994). Miosge et al. 
(1994) found collagen fibrils of human articular cartilage decorated with 
biglycan. Also, Schonherr et al., (1995) provided evidence indicating a 
weak interaction between biglycan and purified type I collagen fibrils, 
suggesting binding is possibly dependent upon ionic strength. Biglycan 
also interacts with fibronectin (Schmidt et al., 1991), suggesting this 
protein is important for matrix assembly. Biglycan may fulfil some tissue- 
specific functions in the vascular system too. Heparin co-factor II inhibition 
of thrombin is accelerated by intact biglycan (as well as decorin) (Whinna 
etal., 1993).
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A role for biglycan in mineral deposition has also been reported. Boskey et 
al. (1997) showed low concentrations of CS- and DS-biglycan induced 
apatite formation within a gelatin gel system, whilst DS-decorin had no 
effect on mineral accumulation compared to the PG free controls. Other 
studies using recombinant CS-decorin and CS-biglycan indicated that 
binding to hydroxyapatite crystal (HAP) was greater to biglycan than to 
decorin (Sugars et al., 2003), thus leading to the proposal that biglycan 
plays a more predominant role in interacting with HAP and thus regulating 
mineral deposition (Sugars et al., 2003). Waddington et al. (2003) 
investigated the role of SLRPs during bone formation. DS substituted
biglycan was expressed during cell proliferation, which ceased at early 
matrix deposition. Biglycan was re-expressed at the onset of mineralisation, 
substituted with CS. DS substituted decorin expression was associated with 
early matrix deposition, and continued to the mineralisation stages, 
substituted with CS. These results indicate the importance of GAG 
substitution in dictating the role SLRPs play in cell signalling, matrix 
formation and control of mineral deposition.
1.2.5.3 Cell surface proteoglycans
Cell surface PGs consist of mainly HS-containing PGs such as syndecan, 
fibroglycan, glypican and CD44 that have been ascribed important 
functions relating to cell-cell and cell-matrix interactions. Syndecan is 
around 33kDa and has three distinct domains; a 34 amino acid cytoplasmic 
domain, a hydrophobic trans-membrane and an extracellular domain 
containing five potential GAG attachment sites for CS or HS (Saunders et 
al., 1989). Fibroglycan is an integral membrane PG with a core protein of 
around 48kDa. It displays widespread homology to syndecan as it has a 
cytoplasmic, trans-membrane domain (Bemfield et al., 1992). However, 
fibroglycan has one potential site for N-glycosylation (Bourdon et al., 
1987).
1.2.6 Glycoproteins
A variety of glycoproteins have been identified as important ECM 
components, which differ in their molecular size, structures, functions and 
distribution. Their diversity and versatility is indicative of their importance 
in the ECM (Embery et al., 2000).
Glycoproteins are a heterogeneous group of molecules that collectively 
contain a protein core with attached N- or O- linked oligosaccharide chains 
that can be branched or linear. Glycoproteins exhibit several structural 
features, including binding domains such as Arg-Gly-Asp (RGD), which 
allow interactions of various ECM proteins and cell binding sequences. 
Therefore, glycoproteins have been allocated roles in cell attachment, cell 
behaviour, and formation of an organised matrix.
The most significant glycoproteins within periodontal ligament and 
gingival connective tissue are the adhesive glycoproteins; fibronectin, 
vitronectin, laminin and thrombospondin. Osteonectin, elastin, and 
tenascin are also found diffusely within gingiva (Waddington et al., 2001). 
Specific glycoproteins have also been reported in mineralised tissues, such 
as, bone sialoprotein, osteonectin, and osteopontin all contain highly 
conserved regions rich in acidic amino acids. The structurally significant 
highly negative charge on these molecules lends themselves to potential 
roles in controlling mineralisation and they provide the resilient hardness 
of bone (Bartold and Narayanan, 1998).
1.2.7 Catabolism of the extracellular matrix
The ECM is not static: it is remodelled constantly, which implies constant 
breakdown by proteases, most notably the family of matrix 
metalloproteases (MMPs) (Bosman and Stamenkovic, 2003). MMPs 
comprise a large family of zinc-dependent extracellular enzymes that share 
common structural features, particularly those regions involved in the
regulation of proteolytic activity. MMP-mediated proteolytic processing 
has several possible roles in dental tissue. MMPs, together with their 
inhibitors, may act in the process of synthesis and mineralization of dentin 
and osteoid matrix. They could also be responsible for tissue destruction in 
pathological injuries such as caries, attrition or pulpal inflammation 
(Nagase and Woessner, 1999).
Generally, MMPs play a central role in remodelling the ECM, and this is 
essential for embryonic development, morphogenesis and tissue 
remodelling. Members of this family include collagenases, gelatinises, 
stromelysins, and membrane-bound metalloproteinases (MT-MMPs) 
(Birkedal-Hansen et al., 1993; Nagase and Woessner, 1999). With respect 
to PGs, remodelling of the ECM is a two-step process; initially there is 
cleavage at a specific site within the core protein at neutral pH. Then, 
endocytosis and intracellular digestion of the partially digested PG occurs 
by lysosomal proteinases. MMP1, 2, 3, 8 and 13 have been identified in 
the developing tooth tissues and proposed to be part of ECM turnover of 
the tooth tissues and surrounding area (Tsubota et al., 2002; Maruya et al., 
2003).
Many of the secreted MMPs, such as collagenase-1 and -3 , stromolysins 1, 
2 and 3, and gelatinase-B are not expressed in normal, healthy, resting 
tissues or their production and activity are maintained at nearly 
undetectable levels. Some MMPs, including matrilysin, endometase, and 
MT5-MMP are expressed in healthy tissues, implying roles in 
homeostasis. In contrast, increased levels of MMP expression are observed
in repair or remodelling processes, in any diseased or inflamed tissue, due 
to matrix turnover, cell migration, and secreted factors (Pei, 1999; de 
Coignac et al., 2000).
It is becoming increasingly clear that matrix remodelling is neither the 
sole, nor common, function of MMPs. They are, after all, proteinases, 
which can act on an array of proteins. Several studies have demonstrated 
various MMPs can modulate the activity of non-matrix proteins, such as 
matrilysin activating the pro-form of a-defensins (Wilson et al, 1999). 
Several MMPs, such as, collengase-1, stromelysin -1 and -3 , and 
matrilysin, among others, directly modulate the activity of several growth 
factors and chemokines, such as TGF-P (Yu and Stamenkovic, 2000), 
TNFa (Haro et al., 2000), and FGFs (Levi et al., 1996). In addition, 
fragments of matrix proteins released by MMP-mediated proteolysis can 
act as chemoattractants for distant cells. Therefore, MMPs are not only 
proteinases of matrix catalysis but as extracellular processing enzymes 
involved in cell-cell and cell-matrix signalling (Parks and Shapiro, 2000).
Tissue inhibitors of metalloproteinases (TIMPs) are a family of secreted 
proteins that selectively inhibit MMPs (Chang and Werb, 2001). TIMPs 
regulate the breakdown of extracellular matrix components and play an 
important role in tissue remodelling and growth, in both physiological and 
pathological conditions. Four members of the TIMP family have so far 
been characterised, with all being able to inhibit most active MMPs. Of 
these, TIMPs 1, 2 and 3 have been implicated in early tooth 
morphogenesis (Sahlberg et a l, 1999; Woessner and Nagase, 2000).
There must be regulation and balance among the production of ECM 
molecules, the degradation of ECM molecules by MMPs and the inhibition 
by TIMPs for turnover of ECM molecules in alveolar bone, cementum and 
periodontal ligament.
1.3 Microbial adherence to and invasion through the extracellular 
matrix
The structure and function of the periodontium undergo severe stress 
when the matrix components of periodontal tissues are affected by 
inflammatory and fibrotic disease (Narayanan and Bartold, 1996). The 
clinical presentations of periodontitis include the loss of gingival 
epithelium attachment to the tooth root surface, exposure of the cementum 
and formation of periodontal pockets adjacent to the root surface. These 
conditions are symptomatic of PDL destruction and resorption of alveolar 
bone (Armitage, 1996).
Adherence of microorganisms to host tissue is regarded as the first step in 
the pathogenic processes leading to infection. In the healthy state, the ECM 
is not available for bacterial binding. However, exposure of ECM 
components following epithelial trauma may lead to colonisation and 
infection by microbes as they interact with various sub-epithelial ECM 
structures (Ljungh and Wadstrom, 1995; Trelstad, 2004).
PGs are present in the ECM and membranes of virtually all animal cells, 
and are among the first host macromolecules encountered by pathogenic 
agents (Menozzi et al., 2002). The versatility of PGs and their GAG chains
capacity for multiple interactions with many different protein ligands gives 
them the ability to function as multi-purpose “glue” in cellular interactions 
(Rostand and Esko, 1997). Due to their wide distribution and ease of 
access, pathogenic bacteria appear to have evolved mechanisms to exploit 
PGs for their own functions (Menozzi et al., 2002). A large array of 
glycoproteins, glycolipids, and PGs are known to be targets of bacterial 
adherence including; fibronectin, collagen, fibrinogen/fibrin, elastin, and 
laminin, as well as decorin and HS-containing PGs (Joh et al, 1999).
Following binding to ECM components, microorganisms may use them as 
a stronghold for propagating and spreading to other parts of the body (He 
et al., 2004). Migration is a prerequisite for the spread of infectious agents. 
Direct or bridge molecule-mediated interactions occur between invaders 
and host ECM and cells, and may be crucial events for successful infection 
(Marino et al., 2003).
Overall, the experimental evidence for the adherence of a range of 
microbes to host ECM proteins is compelling (Rostand and Esko, 1997), 
and streptococcal spp. have been examined in detail (see table 1.2). 
Decorin, bound to collagen has been shown to be utilised by pathogens for 
their entry and colonisation of tissues. The spirochete Borrelia 
burgdorferi, the causatiye agent of Lyme disease, adheres to collagen- 
associated decorin but does not adhere directly to collagen types I or III 
(Brown et al., 1999). The conformation of some ECM components, such 
as fibronectin and vitronectin, differs significantly when the glycoprotein 
is immobilised in tissues or on surfaces, as opposed to the soluble form.
Microbial adhesins such as Yad A of Yersinia enterolitica and P fimbriae 
of Escherichia coli bind immobilised but not soluble fibronectin. This may 
indicate that these adhesins only recognise an exposed domain when the 
fibronectin is immobilised in tissues (Westerlund et al., 1991; Schulze- 
Koops e ta l., 1993).
Cryptic or hidden sites within native ECM molecules may become 
activated or exposed upon disassembly or degradation of the ECM 
component structure. Degradative or proteolytic enzymes may be released 
by bacteria or by host tissue invading leucocytes. As a biological 
consequence, the ECM breakdown products may facilitate invasion of 
target cells by the bacteria (Marino et al., 2003). There is evidence to show 
that Trypanosoma cruzi interacts with host ECM components producing 
breakdown products that play an important role in parasite mobilisation 
and infection (Marino et al., 2003).
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Adhesin Approx. Mol. 
Mass (kDa)
Species Substrate
sfbl family 70 S. pyogenes (group A), 
group G streptococcus
Fibronectin
sfbl, SOF 113 S. pyogenes Fibronectin
FnbA 117 S. dysgalactiae (group C) Fibronectin
FnbB 122 S. dysgalactiae Fibronectin
Fnb 120 S. equisimilis (group C) Fibronectin
FBP54 54 S. pyogenes M-type 5 Fibronectin, fibrinogen
SDH 39 S. pyogenes Fibronectin, lyzozyme, 
myosin, actin
28-kDa antigen 28 S. pyogenes Fibronectin
14-kDa protein 14 S. anginosus Fibronectin
Laminin binding protein 145 S. gordonii Laminin
Collagen adhesin 90 S. mutans UA140 Collagen
Collagen adhesin 57 S. pyogenes 6414 Collagen (type II)
GAG-BP 9 S. pyogenes M-type 12 Heparin, heparan sulphate
Table 1.2 Streptococcal protein adhesins recognise extracellular matrix components (modified from Jenkinson and Lamont, 1997).
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1.4 Streptococcus anginosus group
The SAG is a collective name for a group of facultative, microaerophilic, 
Gram-positive cocci. Until recently, the SAG were also known as the 
Streptococcus milleri group and there is a long history of taxonomical 
confusion. The SAG were first described in 1906 as streptococci that 
fermented lactose, saccharose, and clotted milk. Later, Lancefield et al 
(1934) characterised these streptococci as possessing beta-haemolysis and 
the F antigen. In 1943, the species “Streptococcus M G ” was proposed, 
which was a group of non-haemolytic (alpha haemolysis) streptococci that 
were bile resistant and fermented sialicic but not inulin or raffinose. Five 
decades have passed since Guthof (1956) coined the term S. milleri to 
describe non-haemolytic oral streptococcal species isolated from dental 
abscesses. However, Colman and Williams (1972) proposed that S. milleri 
consisted of both minute beta-haemolytic streptococci along with non- 
haemolytic streptococci. Subsequently, Coykendall et al., (1987) proposed 
the unification of these streptococci into a single species. However, the 
term S. milleri was not accepted by taxonomists (Facklam, 2002).
Through DNA-DNA reassociation studies and ribotyping studies, 
supported by phenotypic characteristics, it is now regarded that the group 
consists of: S. constellatus, S. intermedius and S. anginosus, S. constellatus 
subsp. constellatus and S. constellatus subsp. pharyngis. These species are 
similar, but show various haemolytic, serological and physiological 
characteristics (Whiley et al., 1990; Jacobs and Stobberingh, 1995; Whiley 
et al., 1999; Facklam, 2002).
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1.4.1 Commensal to pathogen
The SAG are frequently isolated from humans (Toyoda et al, 1995) and 
are regarded as commensals of mucocutaneous surfaces including the oral 
cavity, oropharynx, gastrointestinal tract and urogenital tract (Jenkinson 
and Lamont, 1997). However, members of the normal flora can become 
important pathogens (Fujiyoshi et al, 2001). Under the appropriate 
conditions, and in the presence of predisposing factors, such as trauma, 
diabetes, immunodeficiency, malignancy and prosthetic devices (Toyoda 
et al, 1995), previous ‘harmless’ bacteria can initiate both localised and 
systemic diseases (Homef et al., 2002).
1.4.2 SAG infections
In most purulent clinical infections, the SAG are isolated alongside 
obligate anaerobes. However, they can be isolated alone in pure culture, 
even after inoculation as part of a mixed culture (Lewis et al., 1988). It has 
been suggested that the SAG may initiate infection and prepare the way for 
subsequent colonisation by anaerobic species. Furthermore, a degree of 
synergy between SAG and anaerobic bacteria has been proposed 
(Nagashima et al., 1999).
In purulent infections, the SAG is usually isolated as part of a mixed 
infection usually in combination with Gram-negative strict anaerobes such 
as Prevotella species, Fusobacterium species, Veillonella species and 
Eikenella species (Van der Auwera, 1985; Shinzato and Saito, 1995). 
Shinzato and Saito (1995) investigated the synergy between strains of SAG 
and anaerobic bacteria in infectious disease. They infected mice with a
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mixture of S. constellatus and Prevotella intermedia. When infected 
individually, the mice showed only 10% mortality compared to 60% when 
both organisms were present. Evidence from this study also suggested that 
metabolites of anaerobes act to boost the growth rate of the streptococcus 
spp. by acting as a barrier to any bactericidal action from the host Also, 
Kuriyama et a l (2000) showed that S. constellatus behaved synergistically 
in the presence of Fusobacterium nucleatum.
1.4.2.1 Oral infection
A dentoalveolar abscess usually develops by the extension of the initial 
carious lesion into dentine, and spread of bacteria to the pulp via the 
dentinal tubules. Once pus formation occurs, an acute or chronic abscess 
forms and may develop into focal osteomyelitis; or spread into the 
surrounding tissues (Samaranayake, 2001).
As mentioned, the association of SAG with dental abscess formation was 
first described by Guthof (1956). Fisher and Russell (1993) examined 45 
samples from dental periapical abscesses and identified 15 as S', anginosus 
and one as S. intermedius. Okayama et al. (2005) examined the abscess- 
forming ability of native human dental plaque in mice and the microbial 
features of the infectious locus produced by the plaque. The microbial 
composition of pus was examined in 17 of 76 abscesses. Of these 17 cases, 
the majority of isolates belonged to the SAG. S. anginosus was the most 
frequently detected (76.5%), and S. intermedius (47.1%) and S. constellatus 
(35.3%) were predominant in abscess samples. Siqueira et al. (2002) 
studied the microbiology of primary root canal infections of 53 teeth. The
most prevalent bacterial species found were members of the SAG. With 
regard to asymptomatic lesions, the most dominant species were S. 
intermedius (11.5% of cases) and S. anginosus (7.7% of cases), whereas S. 
constellatus was the most common species within pus samples (25.9% of 
cases).
1.4.2.2 Non-oral SAG infections
The SAG are also associated with a range of other infections, including 
brain and liver abscesses, meningitis, infective endocarditis, obstetrical 
infections and neonatal sepsis. It has been found that S. anginosus is more 
frequently associated with abdominal and urogenital sites than the other 
two species, whereas S. intermedius was frequently isolated from purulent 
head and neck specimens and liver abscesses (Bantar et al, 1996). S. 
constellatus has been isolated from abdominal and respiratory tract 
infections (Whiley et al., 1992).
Cardiothoracic infections
The SAG are significant pulmonary pathogens and are associated with 
thoracic infection, such as pneumonia, purulent empyema and lung abscess 
(Wong et al., 1995). Thoracic infection resulting from secondary spread 
due to abscess formation elsewhere within the body has been reported, thus 
the SAG appear to have a propensity to spread haematogenously via the 
bloodstream (Molina et al., 1991)
Microaerophilic streptococci account for 10-20% of anaerobic isolates 
recovered from properly obtained samples of pulmonary infections (Cade
et al., 1999). Wong et a l (1995) identified twenty-five cases of pulmonary 
disease caused by SAG, including 16 empyema, five lung abscesses, and 
four with both lung abscess and empyema. Predisposing factors were 
present in 80% of patients and included the following: pneumonia, 
periodontal disease, excess alcohol intake, previous thoracic surgical 
procedures, and malignancy. Recently, Woo et al (2004) reported SAG- 
associated cases of infective endocarditis caused by S. anginosus. Two out 
of the 6 cases had had previous oral intervention procedures, such as tooth 
extraction. However, limited data exists on infective endocarditis due to the 
SMG (Lefort et al, 2002).
Bacteraemia
In a prospective study of bacteraemia caused by SAG, Casariego et al 
(1996) observed 32 patients over a 7-year period. The majority (84.7%) of 
SMG bacteraemia cases were shown to be monomicrobial. The species 
isolated were S. constellatus (n=14), S. intermedius (n=14) and S. 
anginosus (n=4) of the sample population, 69% were male with a mean age 
of 64 years. One or more underlying diseases or factors were present in 
47% of the patients, including neoplasia, diabetes mellitus, chronic 
alcoholism, chronic renal failure, glucocorticoid therapy and 
granulocytopenia. In eleven of these patients, a possible origin of infection 
was odontogenic infection. Other causes were biliary or gastrointestinal 
disease and/or abdominal surgery, observed in seventeen patients. Tsai et 
al (2004) reported a case of S. constellatus bacteraemia that resulted in the 
rare complications of myocardial abscess and cerebritis.
Skin and soft tissue infections
Within direct skin and soft tissue injuries, SAG are generally isolated in 
mixed culture with other aerobic and anaerobic species. Humar et al., 2002, 
reported three cases of necrotising soft tissue infection, resembling group A 
streptococcus disease, but which were caused by a p-haemolytic group G 
streptococcus belonging to the SMG. There was a severe underlying 
medical condition present in each case.
1.4.3 Pathogenic mechanisms of the Streptococcus anginosus 
group
The pathogenic mechanisms of the SAG are unclear. It is important to note 
that the outcome of the interaction between a mammalian host and an 
invading bacterium depends on interplay between a constellation of host 
defences and microbial virulence factors. These virulence factors include 
the ability to target and colonise an appropriate tissue surface by specific 
adhesion, produce toxins, and to resist the immune defences of the host 
(Klemm and Schembri, 2000).
1.4.3.1 Adherence
The SAG surface properties have been investigated in the context of 
adherence and surface binding. Importantly, any receptor-binding event 
may activate complex signal transduction events in the host cell that can 
have diverse consequences including the activation or alteration of innate 
host defences or the subversion of cellular processes facilitating bacterial 
colonisation or invasion. In addition, the binding event may also activate
1.4.3.1.1 Surface-associated proteins involved in adherence
Many bacteria possess adhesins on their surfaces that bind in a 
stereochemically specific manner to complementary molecules, or 
receptors, on the tissue surface. Most bacterial species express several 
types of adhesins (Gibbons, 1989). In many instances, adhesins assemble 
into hair-like appendages called pili or fimbriae that extend out from the 
bacterial surface. In other cases, the adhesins are directly associated with 
the microbial cell surface (Soto and Hultgren, 1999).
Willcox and Knox, (1990) studied the adherence characteristics of the 
SAG that are possibly associated with pathogenicity and compared them to 
type strains of other streptococci. They found that abscess related strains 
adhered to buccal epithelial cells to a greater extent than commensal 
strains. It was also reported in this study that the SMG were not readily 
aggregated by human saliva and exhibited low levels of binding to 
hydroxyapatite. Later, Willcox (1995) and Willcox et al. (1995a) reported 
that all SAG strains studied bound fibronectin via a cell-surface protein. 
These strains also bound to platelet fibrin or fibrin clots and fibrinogen, 
and members of the S. constellatus species produced thrombin-like 
activity. Subsequently, a fibronectin receptor from S. anginosus strain F4 
was characterised as a 14-kDa protein, exhibiting specific binding.
Oral streptococci express a family of structurally and antigenically related 
surface proteins termed antigen I/II, which are capable of binding to 
soluble ECM glycoproteins and to host cell receptors. They are also 
responsible for co-aggregation with other microbes, interaction with
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salivary glycoproteins and activation of monocytic cells (Jenkinson and 
Demuth, 1997; Petersen et al., 2001). S. intermedius antigen I/II proteins 
have been investigated with regard to adhesive properties. Petersen et a l 
(2002) demonstrated antigen I/II of S. intermedius was not involved in 
adhesion to a salivary film under flowing conditions. Also, adhesion to 
collagen types IV or I was negligible whereas binding to human 
fibronectin was a common function. Hydrophobicity was unaltered, as 
measured by water contact angles and zeta potentials (Petersen et al, 
2002).
Allen et a l (2002) studied the adherence of S. intermedius and S. 
anginosus adherence in the initial stages of native valve endocarditis. Using 
an in vitro endothelial monolayer model to mimic in vivo areas of exposed 
basement membrane, components of the ECM were utilised as receptors for 
bacterial adhesion. They demonstrated binding of both SAG species to 
laminin, fibronectin, fibrinogen, and collagens type I and IV. S. anginosus 
(an IE-associated blood isolate) exhibited a higher level of adherence to all
of the matrix components and laminin in particular.
\
1.4.3.2 Enzyme and toxin production
Production of tissue destroying enzymes and extracellular products have 
been observed as virulence factors in these bacteria (Willcox et al, 1995b; 
Jacobs and Stobberingh, 1995).
Strauss and Falkow (1977) described a strain of S. intermedius from a case 
of infective endocarditis (hat produced several extracellular enzymes with
proteolytic activity. The growth of this strain, in conditions mimicking a 
fibrotic heart lesion, resulted in a 4-8 fold increase in proteinases 
compared with controls. More recently, intermedilysin (ILY) is a human 
specific cytolysin, and its distribution amongst the SAG has been studied. 
Nagamune et a l (1996) first recognised ILY as a cytotoxin responsible for 
haemolysis caused by the SAG. PCR and Southern hybridisation specific 
for the ILY gene revealed the toxin gene exists only in S. intermedius and 
there is no homologue to the toxin gene in S. constellatus or S. anginosus. 
ILY production was found to be greater in isolates from deep-seated 
infections, such as brain and liver abscesses (6.2- to 10.2-fold, 
respectively), than in commensal strains from dental plaque or peripheral 
infection sites. This toxin also affects human red blood cells and causes the 
lysis of phagocytes. The authors suggested that ILY could be the 
pathogenic or triggering factor of significance in inducing deep-seated 
infections with S. intermedius (Nagamune et al., 2000).
Other bacterial enzymes include glycosidases, which remove terminal 
sugar residues from naturally occurring polysaccharides and glycoproteins 
(Whiley et al, 1990). Glycosaminoglycan (GAG) depolymerising enzymes 
such as hyaluronidase (HAase) degrade connective tissue components. HA 
contributes to the elastic properties of soft tissues, and is present in many 
tissues including gingivae tissues and heart valves. HAase production 
degrades HA and has been detected in S. intermedius and S. constellatus, 
with increased levels of activity in the former (Takao et al., 1997). This 
enzyme is valuable in the discrimination of these species from S. 
anginosus, which is unable to degrade HA (Whiley et al, 1990). Shain et
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al (1996) suggested that the role of HAase was as a proliferator for the 
SAG in pyogenic infection due to its destruction of the extracellular matrix 
whilst releasing carbohydrates useful for bacterial metabolism. S. 
intermedius spreads very rapidly through the soft tissues, presumably 
because of its ability to produce HAase and streptokinase to break down 
ground substance and fibrin (Green et al, 2001). Poole and Wilson (1979) 
showed a positive association between HAase production in SAG and 
haemolysis. HAase production was most frequent in P-haemolytic strains 
of Lancefield groups A, C and F. Strains of SAG isolated from systemic 
abscesses and dental plaque produced type IV HAase. Unsworth (1989) 
showed significant HAase production in SAG strains isolated from abscess 
sites, and strains from sites of deep seated infection had a higher frequency 
of HAase production than strains isolated from surface sites. Takao (2003) 
cloned and expressed hyaluronate genes and reported HAse is possibly 
anchored to the cell surface in S. intermedius and S. constellatus.
Chondroitin sulphate depolymerase (CSase) is capable of breaking down 
the GAG CS in tissue structures to release carbohydrates that can be 
utilised metabolically, and contribute to the “spreading” of 
microorganisms. Homer et al. (1993) reported that strains of S. 
intermedius produced CSase when the organisms were cultured in the 
presence of the GAG, suggesting that the enzyme is inducible. Jacobs and 
Stobberingh (1995) also examined the link between the SAG and CSase 
production. They demonstrated that only certain strains of S. intermedius 
and S. constellatus, isolated from suppurative infection, produced the 
enzyme. Shain et al, (1996) observed S. intermedius readily manufactured
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an A form of the enzyme when grown in the presence of chondroitin 
sulphate A. The production of the enzyme became inhibited in the 
presence of glucose, as this was more easily broken-down.
Bacterial sialidases are enzymes that cleave terminal non-reducing sialic 
acid residues from sialoglycoconjugates. This mechanism may represent a 
virulence factor in the exposure of cryptic carbohydrate binding sites on 
host cells to which invading organisms may attach (Gibbons et al., 1990). 
The action of this enzyme may allow the breakdown of the mucosal 
defence barriers of the host in addition to freeing sialic acid as a 
fermentable carbohydrate (Corfield, 1992). Beighton and Whiley (1990) 
detected sialidase activity in all three species of the SAG. However, they 
did not detect any activity in many other species of oral streptococci such 
as S. parasanguis, S.salivarius, S. vestibular is, S. sanguis, S. mutans, S. 
mitis or S. sobrinus.
The production of nucleases (DNase and RNase), collagenase and 
gelatinase is documented for the SAG (Steffen and Hentges, 1981; 
Marshall and Kauffman, 1981). Most bacteria produce nucleases (DNase 
and RNase) in order to defend themselves against other species. Jacobs 
and Stobberingh, (1995) established that of the three SAG species, S. 
intermedius and S. constellatus produce nuclease enzymes and that DNase 
is only detected in those strains isolated from sites of infection. In 1998, 
Dedkov and Degtyarev isolated novel restriction endonucleases from 
bacteria of the microflora of human teeth. The main producers were S. 
milleri along with Actinobacillus suis. The new enzymes were
isoschizomers of the restriction endonucleases R. HphI, R. Saul, R. Nhel, 
R. Mbol and R. Swal
1.4.3.3 Avoidance of the host response
The way in which a host responds to bacteria is determined by the nature 
and control of both the innate and adaptive responses. The host response to 
bacteria and their activities is dominated by the heavy infiltration of 
neutrophils into the surrounding tissues, which contributes both to the 
elimination of bacteria and the destruction of host tissue. The innate 
immune response may be responsible for a significant amount of damage to 
surrounding tissue. This is via the release of inflammatory mediators and 
cytokines, which leads to increased inflammation (Seymour and Taylor, 
2004).
SAG exhibit a striking propensity for abscess formation (Wanahita et al, 
2001) and systemic illness, suggesting they are capable of withstanding the 
host response in order to disseminate within the body (Gossling, 1988). 
This ability may be related to the pathogenicity of the SAG and hereby 
follows a summary of the potential mechanisms underlying this important 
property (Willcox, 1995; Corredoira et al, 1998).
Some streptococcal surface structures and extracellular products have 
been found to possess immuno-protective properties (Edwards et al.,
2003). As well as adherent properties, antigen I /II has been shown to 
display antibody suppressive traits (Jenkinson and Demuth, 1997). 
Evidence has emerged to show that some strains of SAG have the ability
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to produce extracellular products with the ability to reduce the 
effectiveness of the immune system. Higerd et al. (1978) were the first to 
identify an extracellular product named EP-Si. This protein suppressed 
fibroblast formation and altered lymphocytic response in-vivo. Arala- 
Chaves et a l (1979) expanded on this by examining the extract and found 
an immunosuppressive non-cytotoxic protein named F3’ EP-Si. This 
protein could induce T-cell suppressor lymphocytes and possess B-cell 
mitogenic activity (Arala-Chaves et al., 1981). Limia et a l (1992) re­
named this protein P90. Their studies indicated that treating mice with P 
90 made them 50-fold more vulnerable to infection with strains of S. 
intermedius. B-cells obtained from these mice were less able to respond to 
antigenic challenge, and furthermore, T-cells actively suppressed the 
specific immune response produced by B-cells. However, a much higher 
concentration of P 90 was utilised in this study, than S. intermedius would 
actually be able to produce in vivo.
Virulent SAG strains appear highly resistant to phagocytosis by human 
polymorphonuclear neutrophils (PMNs). Wanahita et al, (2002) examined 
the interaction of SMG with human PMNs. More specifically, the 
pathogenicity of S. constellatus in pulmonary infections was investigated 
in mice in correlation with the phagocytic killing of the microorganisms 
by PMNs. Histological inflammation score of the lungs in mice inoculated 
with RZYK001 (virulent strain obtained from bronchoalveolar fluid of a 
pneumonia patient) was significantly higher than in mice inoculated with 
RT4303 and RT6002 (non-virulent strains obtained from saliva of healthy 
adults). This suggests a ppssible pathogenic mechanism of S. constellatus,
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as a virulent strain is less likely to be killed than a non-virulent strain, 
predisposing it to survive in infection sites (Toyoda et al, 1995). Okayama 
et al. (2005) demonstrated all three SAG species, isolated from dental 
plaque induced abscesses in mice, possessed high anti-phagocytic 
capacities against human PMNs in the presence of complement. This was 
in comparison to a strain of Staphylococcus aureus, a well-known 
abscess-inducing pathogen, which was killed. Furthermore, S. intermedius 
produces the human erythrocyte-lytic enzyme ILY, which has the 
capability to lyse human PMNs (Macey et al., 2001). Such a direct effect 
of ILY could support bacterial survival by reducing the number of intact 
PMNs.
Capsules are a well-established virulence factor as encapsulated bacterial 
cells have increased resistance to cellular phagocytosis and offer a degree 
of protection against serum antibodies when in the host (Kanamori et al.,
2004). A small number of SAG have been isolated with capsules, although 
their structure is unknown. Brook and Walker (1985) documented that 
encapsulated SAG strains induced pyogenic abscesses when injected into 
mice, while strains without capsules required the presence of a capsulated 
organism to do so. In addition, Lewis et al. (1988) demonstrated that 
encapsulated SAG strains are capable of inducing abscesses in pure 
culture, and demonstrated the isolation of encapsulated strains from 
dentoalveolar abscesses. Recently, Kanamori et a l (2004) studied the 
pathogenicity of encapsulated strains of the SAG by examination of the 
ability to cause subcutaneous abscesses in mice and by phagocytosis and 
phagocytic killing by human PMNs of the bacteria. Three encapsulated
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isolates from patients with pneumonia or lung abscesses induced 
abscesses in mice, whereas only 2 of 20 unencapsulated isolates from 
patients with lung abscess or phagocytosis and phagocytic killing of 
PMNs to a greater extent than the unencapsulated forms.
Platelet aggregation is important in the induction and progression of 
endocarditis and, maybe in abscess formation, whereby bacteria are 
localized in a platelet / fibrin clot (Willcox et al., 1994). Willcox et a l 
(1994) reported that Lancefield group C members of the SAG aggregated 
human platelets. The platelet-interacting substance on the surface of SAG 
appeared to be proteinaceous as digestion of cells with protease inhibited 
aggregation, whereas treatment with lipase, periodate or antisera to 
Lancefield group C polysaccharide had no effect. Willcox (1995) also 
observed certain strains of the SAG produced thrombin. Thrombin 
converts fibrinogen to fibrin to produce blood clotting, therefore the SAG 
may produce clotting to seal off areas of systemic colonisation and leads to 
a platelet/fibrin clot, effectively producing a pyogenic abscess structure, 
which in turn serves to offer protection from the circulating host defences.
1.5 Aims of thesis
The above review has highlighted the importance of the ECM 
components, such as PGs and GAGs, in both healthy and diseased 
periodontium. Furthermore, the numerous studies on the potential 
adherence mechanisms and virulence factors of the SAG, suggest that 
periapical abscesses caused by these bacteria is complex, therefore a better 
understanding of host-SMG interactions is essential. The aims of this
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thesis were investigate the disease process caused by SAG, from initial 
adherence to host ECM components through to the potential SAG 
virulence factors that may affect, or be affected, by certain cellular 
components of host tissues.
The specific aims of this thesis were to;
1) investigate the interactions of SAG, with characterised recombinant 
decorin and biglycan from a mammalian protein expression system and 
mixed decorin and biglycan from ovine tissues, utilising real-time bio­
specific interactions;
2) observe the effects of SAG on periodontal ligament fibroblasts and 
endothelial cells;
3) observe the effects of ECM on SAG.
/
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Chapter 2
Isolation, purification and characterisation of the small leucine-rich 
proteoglycans, decorin and biglycan.
2.1 Introduction
The SLRPs are a family of ECM molecules characterised by the presence 
of tandem leucine-rich repeats flanked by disulphides. Within this family, 
variation is brought about through the number of leucine-rich repeats, 
amino acid substitutions, and differences in glycosylation (Iozzo, 1997). 
Most investigations have focused upon the Class I SLRPs decorin and 
biglycan. These PGs have been ascribed many roles within the ECM. 
Studies involving decorin have highlighted numerous potential binding 
domains, such as those for collagen and TGF-P, which are important in 
matrix formation, cell proliferation, and differentiation (Hildebrand et al., 
1994; Schonherr et al., 1995, 1998; Kresse and Schonherr, 2001). 
Biglycan has not been as widely studied as decorin, but it has been 
ascribed roles in cellular signalling and mineralisation. The role of 
biglycan in osteogenesis is apparent (Xu et al., 1998), where it also binds 
TGF-p and regulates crystal growth (Hildebrand et al., 1994). The use of 
knockout models has highlighted the importance of both decorin and 
biglycan in connective tissue formation. The single decorin knockout 
mouse showed fragile skin and reduced tensile strength (Danielson et al., 
1997) and the biglycan knockout mouse possessed an osteoporosis-like 
phenotype, representing a decrease in bone mass that correlates with the 
lack of biglycan (Xu et al., 1998). The double knockout mouse produced a
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severe phenotype, one that could not breed. The bone phenotype was more 
severe than for the single knockout mice with dramatic changes in 
collagen fibril formation (Corsi et al., 2002).
Recent advances in molecular techniques have allowed for the genetic 
analysis of PGs, including decorin and biglycan. These analyses have 
provided valuable insights into the functional regulation of PGs. Despite 
representing different gene products, the primary structure of decorin and 
biglycan are very closely related. In humans, both SLRPs are encoded by 
genes composed of eight exons and seven introns. Decorin is mapped to 
chromosome 12q23 (Vetter et al.} 1993) and biglycan is located on Xq28 
(Fisher et al., 1991). Of significance in functional studies is that decorin 
and biglycan genes are highly conserved across different species 
(Scholzen et al., 1994).
Structural and functional studies of PG domains can be facilitated by the 
isolation and purification of native PG. Most current procedures for 
isolation of PGs from mineralised and soft tissues require sequential 
dissociative extraction and fractionation techniques. Previous 
investigations involving the extraction of ECM components include anion- 
exchange and affinity chromatography (Fisher et al., 1987, Waddington et 
al., 1989, Waddington and Embery, 1991). Due to the highly anionic 
nature of PGs, anion-exchange chromatography has been extensively used 
in their purification, particularly for mineralised tissues. The technique 
relies upon the use of chaotrophic agents and strict anionic conditions to
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facilitate the separation of these proteins. A number of further purification 
procedures have been used as a final purification stage, to ensure the 
purity of the isolated protein species. These procedures include a second 
anion exchange chromatography step, gel filtration chromatography or 
hydroyapatite chromatography. PGs, including decorin and biglycan, have 
been isolated from many tissues by chromatographic methods, including 
ovine gingiva and alveolar bone (Moseley, 1996), pig knee menisci (Scott 
et al., 1997), and predentine, the transitional phase at the predentine- 
dentine interface, and mineralised dentine (Milan et al., 2005).
In this study, ovine tissues were used to isolate and purify PGs from 
alveolar bone and gingiva. The choice sample tissue is important in PG 
analyses. Domestic sheep suffer a naturally occurring form of periodontitis 
called ‘broken-mouth’, which can cause the premature spontaneous 
exfoliation of teeth (Spence et al, 1988). The oral microbial flora in 
periodontally diseased sheep from many countries is consistent with 
findings from humans with periodontitis (McCourtie et al., 1990; Dreyer 
and Basson, 1992). Duncan et a l (2003) were able to demonstrate that 
clinical, microbiological (P. gingivalis, P. intermedius and F. nucleatum) 
and serological characteristics (increased IgG titres to bacterial strains) of 
sheep oral infections have important similarities to human oral infections, 
thereby suggesting ovine tissue sources can be utilised for human 
research.
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However, components with similar structures within tissues, such as 
decorin and biglycan, have proved difficult to isolate alone and hence 
mixed protein preparations are often obtained, although they have been 
reasonably well separated from collagen, glycoproteins and 
phosphoproteins. Hydrophobic separation of these PGs has been 
unsuccessful for mineralised tissues in past studies (personal 
communication with R. J. Waddington). Therefore, an alternative method 
to tissue extraction is the use of recombinant protein expression systems. 
These systems overcome the problem of mixed protein preparations so 
relatively pure decorin or biglycan preparations inclusive of the GAG 
chains can be obtained (Hocking et al., 1996; Ramamurthy et al., 1997; 
Sugars, 2001). The development of such systems has allowed the synthesis 
of proteins with an epitope tag, usually six consecutive histidine residues. 
The purification of these recombinant proteins can therefore utilise nickel 
affinity chromatography, which is a rapid procedure, achieving a highly 
purified protein in a single step (Crowe et al., 1996). Many studies have 
used recombinant expression systems to study the interactions of decorin 
and biglycan with other ECM components, mainly the interactions with 
collagen type I (Schonherr et al., 1995; Ramamurthy et al., 1996; 
Krishnan et al., 1999; Sugars, 2001).
This chapter describes the procedures used for the extraction, purification 
and characterisation of SLRPs from ovine alveolar bone and gingival 
tissues. It also describes the purification and characterisation of a 
previously developed recombinant mammalian protein expression system
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(Sugars, 2001), to ensure this system is sustaining the production of large 
quantities of highly pure intact decorin and biglycan. These purified PGs 
will be utilised to examine specific interactions with the SAG, studied 
through biomolecular interaction analysis, in order to produce a successful 
model for studying host-microbial interactions in relation to infection 
caused by SAG, primary* interactions which could progress into periapical 
abscess formation.
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2.2 Materials and methods
2.2.1 Source of periodontal proteoglycans
Nine-month-old Welsh Mule breed sheep, which had been slaughtered at a 
local abattoir within the previous l-2hr, were decapitated and the heads 
collected from the abattoir on request. The heads were stored on dry ice 
(BOC Gases Ltd., Surrey, UK) on the journey to the Cardiff Dental School 
and then stored at -20°C, until required for dissection. The gingiva was 
dissected l-2mm below the gingival-tooth junction from around the upper 
and lower dentition and sliced into smaller pieces with a scalpel. The ovine 
gingival tissue exhibited no signs of gingival recession or inflammation 
and therefore was regarded as relatively healthy. The molar and premolar 
teeth were extracted from both the maxillae and mandibles using a dental 
drill with a circular saw, followed by excision with a surgical chisel and 
hammer. The alveolar bone was removed from around the roots of the 
extracted teeth and from the immediate areas around the sockets of these 
teeth using a surgical chisel and hammer. All the alveolar bone and 
gingival tissue collected was stored at -20°C until required.
2.2.2 Isolation of non-collagenous extracts from alveolar bone
The PGs were isolated from the ovine alveolar bone according to the 
method of Waddington and Embery (1991). Non-collagenous material was 
removed from small alveolar bone pieces with 4M guanidinium chloride 
(GuC12), 0.05M sodium acetate, pH 5.9. The cleaned alveolar bone was 
successively washed twice in ethanol, to dehydrate the tissue, followed by
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diethyl ether for lOmin, to remove lipids. The alveolar bone pieces were 
left at room temperature for the residual solvent to evaporate.
The alveolar bone was immersed in liquid nitrogen and powdered in an 
oscillating ball mill. The powdered bone was placed in dialysis sacs 
(Scientific Instrument Centre Ltd, Hampshire, UK), together with 10% 
EDTA (trisodium salt) solution, pH 7.45. The dialysis sacs with a 
molecular weight cut off of 12-14kDa were suspended in 51 of 10% EDTA 
solution, pH 7.45, containing the protease inhibitors benzamidine 
hydrochloride (5mM), iodoacetic acid (ImM) and N-ethylmaleimide 
(5mM), and left at 4°C for 13 days to demineralise, with 2 changes of the 
EDTA solution. EDTA was removed from the sample by exhaustive 
dialysis against 51 of double distilled water (ddH20) with protease 
inhibitors (as above) for 4 days, changing the ddH20 twice a day, and a 
final day of ddH20 with no protease inhibitors. The demineralised bone 
was recovered by lyophilisation.
The crude non-collagenous tissue components containing the PG were 
extracted into 4M GuCk, 0.05M sodium acetate buffer, pH 5.9, containing 
protease inhibitors (as above), at 4°C for 48h under constant agitation. The 
extract was centrifuged at 1800g for 15 min. The supernatant, containing 
the non-collagenous proteins, was recovered and dialysed against ddH2 0  
with protease inhibitors (as above) followed by 1 day with ddH2 0  only and 
then recovered by lyophilisation.
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2.2.3 Isolation of non-collagenous extracts from gingival tissue
The gingival tissue was briefly washed in phosphate buffered saline (PBS) 
then sequentially washed twice in ethanol, followed by diethyl ether for 10 
min and left at room temperature for the remaining solvent to evaporate. 
The non-collagenous gingival tissue components were extracted into 4M 
GuCb, 0.05M sodium acetate buffer, pH 5.9, containing protease 
inhibitors (as in section 2.2.2) at 4°C for 48h under constant agitation. The 
extract was centrifuged at 1800g for 15 min and the supernatant, 
containing the non-collagenous proteins, was dialysed against ddH2 0  
followed by 1 day with ddH2 0  only, and then recovered by lyophilisation.
2.2.4 Purification and identification of proteoglycans from ovine and 
gingival tissue extracts
2.2.4.1 Q-Sepharose Anion Exchange Chromatography
The crude alveolar bone and gingival tissue non-collagenous protein
extracts were dissolved in 7M urea, 0.05M sodium acetate buffer, pH 6.8, 
at a concentration of lOmg/ml. Samples (1ml) of the dissolved tissue 
extracts were applied to a Q-Sepharose column (Sigma), integrated into a 
fast performance anion exchange chromatography system (Amersham 
Pharmacia Biotech, UK), and eluted with 7M urea, 0.05 M sodium acetate 
buffer, pH 6.8. The bound material was selectively eluted with an 
increasing linear sodium chloride gradient to a concentration of 1M, at a 
rate of 2ml/min. The eluant was continuously monitored at 280nm and 4ml 
fractions were collected over a 240ml period. Larger fractions were pooled 
according to the protein peaks identified in the 280nm profile.
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The pooled fractions were dialysed against ddtfeO with protease inhibitors 
(as in section 2.2.2) and recovered by lyophilisation. Samples were stored 
at -20°C until required. Those fractions containing PG were characterised 
using dot blot analysis for CS (section 2.2.4.2), and SDS-PAGE (section 
2.2.4.3) followed by silver staining (section 2.2.4.4).
2.2.4.2. Immuno-identification of PG-rich fractions by 
glycosaminoglycan dot blot analysis
To determine the PG-rich fractions obtained following chromatography, 
each pooled fraction was subjected to dot blot analysis. Pooled protein 
fractions were examined by dot blot analysis to quickly determine those 
samples that contained the CS GAG chains, lp l of each of the pooled 
fraction samples (lOmg/ml) were directly dotted onto a PVDF membrane 
(Hybond™ C, Amersham Pharmacia Biotech). The membrane was 
blocked in 10% non-fat milk (Marvel™), in TBS (lOmM tris-HCl, pH 7.4 
and 0.9% sodium chloride), for 30 min to prevent non-specific binding. 
Subsequent incubation in mouse anti-CS-56 (detailed in table 2.1) diluted 
in 3% non-fat milk in TBS for 30 min, was followed by three 5min washes 
of TBS. The membrane was subsequently incubated with a secondary 
antibody, anti-mouse IgM (detailed in table 2.1), conjugated to alkaline 
phosphatase, diluted in 3% non-fat milk in TBS, for 1 h. The membrane 
was washed for a further three times in TBS, lOmin each wash.
Immunoreactivity was visualised by incubation of the membrane with 
NBT/BCIP chromogenic substrate (Promega). Briefly, the membrane was 
submerged with 10ml alkaline phosphatase buffer (lOOmM Tris, lOOmM
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sodium chloride, 5mM magnesium chloride, pH 9.55) containing 66pl 
NBT substrate (50mg/ml nitroblue tetrazolium in 70% 
dimethylformamide) and 33 j l i 1 BCIP substrate (50mg/ml 5-bromo-4- 
chloro-3-inodyl phosphate in dimethylformamide) (Promega). Dark bands 
were allowed to develop (10-20min) and the reaction stopped by washing 
in ddH20. Membranes were air-dried.
2.2.4.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS- 
PAGE) was utilised to determine the molecular weight of the purified PG 
and to assess the purity of the samples. This technique was performed on 
the Phast™ System (Amersham Pharmacia Biotech), which provided a 
rapid separation of small sample volumes, providing highly reproducible 
and highly sensitive results.
PG samples were lyophilised and dissolved to a concentration of lOmg/ml 
in dissociating sample buffer (0.062M tris-HCl, pH 6.8, 10% glycerol, 2% 
SDS, 5% 2-P-mercaptoethanol, 0.002% bromophenol) and samples were 
heated to 100°C for 5min.
3cm2 preformed 4-15% gradient gels (Amersham Pharmacia Biotech) were 
positioned horizontally onto 70pl d d ^ O  on a separation bed, pre-cooled 
to 16°C. SDS buffer strips (Amersham Pharmacia Biotech) were placed 
into the anode and cathode compartments and lp l samples were applied to 
the applicator comb and inserted into the applicator arm. Each gel
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contained the separation of a molecular weight marker (Sigma Chem. Co.) 
containing carbonic anhydrase (29kDa), ovalbumin (45kDa), bovine serum 
albumin (66kDa), phosphorylase B (97.4kDa), p-galactose (116kDa) and 
myosin (205kDa). Two separation phases were carried out, an initial low 
output current (100V, 1mA, 1W, 4Vh), followed by a higher output step 
(250V, 10mA, 3W, 66Vh).
2.2.4.4 Silver staining
Silver staining of polyacrylamide gels is a highly sensitive visualisation 
technique that allows for the detection of protein in the nanogram range. A 
commercially prepared Phast System Silver Stain Kit (Amersham 
Pharmacia Biotech) was used for this procedure. Gels were washed with 
10% ethanol / 5% acetic acid for 6min, with a change of solution after 
2min. The gels were transferred to fixing buffer (4% background reducer 
(described below), 0.05% glutaraldehyde, 28.5% ethanol, 1.5% 
isopropanol, 3% sodium acetate, 56% ddfkO) for 6min and then returned 
to ethanol / acetic acid solution for 8min, with the solution changed after 
3min. Gels were rinsed twice in ddl^O (2min each wash) before placing 
in 0.4% silver nitrate solution for 6.5min. Two subsequent washes 30sec 
washes with ddffeO were followed by incubation in developer solution 
(0.013% formaldehyde ip 2.5% sodium carbonate) for lmin. Gels were 
placed in fresh developer until bands appeared. Development was stopped 
by replacing the solution with background reducer (0.016% sodium 
thiosulphate, 0.355% Tris) for 2min. Gels were then fixed in 2% glycerol 
for lhr and left to air dry.
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2.2.4.5 Resource-Q Anion Exchange Chromatography
Previous studies have indicated that PGs co-elute with other matrix 
proteins such as soluble collagens and CX2HSG protein (Sugars, 2001). To 
further purify the PGs from any remaining anionic glycoconjugate species, 
the separated alveolar bone and gingival PG rich fractions were 
redissolved in 7M urea, 0.05M Tris-HCl buffer, pH 6.8, to a concentration 
of 5mg/ml. 1ml samples were applied to a Resource Q column 
(Pharmacia) integrated into a fast performance anion exchange 
chromatography system (Pharmacia). Unbound material eluted at room 
temperature with 7M urea, 0.05M Tris-HCl buffer, pH 6.8. The bound 
material was removed with an increasing linear sodium chloride gradient 
to a concentration of 2M. The eluant was continuously monitored at 
280nm and 2ml fractions were pooled over a 35ml period. Larger fractions 
were pooled according to the 280nm profile produced. The samples were 
then dialysed against ddH2 0  (as in section 2.2.2), recovered by 
lyophilisation, and PG-rich fractions identified through dot blot analysis 
(section 2.2.4.2) and SDS-PAGE analysis (section 2.2.4.3) followed by 
silver staining (section 2.2.4.4).
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Table 2.1. Antibodies utilised in immuno-detection of ovine gingival and 
alveolar bone proteoglycans, recombinant proteoglycans and chondroitin 
sulphate glycosaminoglycan
Prim ary antibody Epitope Secondary antibody Reference
Anti-decorin
LF-113
(Recombinant decorin)
Raised against 
sequence 
IIPVDPDNPLIMC 
located in the N-terminal 
of mouse decorin
Goat anti-rabbit IgG 
whole molecule 
conjugated to horse 
radish peroxidase/ 
alkaline phosphatase
Fisher et al., 1995
Anti-decorin
LF-122
(Ovine decorin)
Recombinant protein 
including propeptide
Goat anti-rabbit IgG 
whole molecule 
conjugated to horse 
radish peroxidase/ 
alkaline phosphatase
Fisher etal., 1995
Anti-biglycan
LF-106
(Recombinant biglycan)
Raised against 
sequence 
VPDLDSVTPTFS 
located in the N-terminal 
of mouse bilycan
Goat anti-rabbit IgG 
whole molecule 
conjugated to horse 
radish peroxidase/ 
alkaline phosphatase
Fisher etal., 1995
Anti-biglycan
LF-51
(Ovine biglycan)
Raisd against 
sequence 
GVLDPDSVTPTYSA-[BSA]
Goat anti-rabbit IgG 
whole molecule 
conjugated to horse 
radish peroxidase/ 
alkaline phosphatase
Fisher et al., 1989
Anti-chondrotin sulphate 
CS-56
Monoclonal antibody 
specific for CS- 
containing PG
Goat anti-mouse IgM 
conjugated to 
alkaline phosphatase
Anvur & Geiger, 1984
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2,2.5 Isolation of recombinant proteoglycans
A previously established HeLa cell line (a human epithelial carcinoma cell 
line) transfected with vectors carrying complementary DNA (cDNA) for 
either decorin or biglycan were used. Briefly, murine cDNA for decorin 
and biglycan were cloned into a mammalian protein expression vector, 
pcDNA3.1 myc/his, followed by liposomal transfection into the HeLa cells. 
The vector facilitated the expression of either recombinant decorin or 
biglycan synthesised with a fusion of six-histidines (His-tag), attached to 
the C-terminus (Sugars, 2001).
HeLa cells were cultured in Eagles Minimum Essential Medium (EMEM) 
with Earles Balanced Salt Solution (EBSS), supplemented with 2mM 
glutamine, 1% antibiotic/antimycotic solution and 2% foetal bovine serum 
(FBS). The cells incubated at 37°C, in 5% carbon dioxide (CO2), with the 
media changed every two days, retained and stored at -20°C until required.
2.2.5.1 Purification of recombinant proteoglycans by poly-histidine tag 
nickel affinity chromatography
The presence of the His-tag allowed for purification by nickel affinity 
chromatography. HiTrap chelating 1ml columns (Amersham Pharmacia 
Biotech) were used to purify recombinant decorin and biglycan directly 
from tissue culture media. The lyophilised sample was reconstituted to a 
concentration of lOmg/ml in 0.02M sodium phosphate buffer, pH 7.4 
containing 0.5M sodium chloride.
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HiTrap columns were prepared for use by washing with 5ml ddffeO to 
remove any traces of 20% ethanol (used later as storage buffer), using a 
peristaltic pump (Pharmacia LKB) at a flow rate of lml/min. The columns 
were charged by elution with 500pl of 0.1M nickel sulphate (Sigma 
Chemical Co) followed by a further wash of 5ml ddFbO. After charging 
the column, a blank run containing no protein sample, was performed to 
elute any unbound metal ions that may be eluted during the desorption 
stage. The column was equilibrated with 10ml 0.02M sodium phosphate, 
0.5M sodium chloride, pH 7.4 (Sigma Chemical Co.), followed by the 
application of 1ml of sample to the column. The column was then washed 
with 10ml of 0.02M sodium phosphate, 0.5M sodium chloride and lOmM 
imidazole, pH 7.4 (Sigma Chemical Co.). The His-tag containing protein 
was then eluted with 5ml 0.02M sodium phosphate, 0.5M sodium chloride 
and 500mM imidazole, pH 7.4. Imidazole was included within the wash 
buffer and the elution buffer to reduce the non-specific binding and to 
facilitate high elution purity. The column was regenerated with 0.02M 
sodium phosphate, 0.5M sodium chloride, pH 7.4.
The samples were dialysed against ddH20 (as in section 2.2.2) and 
recovered by lyophilisation. The samples were analysed by dot blot for 
CS-GAG (section 2.2.4.2), to identify those fractions containing PG.
2.2.5.2 Further purification of recombinant proteoglycans
Further purification of the isolated recombinant PGs, was performed by 
anion exchange using 1ml Resource Q column as previously described 
(section 2.2.4.5). Recombinant PGs were dissolved in 7M urea, 0.05M tris-
[Type text] 66
[Type text]
HC1 buffer, pH 6.8, to a concentration of lmg/ml, and applied to the 
Resource Q column, and pooled fractions were obtained, according to the 
280nm profile. Samples were dialysed against ddH20 (as in section 2.2.2), 
recovered by lyophilisation and PG rich fractions identified by dot blot 
analysis (section 2.2.4.2).
2.2.6 Protein standardisation
A protein (BCA) assay kit (Pierce Endogen Ltd., Cheshire, UK) was used 
to determine the amount of protein present in the PG-rich fractions. The 
BCA assay was performed in 96 well microplates. Working reagent was 
freshly prepared in 50:1, reagent A:B (supplied in kit). Albumin standards 
(supplied within kit) were prepared to give a 50pg/ml to 1200pg/ml 
concentration range. lOpl of either the standard or sample was pipetted (in 
duplicate) into a well and 190pl of the working reagent added to each of 
the standards or samples and mixed thoroughly. The plate was incubated at 
37°C for 30min, after which, the plate was cooled to room temperature and 
the absorbance taken at 540nm (Microplate autoreader, Bio-Tek 
Instruments). The mean absorbance readings of the standards were plotted 
against protein concentration and the protein concentration (pg/ml) of each 
sample determined. Each PG-rich fraction protein content was then 
adjusted accordingly to each method, by appropriate dilution in ddH2 0 .
2.2.7 Characterisation of the purified intact proteoglycans and core 
proteins
At each stage of the purification process, pooled protein fractions of 
alveolar bone, gingiva and recombinant PGs were examined to identify the
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PG-rich fractions. These fractions were then analysed to characterise the 
purity of both the intact PG and the molecular size of the core protein, 
using SDS-polyacrylamide gel electrophoresis and Western blot analysis.
2.2.7.1 Release of the proteoglycan core protein
To isolate the core proteins of alveolar bone and gingiva, the samples 
were dissolved at lOmg/ml, with 0.1M tris-HCl buffer, 0.03M sodium 
acetate, pH 8. In order to digest the GAG chains from the core protein, an 
equal volume of 2 units/ml chondroitinase ABC (protease free, Seikagku 
Corporation, Tokyo), in the above buffer, was added and incubated at 37°C 
for l-2h.
The digested core protein products were separated from the chondroitinase 
ABC and GAG fragments using gel filtration chromatography on a pre­
packed Sephadex 75 HR 10/30 column (Amersham Pharmacia Biotech.), 
with a molecular weight fraction range of 3-70kDa. The separation was 
carried out at room temperature, incorporated into and FPLC system 
(Amersham Pharmacia Biotech.). The void volume (Vo) and the total bed 
volume (Vt) of the column were calculated by applying a solution of 
2mg/ml blue dextran 2000 (Sigma Chemical Co.), and 0.5% p-nitrophenol 
(spectroscopic grade, BDH), to the columns. The elution profiles for Vo 
and Vt were determined by monitoring the 1ml fractions at 254nm. 
Samples of digested PG (500|Jl) were applied at a concentration of 5mg/ml 
and eluted with 4M urea, 0.05M Tris-HCl, pH 8, containing 0.35M sodium 
acetate, at a flow rate of lml/min. The absorbance was monitored and 1ml 
fractions were collected. Based on elution profiles, protein fractions were 
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pooled, dialysed against ddH2 0  with protease inhibitors (as described in 
section 2.2.2) and lyophilised. The pooled fractions were characterised by 
SDS-polyacrylamide gel electrophoresis (see section 2.2.4.2), followed by 
silver staining (see section 2.2.4.3) and Western blot analysis (detailed in 
section 2.2.12).
2 2 2 ,2  Immuno-identification of proteoglycans by W estern blot 
analysis
Western blot analysis was performed to further confirm the identification 
of the proteins within the PG-rich and digested samples. The samples were 
separated by SDS-PAGE, each gel containing the separation of a pre­
stained molecular weight marker (as described in section 2.2.4.3).
Gels were electroblotted using the Phast System electroblot assembly. The 
polyacrylamide gel, nitro-cellulose membrane and six pieces of filter paper 
were equilibrated in transfer buffer (25mM Tris HC1 buffer in 20% 
methanol, containing 192mM glycine, pH 8.3) for 5min. Three pieces of 
filter paper were placed onto the anode of the electroblotting apparatus and 
the nitro-cellulose membrane applied on top of filter paper. The gel was 
removed from the Perspex backing by a wire cutter, and the gel placed on 
top of the membrane. The gel was then covered with another three pieces 
of filter paper. The cathode, was applied above the ‘transfer sandwich’ and 
electroblotted with an electrical gradient of 20V, 25mA, 1.0W, 5.0vH, for 
30min.
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Following electroblotting, non-specific protein binding was blocked with 
5% non-fat milk (Marvel™) in TBS at room temperature for lh, with 
constant agitation. The membrane was then incubated with the relevant 
primary antibody to PG (as described in table 2.1) diluted in 3% non-fat 
milk in TBS for lh  at room temperature, with constant agitation. The 
membrane was washed three times for 5 min with TBS, and re-incubated 
with the appropriate secondary antibody (as described in table 2.1) diluted 
in TBS containing 3% non-fat milk for lh, with constant agitation. The 
membrane was re-washed with TBS, three times for lOmin.
Throughout this study, two methods were employed to visualise the 
immuno-reactivity of the tissue PGs, ECL Plus Western Blotting Detection 
Reagent kit (Amersham Pharmacia) and alkaline phosphatase chromogenic 
detection (Promega). During the final washes, the visualisation reagents 
were prepared according to manufacturers’ instructions. For ECL, 10ml of 
chemiliminescent reagent was added to the membrane for lmin at room 
temperature. Once completed, the excess reagent was removed and the 
membrane was wrapped in SaranWrap®. The membrane was then placed 
in a film cassette, protein side up, and taken to a dark room where a sheet 
of autoradiographic film (hyperfilm-ECL) was placed on top. The 
autoradiographic film was exposed for up to 20min, after which films were 
developed using an automatic developer (Curix 60, Agfa Gevaert N. V., 
Germany). For alkaline phosphatase detection, the membrane was 
incubated with 10ml alkaline phosphatase buffer, 66pl NBT substrate and 
33pi BCIP substrate (Promega) (as described in section 2.2.4.2).
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2 2 ,1.3 Glycosaminoglycan characterisation
GAG components from ovine tissues or recombinant cell lines were 
examined by cellulose acetate electrophoresis (Waddington, 1988). Prior 
to electrophoresis, GAG chains were released from the core protein by 
treatment with a non-specific protease (type XIV) (Sigma Chemical Co.). 
An equal volume of the PG sample (lOmg/ml) was mixed with an equal 
volume of non-specific protease (Sigma) (lOmg/ml) in 0.2M tris-HCl, 
lOmM calcium chloride, pH 7.5 and incubated at 55°C for 20h. The 
samples were subsequently recovered by lyophilisation and reconstituted 
with ddH20 to the equivalent of the original starting volume of the PG 
sample.
Cellulose acetate electrophoresis was performed using cellulose diacetate 
sheets (Electrafor, Cellulose diacetate, Shandon Southern Ltd). Sheets 
were immersed in running buffer (0.2M calcium chloride buffer, pH 7.2) 
and positioned centrally in the electrophoresis tank (Shandon Southern 
Ltd). Electrical contact was made using filter paper wicks (Whatman 
chromatography paper). 2pl samples were applied onto the electrophoresis 
sheets at an origin 6.5cm from the anode end of the sheet, over 0.5cm 
lanes, each sample being 0.5 -1.0 cm apart and 1.0cm from the edge (in 
order to prevent drag effects). Sheets were run at 0.6mA per cm width for 
4.5h. A GAG standard mixture (Sigma Chemical Co.) containing 
hyaluronan (HA), dermatan sulphate (DS), chondroitin 4-sulphate (C4S) 
and chondroitin 6-sulphate (C6S) was included on each electrophoretic 
run.
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The separated GAGs were visualised by staining with 0.05% w/v Alcian 
blue 8 GX (Gurr Biological Stain, BDH) in 3% acetic acid, containing 
0.05M magnesium chloride, pH 3.9, for 15 min. The sheets were destained 
with 1% acetic acid with 0.Q5M magnesium chloride, pH 3.9 with several 
changes. Sheets were washed in ddH20 and air-dried.
Specific enzyme digestion o f  glycosaminoglycan chains 
Individual GAG species were characterised based on their susceptibility to 
chondroitinase ABC and AC. Chondroitinase ABC (Proteus vigaris) 
(Sigma) depolymerises both glucuronic acid and iduronic acid containing 
GAG, such as C4S, C6S, DS and HA. The enzyme was diluted to 
0.2units/ml in 0.1M Tris-HCl, pH 8.5. Equal volumes of the protease 
digested sample were digested with an equal volume of chondroitinase 
ABC (working dilution) at 37°C for 20h. Chondroitinase AC 
(Flavobacterium heparinium) (Sigma) depolymerises glucuronic acid 
containing GAG only at the P(l-4) bond, such as C4S, C6S and HA but 
not DS, KS, or HS. Chondroitinase AC was diluted to 0.2units/ml in 0.1 
Tris-HCl, pH 7.1 and incubated with equal volumes of the protease 
digested sample for 37°C for 20h. Samples were separated by cellulose 
acetate and stained with alcian blue, as above.
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2.3 RESULTS
2.3.1 Purification and characterisation of proteoglycans from the 
isolated alveolar bone and gingival tissue extracts
Initially, the non-collagenous proteins were extracted from the alveolar
bone and gingival tissues into 4M GuC^. These protein extracts were then 
separated using anion exchange chromatography. This method allowed for 
the bulk preparation of ECM components from mineralised and soft 
tissues, to yield a PG-rich fraction of approximately 85-90% purity.
2.3.1.1 Q-Sepharose anion exchange chromatography purification of 
ovine alveolar bone tissue extracts
Figure 2.1 (a) is a typical 280nm elution profile for GuCl2 extracts of 
alveolar bone by Q-Sepharose anion exchange chromatography. From 
these profiles, six major protein fractions (I-VI) were identified and 
pooled. These fractions were examined by dot blot analysis (figure 2.2) to 
ascertain the PG-rich peak. A large amount of material was identified in 
fraction IV for ovine alveolar bone extracts, which eluted with 
approximately 0.3M NaCl. There was also a small quantity of material 
present in fraction V (figure 2.2), which eluted at about 0.4M NaCl. 
Therefore, fractions IV and V were pooled to form the alveolar bone PG- 
rich fraction
The PG-rich fraction derived from alveolar bone was subsequently 
examined by SDS-PAGE, with protein bands stained with silver (figure 
2.3). Also shown are the separations of the core proteins obtained 
following digestion with chondroitinase ABC. SDS-PAGE obtained for
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the intact fraction IV showed bands ranging from 200kDa to 29kDa, with 
prominent bands at 98-, 70- and 45kDa. However, streaking was a noted 
feature when separating these intact alveolar bone PGs, which led to poor 
resolution. Streaking is a common occurrence when separating intact PG 
molecules and is believed to be due to the heterogeneous nature of the 
attached GAG chains. Following digestion with chondroitinase ABC, 
alveolar bone PG-fraction, silver staining revealed a band at 45kDa. Bands 
observed below 45kDa were assumed to be products of core protein 
degradation.
Western blot analysis for decorin and biglycan in the alveolar bone PG- 
rich extract are shown in figures 2.4 (a) and (b), respectively. For decorin, 
apparent visualisation was noted from 120kDa- 29kDa. Following 
digestion, clear bands are visible at 45- and 50kDa. Immuno-reactivity of 
biglycan in intact alveolar bone was observed from 200-29kDa. Upon 
digestion with chondroitinase ABC, there are noticeable bands at about 
45kDa. The presence of a core protein band at 45kDa is similar to previous 
reports of the core protein molecular weights for the alveolar bone decorin 
and biglycan from rabbit, sheep and human sources (Oosawa, 1986, 
Waddington and Embery, 1991, Moseley, 1996). Comparison of SDS- 
PAGE with Western blot analysis of the alveolar bone PG-rich fraction 
reveals there are additional bands present in the former, which are non­
reactive to decorin or biglycan antibodies, indicating the presence of co- 
purifying proteins.
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2.3.1.2 Q-Sepharose anion exchange chromatography purification of 
ovine gingival tissue extracts
Figure 2.1 (b) illustrates a typical elution profile of gingival proteins 
separated by Q-Sepharose chromatography. As for alveolar bone, gingival 
proteins were pooled and the PG-rich fraction identified by SDS-PAGE 
followed by silver staining, and Western blot analysis for decorin and 
biglycan.
Following silver staining, a high proportion of protein was identified in 
fraction IV for the gingival extract (figure 2.5), which was eluted at 
approximately 0.3M NaCl. The intact gingival PG-rich fraction showed 
bands ranging in molecular weight from 200-29kDa. Streaking was 
evident due to the presence of the GAG chain. Following digestion with 
chondroitinase ABC, the gingival fraction IV revealed a prominent band at 
45kDa. However, there were also a number of bands below 45kDa, 
considered as degradation products of digestion.
Figures 2.6 (a) and (b) show the presence of decorin and biglycan, 
respectively, following Western blot analysis of the gingival PG-rich. 
There are a number of bands with a range of molecular weights. For 
decorin, there were visible material at approximately 120-, 98- and 66kDa. 
Also visible was a doublet at 45- and 50kDa. After digestion with 
chondroitinase ABC, higher molecular weight bands were not visible. 
However, a double band was visualised at 45- and 50kDa and there were 
bands visible at about 30- and 15kDa. The presence of a core protein band
in the 40-55kDa region is similar to previous reports of the decorin core
/
[Type text] 75
[Type text]
protein weight from bovine and ovine gingival tissues (Rahemtulla, 1992, 
Moseley, 1996). Stained materials below 45kDa are probable degradation 
products.
Biglycan immuno-reactivity within the gingival PG-rich fraction showed 
bands from 200kDa to 29kDa. The digestion of the gingival PG with 
chondroitinase ABC produced several band regions at around 45kDa and 
below. Bands detected below 45kDa were regarded as core protein 
degradation products. The additional bands at 66kDa observed in SDS- 
PAGE were not immuno-reactive to either decorin or biglycan verifying 
the presence of co-purifying proteins.
The presence of the GAG chain conjugated to the intact alveolar bone and 
gingival PG was confirmed by cellulose acetate electrophoresis followed 
by alcian blue staining of these separated GAG components, as judged by 
their electrophoretic mobility. Chondroitin sulphate was found within the 
PG-rich fraction of alveolar bone (figure 2.7a) and dermatan sulphate was 
predominant in the PG-rich fraction IV of gingiva (figure 2.7b).
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Figure 2.1 Typical elution profiles for the separation o f (a) 
alveolar bone and (b) gingival connective tissue extracts by 
anion exchange chromatography, on a Q-Sepharose
column. absorbance (280nm ) NaCl gradient
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Figure 2.2. Dot blot analysis for the identification o f  
chondroitin sulphate in alveolar bone fractions following Q- 
Sepharose chromatography
Fraction Immuno-■reactivity
Gingiva Alveolar
bone
I
I I
I I I
IV
V
V I
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Figure 2.3 SDS-PAGE o f  alveolar bone PG-rich fraction 
following Q- Sepharose chromatography
Intact +ABC
98kDa—►
62kDa—►
|  <«—45kDa—►
|j<«-17kDa—►
Figure 2.4 Western blot analysis o f alveolar bone PG-rich 
fraction following Q-Sepharose anion exchange for (a) 
decorin and (b) biglycan
(a) (b)
DCN +ABC BGN +ABC
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28 
17
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Figure 2.5 SDS-PAGE o f gingiva (fraction IV) following
Q-Sepharose chromatography
Intact +ABC
-98kDa—
-62kDa-
- 45kDa-
-  28kDa-
-  17kDa-
Figure 2.6 Western blot analysis o f  gingival tissues 
(fraction IV) following Q-Sepharose anion exchange for (a) 
decorin and (b) biglycan
(a) (b)
DCNIV +ABC BGNIV +ABC
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66
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Figure 2.7 Cellulose acetate electrophoresis o f  (a) 
alveolar bone and (b) gingival glycosaminoglycans
(a)
HA DS C4SC6S 
1 1 11
Standard ■
Alveolar bone IV & V
HA DSC4SC6S
(b) i i i l
Standard
Gingiva IV
HA = Hyaluroan 
DS = Dermatan sulphate 
C4S = Chondroitin-4-Sulphate 
C6S = Chondroitin-6-Sulphate
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2.3.1.3 Resource Q anion exchange chromatography purification of 
ovine tissue proteoglycans
To remove co-purifying eluting components from the PG-rich fractions of 
ovine alveolar bone and gingival extracts, a second anion-exchange 
method was employed. Figures 2.8 (a) and (b) illustrate typical 280nm 
elution profiles for the further purification of PGs derived from ovine 
alveolar bone and gingiva, respectively. Initial peaks (fractions I and II) 
produced are assumed to be collagens and other glycoproteins, supporting 
the necessity for, and the accomplishment of, a further purification step. 
Four major fractions were resolved for both alveolar bone and gingiva. 
The PG-rich fractions were identified through SDS-PAGE followed by 
silver staining and Western blot analysis for decorin and biglycan. Fraction 
III was PG-rich for both alveolar bone and gingiva, eluted at 0.35-0.4M 
NaCl.
Figure 2.9 shows the protein profile for alveolar bone following Resource 
Q chromatography. Protein stained material was identified in a molecular 
weight range of 200 -  45kDa. There was a streaking effect, again due to 
the nature o f the GAG attached, illustrating the effects of the 
heterogeneous nature of the GAG attachment. Also, there were less 
prominent bands visible compared to the initial purified PG-rich fraction. 
When digested with chondroitinase ABC, a single band was visible at 
approximately 45kDa. Western Blot analysis of intact fraction III of 
alveolar bone, for both decorin and biglycan (figure 2.11), show single 
bands at about 45kDa for each PG, indicating the presence of a mixture of 
decorin and biglycan within the purified alveolar bone extract following
t
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two purification steps. The absence of additional bands subsequent to 
silver staining indicates the removal of any co-purifying proteins from the 
initial purification step. Electrophoretic separations by SDS-PAGE of the 
intact gingival PG-rich fraction (III), followed by silver staining are shown 
in figure 2.10. The molecular weight of stained material ranged from about 
120- to 45kDa, with a double band present at 45- and 50kDa. Streaking 
was present but there was a loss of protein bands compared to initial SDS- 
PAGE following Q-Sepharose chromatography, particularly a band at 
66kDa, thereby suggesting successful further purification of gingival PGs. 
Following digestion with chondroitinase ABC, a single band was visible at 
45kDa. Western blot analysis of the digested gingival PG-rich fraction for 
decorin and biglycan are shown in figure 2.12. Immuno-reactivity was 
apparent for both PGs, with a band observable at approximately 45kDa. 
This indicates that the material present within the gingival sample was a 
mixture of decorin and biglycan, without the presence of co-purifying 
proteins.
The presence of the GAG chains within the intact alveolar bone and 
gingival PG were confirmed by alcian blue staining (figure 2.13), with CS 
in alveolar bone PG-rich fraction and HA and DS in the gingival PG-rich 
fraction. Following digestion with chondroitinase AC, staining was absent 
from the alveolar bone PG-rich fraction whereas DS remained present 
within the gingival PG-rich fraction (data not shown). Staining was absent 
from both alveolar bone and gingival PG samples following treatment with 
chondroitinase ABC (data not shown), demonstrating the ability of this 
enzyme to digest the GAG chains within these samples.
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Figure 2.8 Typical elution profiles for the further purification 
of (a) alveolar bone and (b) gingival extracts by anion exchange
chromatography, on a Resource Q column.  absorbance
(280nm) — NaCl gradient (2M)
(a)
Alveolar bone
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Figure 2.9 SDS-PAGE o f alveolar bone (fraction III) 
following Resource Q chromatography
Intact
98kDa
62kDa
45kDa
Figure 2.10 SDS-PAGE o f  gingiva (fraction III) following 
Resource Q chromatography
Intact +ABC
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Figure 2.11 Western blot analysis o f  digested alveolar bone 
tissue (fraction III) for decorin and biglycan, following 
Resource Q anion exchange
Decorin Biglycan
< —  45kDa— ►
Figure 2.12 Western blot analysis o f digested gingival 
tissue (fraction III) for decorin and biglycan, following 
Resource Q anion exchange
Decorin Biglycan
45kDa
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Figure 2.13 Cellulose acetate electrophoresis o f  (a) alveolar 
bone fraction IV and (b) gingiva fraction IV
(a)
HA DS C4S C6S
1 4 W
Standard
Alveolar bone IV
(b)
HA DS C4SC6S
Standard
Gingiva IV
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2.3.2 Purification and characterisation of recombinant proteoglycans
2.3.2.1 Nickel affinity chromatography purification of recombinant 
proteoglycans
Initially, the culture media obtained from the HeLa cells transfected with 
pcDNA3.1 myc/his decorin or biglycan were subjected to purification by 
nickel affinity chromatography on a HiTrap Chelating column. This 
method exploited the presence of the His-tag present on the C-terminal of 
the expressed protein. Nickel affinity chromatography allowed for the 
rapid throughput of protein and achievement of a good degree of purity, 
equivalent to that obtained by Q-Sepharose anion exchange 
chromatography (Sugars, 2001).
Pooled samples containing the recombinant PGs were identified following 
monitoring through absorbance at 280nm, together with their immuno- 
reactivity to the monoclonal antibody (CS 56) using dot blot analysis 
(figure 2.14). The intact, pooled PG-rich fraction was subjected to SDS- 
PAGE followed by silver staining (figure 2.15). Recombinant biglycan 
demonstrated protein material from 200kDa to 17kDa, with prominent 
bands visible at 98-, 66- and 45kDa. For recombinant decorin, stained 
material was visible from 200-29kDa, with noticeable bands at 66- and 
38kDa. The attached CS-GAG chain is probably responsible for the 
streaking effects observed, producing the higher molecular weight 
material. Co-purifying proteins were assumed to be present due to the 
extra bands detected within the recombinant samples (Sugars, 2001) thus 
the need for a further purification step.
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Figure 2.14 Dot blot analysis for chondroitin sulphate in 
recombinant decorin and biglycan-rich fractions following 
nickel affinity chromatography
Negative
control Decorin Biglycan
Figure 2.15 SDS-PAGE o f intact recombinant decorin and 
biglycan following initial purification by nickel affinity 
chromatography
Decorin Biglycan
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2.3.2.2 Resource Q anion exchange purification of recombinant 
proteoglycans
Following resource Q anion exchange of recombinant PGs six major 
fractions were resolved for the recombinant PGs (figure 2.16). Initial peaks 
(fractions I and II) were assumed to be elution of collagen and co- 
purifying proteins, reinforcing the need for a second purification step. 
Fraction IV, for both recombinant PGs, eluted at 0.3-0.35M NaCl, were 
determined to be PG-rich subsequent to examination by SDS-PAGE 
followed by silver staining and Western blot analysis for decorin and 
biglycan. Digestion of recombinant biglycan and decorin with 
chondroitinase ABC are shown in figure 2.17 (a). Protein stained material 
was determined to be approximately 45kDa for recombinant biglycan and 
about 38kDa for recombinant decorin. In both samples, a single protein 
band was apparent, thereby suggesting the presence of an isolated protein 
species.
The presence of either recombinant biglycan or decorin was confirmed 
following immuno-identification with anti-biglycan (LF-106) and anti- 
decorin (LF-113), respectively (figure 2.17b). Following chondroitinase 
ABC digestion, strong identification was observed at about 45kDa for 
recombinant biglycan, and 38kDa for recombinant decorin, confirming the 
presence of a single species for each recombinant PG without (he presence 
of any co-purifying proteins. Both recombinant biglycan- and decorin-rich 
fractions were found to be CS-rich, following dot blot analysis probing 
with the CS56 antibody (figure 2.18).
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Figure 2.16 Typical elution profiles for the further purification 
o f (a) recombinant biglycan and (b) recombinant decorin by
Resource Q column  absorbance (280nm) - - -NaCl
gradient (2M).
(a)
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Figure 2.17 SDS-PAGE followed by (a) silver staining and
(b) Western blot analysis o f digested recombinant PGs 
(fractions IV), following Resource Q chromatography
(a) (b)
MW BGNIV DCNIV MW BGNIV DCNIV
. 4
n
45kDa
1
0
Figure 2.18 Dot blot analysis for chondroitin sulphate within 
recombinant biglycan and decorin rich fractions
Recombinant Recombinant
biglycan decorin
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2.4 Discussion
This chapter has focused upon the isolation, purification and 
characterisation of ovine alveolar bone and gingival PGs, resulting in a 
mixed population of both decorin and biglycan that are glycosylated with 
respect to the presence of GAG chains. In addition, a mammalian 
expression system allowed for the expression, purification and 
characterisation of single protein species of recombinant decorin and 
biglycan, which are glycosylated through attachment of CS GAG chains.
Anion exchange is a well-established technique used for the purification of 
tissue proteins, including those from mineralised tissues (Waddington et 
al., 1989, 1991). The highly anionic nature of the PG lends itself to the 
procedure. There is a necessity to consider a number of conditions in the 
purification of PGs. The denaturing conditions of guanidinium chloride 
(GdnHCl) extraction serves to disaggregate proteins during purification, 
releasing most non-covalent bonds to supply high yields with nominal 
degradation of PGs. Also, in order to inhibit PG susceptibility to proteases 
present within the tissue, purification processes were carried out in the 
presence of protease inhibitors, at low temperatures which are 
unfavourable for proteases.
In these analyses, the PGs were extracted from ovine alveolar bone and 
gingiva using 4M GdnHCl, followed with extensive purification via anion 
exchange chromatography. The primary purification of ovine tissues at a 
concentration of lOmg/ml was performed using a Q-Sepharose column
facilitating bulk preparation of the PGs. The intact PG-rich fractions for
)
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alveolar bone were analysed by SDS-PAGE and showed a number of 
protein bands with molecular weights ranging from 200- to 29kDa. 
Following digestion with chondroitinase ABC, a prominent band was 
visible at around 45kDa. Additional bands were assumed to be co- 
purifying proteins such as (X2HSG (70kDa) that eluted due to their 
interactions with the proteins of interest. The co-purification of (X2HSG 
with other ECM components isolated from mineralised tissues has 
previously been shown. Mizuno et al. (1991) demonstrated the presence of 
QC2HSG with osteopontin from rat bone, and Milan et al. (1999) showed 
co-elution of ot2HSG within a dentine phosphoprotein fraction, isolated 
from rat incisors. Immuno-probing with a decorin antibody (LF 122), 
known to cross-react with sheep (Fisher et al., 1995), and a biglycan 
antibody (LF51) (Fisher et al., 1989) confirmed the presence of the core 
protein of the two SLRPs within ovine alveolar bone. Following 
chondroitinase ABC digestion of the ovine PG-rich fractions, immuno­
detection of the decorin and biglycan showed intense staining at around 
45kDa, corresponding to SLRPs in previous reports (Waddington and 
Embery, 1991; Moseley, 1996).
SDS-PAGE of gingival tissues following initial purification revealed a 
number of bands ranging from approximately 120-29kDa. A doublet was 
apparent at 45- and 50kDa, which remained visible following digestion. 
Immuno-detection for biglycan revealed a prominent band at about 45kDa, 
which is concurrent with previous reports. Immuno-detection for decorin 
revealed the presence of the doublet core protein. The presence of a
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decorin core protein doublet of 45-48kDa has been reported, representing 
glycoforms containing either two and three AMinked oligosaccharides, 
respectively (Hocking et al., 1996; Seo et al., 2005). Seo et al. (2005) 
analysed the N-terminal amino acid sequence for the doublet core protein. 
They reported that the amino acid sequences of both core protein 
glycoforms were identical and matched exactly with the predicted 
sequence for intact decorin. Not all bands, notably a band at 66kDa 
(evident in SDS-PAGE), were immuno-reactive with anti-decorin or anti- 
biglycan suggesting the presence of co-purifying proteins.
Due to potential co-purifying proteins, the ovine tissue PG-rich fractions 
from the initial bulk purification were subsequently subjected to a second 
anion-exchange step in order to achieve a highly purified protein 
preparation. The samples were applied to a Resource Q column at a low 
concentration and eluted over an expanded sodium chloride gradient, 
thereby attaining a high level of purity. Analysis of the alveolar bone PG- 
rich fraction by SDS-PAGE revealed a protein species that migrated from 
200- to 29kDa. Following digestion with chondroitinase ABC, there was 
staining at approximately 45kDa. The identity of the PG species present 
within the gingival PG-rich fraction was confirmed as a mixture of decorin 
(LF122) and biglycan (LF51) following Western blot analysis. 
Chondroitinase ABC digestion revealed single bands at 45kDa for decorin 
and biglycan, confirming the presence of these SLRPs, as a mixed 
population, within the ovine gingival preparations. Cellulose acetate 
electrophoresis established the presence of CS within the alveolar bone 
PG-rich fraction and DS was the predominant GAG within the gingival
i
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PG-rich fraction. These findings are in agreement with many studies that 
have isolated CS in mineralised tissues (Fisher et al., 1983, Waddington et 
al., 1989) and DS in soft tissues (Heinegard et al., 1985). HA was also 
present within gingival tissues. As previously mentioned, HA is found in 
many tissues and fluids, including umbilical cord, synovial fluid and 
muscle, and is a major component of the ECM especially in soft tissues 
(Laurent and Fraser, 1992), including gingiva. Overall, these results were 
in accordance with previous characterisation of PGs isolated from ovine 
alveolar bone and gingiva (Moseley, 1996), bovine gingival tissues 
(Rahemtulla, 1992) and human alveolar bone (Waddington and Embery, 
1991).
The recombinant PGs were isolated slightly differently to ovine PGs, in 
that initial bulk purification was via nickel affinity chromatography 
followed by a second FPLC anion exchange procedure. The His-tag 
comprising six-histidine residues allowed for the initial purification. These 
residues are uncharged at physiologically pH (Crowe et al., 1996), thus the 
His-tag rarely affects the structure or function of the tagged proteins, and 
there is no need to remove it after purification (Linder et al., 1992). A 
number of studies that have used tagged proteins leave the His-tag intact 
in functional studies, including recombinant decorin interacting with TGF- 
P (Shi et al., 2006) and SLRPs interacting with collagen fibrils (Geng et 
a l , 2006).
Following initial purification, SDS-PAGE analysis of the PG-rich 
fractions revealed a number of protein bands with molecular weights
i
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ranging from 200- to 29kDa, with an intense band at approximately 
45kDa, for both recombinant PGs. Other protein bands ranging from 
200kDa to less than 29kDa were accredited to undigested PG material, 
degradation products and co-purifying proteins.
aHSG is a known co-elutant with recombinant PGs due to the addition of 
foetal bovine serum to the culture system (Sugars et al, 2002). This 
component was used at the relatively low concentration of 2%, as HeLa 
cells fail to survive for prolonged periods in serum-free conditions 
(Sugars, 2001). The strong interactions between PGs and co-purifying 
proteins may be due to an electrostatic affinity considering the highly 
anionic conditions utilised in previous separation procedures (Sugars, 
2001). As described earlier, the co-purification of aHSG with ECM 
components of mineralised tissues has been noted. Decorin is renowned 
for its non-covalent interactions with other ECM components, facilitated 
via functional groups within p-sheets (Iozzo, 1999). The proposed open 
horseshoe configuration provides a general binding area for biological 
ligands, accommodating reversible interactions with matrix components 
such as collagen (Schonherr et al, 1995) and TGF- p (Hildebrand et al., 
1994).
Due to the co-purifying proteins, recombinant PGs were subjected to a 
second fast performance anion exchange step to obtain single species 
samples. Initial identification of recombinant decorin and biglycan, which 
were substituted with a CS chain, was through dot blot analysis for CS.
/
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This finding is similar to the GAG component isolated from mineralised 
tissues such as bone and dentine (Fisher et al., 1983, Waddington et al., 
1989, Bartold, 1990). Subsequent identification was via SDS-PAGE 
followed by silver staining and Western blot analysis of recombinant 
decorin (LF 113) and biglycan (LF 106), which showed material at 
approximately 45kDa. Overall, these results support the findings of Sugars 
(2001), and provide evidence that the transfected HeLa cells are stable and 
continuing to produce intact recombinant decorin and biglycan with CS 
GAG chains attached.
In initial preparations of PG from tissue sources and recombinant cell 
lines, there was a continuous detection of a band at approximately 98kDa, 
following immuno-reactivity for decorin and biglycan. The horse-shoe 
monomeric structure of these SLRP core proteins is based on the a-helix 
rich ribonuclease inhibitor and it is believed to bind collagen monomers 
through its inner P-sheet face (Weber et al., 1996). However, it has 
recently been reported that decorin and its protein core can have molecular 
masses nearly double the size of those previously published (i.e. ~38kDa) 
suggesting a dimeric structure (Scott et al., 2003). At present, there is 
debate as to whether this SLRP exists as a monomer (Goldoni et al., 2004) 
or as a dimer (Scott et al., 2003). According to Scott et al. (2003), the 
inner concave face of decorin facilitates dimerisation. This suggests that 
the higher molecular weight bands of the core proteins at approximately 
98kDa, for decorin and biglycan, may be due to dimer formation. If this is 
correct, it is possible that the dimer structured SLRPs may bind to one or 
more ligands, which could lead to an additional function, compared to the 
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monomeric structured proteins. However, Goldini et al. (2004) provide 
strong evidence that decorin monomers are the biologically active forms 
and that decorin dimers are an in vitro artefact generated by removing 
water and salts, which causes non-specific self-association during the 
freeze-drying step. Indeed, the major difference in experimental design 
between Goldini et a l (2004) and Scott et a l (2003) is that the latter 
authors extensively dialysed their samples against water and subsequently 
freeze-dried them. Also, the former authors experimental conditions kept 
decorin proteoglycan and glycoprotein preparations in solution under non­
denaturing conditions. The dimeric protein core preparations showed 
reduced biological activity on interaction with collagen suggesting this 
conformation was not suited to interact with cell surface receptors and 
trigger a biological response.
Goldini et al. (2004) also reported that biglycan protein core does not 
oligomerise. However, Scott et al. (2006) demonstrated a crystal structure 
of the biglycan dimer and have shown evidence that dimerisation is 
fundamental for the folding and stability of this SLRP. They reported 
biglycan becomes a dimer in solution the same way as decorin, by 
apposition of the concave inner surface of the LRR domains, and 
crystallises as a dimer. This group used GdnHCl to denature biglycan, and 
they demonstrated that it is completely reversible following removal of the 
GdnHCl. They also revealed that biglycan has some unique features, 
including a histidine-lined pocket that is likely to provide a binding site for 
a complex anion.
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It was deemed necessary in the current study to perform chromatography 
separation procedures using 7M urea during anion exchange to ensure 
dissociation of the protein of interest and co-purifying proteins. The use of 
this dissociative agent throughout the purification procedures are of 
particular interest as the use of chaotrophic agents have been questioned 
by certain studies (Ramamurthy et al., 1996; Krishnan et al., 1999). 
However, these studies utilised circular dichromism (CD) to investigate 
the secondary structure of recombinant decorin purified in the presence or 
absence of chaotrophic agents. They suggested that chaotrophic agents 
may have an effect on the tertiary structure of decorin, which results in the 
unfolding of the protein. In addition, extensive dialysis failed to assist 
correct re-folding following removal of these dissociative agents. 
However, these studies did not confirm the removal of co-purifying 
proteins such as soluble collagens or a-HSG, which are likely to influence 
the resulting spectra.
The current study shows the successful purification of both mineralised- 
and soft- tissue PGs and recombinant decorin and biglycan, which closely 
resemble the biochemical characteristics of SLRPs from mineralised 
tissues. The results confirmed the necessity for thorough purification to 
obtain highly purified protein sources. The presence of decorin and 
biglycan has been confirmed through extensive characterisation analyses, 
which have also shown the PGs to be highly glycosylated. These purified 
PGs will be used in subsequent studies to establish a model for interactions 
between SLRPs and the S. anginosus group, in relation to the 
manifestation of periapical abscesses.
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Chapter 3
Interactions of Streptococcus anginosus group with extracellular
matrix components
3.1 Introduction
Bacterial attachment is an essential step for colonisation of commensal and 
pathogenic bacteria (Soto and Hultgren, 1999). Many bacteria are known 
to possess components, called “adhesins”, on their surfaces that bind to 
molecules, or “receptors”, on or within tissue (Gibbons, 1989). It is 
proposed that binding of oral streptococci is a multifactorial process 
involving both specific and non-specific receptors. Specific binding is a 
high-affinity, saturable interaction between the cell and binding surface. 
Conversely, non-specific binding is considered to be a non-saturable, 
generalised, low-affinity reaction (Staat and Peyton, 1984). The bacterial 
surface attachments that bear adhesins include fimbriae, fibrillae, flagella, 
capsule, outer membrane, and other appendages (Gibbons, 1989; 
Whittaker et al.9 1996).
Over time, many microorganisms have adapted to exploit cell surface 
glycoconjugates as receptors for attachment. Studies have shown that a 
variety of microbes, including staphylococci and streptococci, express 
surface components that recognise and bind to ECM components. Joh et 
al (1999) proposed a model describing how staphylococci and 
streptococci employ microbial adhesins known as microbial surface 
components recognising adhesive matrix molecules (MSCRAMMs). 
These molecules bind fibronectin and form a molecular bridge to integrins
on the host cell, thus facilitating bacterial adherence and inducing 
internalisation.
A number of studies have identified the ability of SAG to bind to a range 
of cellular and extracellular components. These include binding to various 
glycoproteins, including fibronectin, laminin, and collagen (Willcox et al., 
1995; Allen and Hook, 2002; Petersen et al., 2002), co-aggregation with 
Actinomyces spp. (Eifuku et al., 1990), haemagglutination with human and 
animal erythrocytes (Yamaguchi et al., 1993), and adherence to glass and 
saliva-coated hydroxyapatite (Eifuku-Koreeda et al., 1991; Yakushiji and 
Inoue, 1992). However, to date, there is no evidence to suggest the SAG 
adhere to the ECM components, PGs; an interaction which could have a 
major influence on the progression of infection with the SAG.
The methods used to assay bacterial adherence include scanning electron 
microscopy of the target surfaces (Vacca Smith and Bowen, 2000), 
scintillation counting of adherent radio-labelled bacteria (Scannapieco et 
al., 1995; Tarsi et al., 1997), colony forming unit counting of adherent 
and/or non-adherent fractions on an agar plate in a suitable medium (Visca 
et al., 1989), and spectrofluorometric micro-assays (Gaines et al., 2003). 
Many of these techniques yield information on defined events in a 
complicated series of host-microbial interactions. Some bacterial adhesins 
exhibit differential affinities for matrix proteins in soluble versus 
immobilised states, presumably due to phase-related conformational 
changes of the ligands. Thus, the solid phase ECM adherence assay may 
mimic conditions present in tissue more closely than the soluble phase
assay (Allen et al, 2002). However, recent developments in surface 
plasmon resonance (SPR) technology have provided us with a technique to 
further our understanding of host-microbial interactions.
SPR is a physical process based on the detection of a small refractive 
index change on a gold surface modified with molecular recognition 
agents. As the target molecule binds to the immobilised recognition 
molecule, there is an increase in the surface concentration of the target 
molecule, which results in measurable changes in the refractive index 
(Biacore AB, 1993).
The BIAcore biosensor has been utilised to study collagen- and 
fibronectin-binding adhesins on the cell surface of Gram-positive bacteria 
of S. aureus, where MSCRAMMs mediate the adherence to host cells 
(Patti et al., 1993 and 1995). Collagen I or fibronectin were immobilised to 
sensor chips and the binding characteristics of the MSCRAMMs were 
evaluated. Immobilised fibronectin has also shown binding with different 
binding proteins from S. aureus and S. epidermidis. Holmes et al. (1997) 
and Wann et al. (2000) identified the fibronectin binding adhesin from S. 
aureus using SPR, and Kawashima et al. (2003) utilised SPR to study the 
interaction of oral streptococci, including S. sanguis and S. mutans, and 
salivary components. SPR technology has also been used in studies of 
adhesion of Gram-negative bacteria to ECM components. Medina and 
Fratamico (1998) reported the binding interactions of immobilised E. coli 
0157:H7 cell surface components with ECM proteins and GAGs, HA and 
CS, and later with type I collagen (Medina, 2001). Also, Nakamura et al.
(1999) studied the binding kinetics of the Porphyromonas gingivalis 
fimbriae with immobilised human ECM proteins (elastin, laminin, type I 
collagen, vitronectin) using SPR and reported that the P. gingivalis 
fimbriae bound to all ECM components.
As previously mentioned the majority of SMG adherence studies have 
been restricted to various glycoproteins and other bacterial cells. However, 
decorin and biglycan are also important considerations due to their ability 
to interact with a range of other ECM components including TGF-p and 
collagen. Chapter 2 detailed decorin and biglycan purification from ovine 
alveolar bone and gingival tissues, and recombinant decorin and biglycan 
from a mammalian expression system. The aim of the current investigation 
was to examine the interactions between commensal and disease isolates 
of SAG with decorin and biglycan by SPR analysis. More specifically, the 
objectives were:
• to investigate any differential binding properties, both inter-species and 
same related species of the SMG to PGs;
• observe whether the SMG exhibit differential binding to intact PGs 
compared to PGs devoid of their GAG chains, and;
• to relate any findings to the potential role of SAG in establishing 
bacterial inflammatory infections, such as abscesses formation.
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3.2 Materials and methods
3.2.1 Bacterial source
The isolates of the SAG studied are shown in table 2.3 and were selected 
from the culture collection of the Oral Microbiology Unit, Cardiff School 
of Dentistry. Plaque samples and swabs taken from the dorsum of the 
tongue were obtained from healthy adult individuals. Pus samples were 
collected by needle aspiration from subjects presenting with dentoalveolar 
abscesses at Cardiff School of Dentistry. Those isolates from extra-oral 
pyogenic infections were kindly donated by the PHLS (UHW, Cardiff, 
UK). The isolates have been characterised extensively by a range of 
phenotypic and genotypic methods (Bartie, 2000). Following routine 
maintenance on blood agar (LabM, Bury, UK) with 5% (v/v) defibrinated 
sheepblood (BA; TCS Microbiologoical Ltd, Buckingham, UK), Gram 
positive, catalase negative cocci exhibiting reduced growth under aerobic 
conditions were subjected to glycosidic and hyaluronidase assays, rapid 
API ID 32 Strep, and SDS-PAGE of whole cell proteins. All phenotypic 
properties correlated with a reference identification system (Whiley et al., 
1990). Haemolysis, sugar utilisation and possession of Lancefield antigens 
tended to be associated with individual species. Macrorestriction 
fingerprinting following Smal and Apal digestion revealed each strain had 
a unique profile but despite this genetic diversity, there was a persistent 
characteristic contained-within the profiles that defined each individual 
species to create species specific clusters (Bartie, 2000).
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3.2.2 Preparation of bacteria
Bacteria were sub-cultured on Fastidious Anaerobic Agar (FAA) (Lab M™ 
International Diagnostic Group pic, Bury, UK), supplemented with 5% v/v 
defibrinated sheep blood (TCS Bioscience Ltd., Buckingham, UK), and 
purity was confirmed regularly. Bacterial cells were inoculated into 10ml 
of Brain Heart Infusion (BHI) broth (Oxoid Ltd., Basingstoke, UK), and 
subsequently incubated overnight, in an anaerobic cabinet (10% v/v CO2, 
20% v/v H2, 70% v/v N2), at 37°C (Don Whitley Scientific Ltd., Shipley, 
UK), until the stationary growth phase. The latter had previously been 
determined by a series of preliminary growth curves experiments.
Bacterial cells were harvested by centrifugation at 3000g for 10 min and 
washed twice in filtered, degassed HBS-EP buffer (0.01M Hepes, 0.15M 
NaCl, 0.003mM EDTA, pH 7.4, containing 0.005% surfactant P20). The 
cells were then sonicated (60W, 10s), to disrupt the streptococcal chains, 
and re-suspended in HBS-EP buffer to an OD(55onm) = 0.5 (the OD had 
previously been deemed as approximately 1 x 108 cfu/ml, determined by 
serial dilutions, plated onto FAA plates, and colonies subsequently counted 
following an overnight incubation at 37°C, as above).
/
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Species Reference Clinical source
S. constellatus 350/96 Dentoalveolar abscess
S. constellatus F436 Lung abscess
S. constellatus 322/95 Dentoalveolar abscess
S. constellatus 48C Tongue
S. constellatus 34C Tongue
S. intermedius HW13 Dentoalveolar abscess
S. intermedius 127/95 Dentoalveolar abscess
S. intermedius 447/96 Dentoalveolar abscess
S. intermedius 11C Tongue
S. intermedius 30C Tongue
S. intermedius 84C Plaque
S. anginosus 43586/96 High vaginal swab
S. anginosus 39/2/14A Unknown
S. anginosus 670/95 Dentoalveolar abscess
S. anginosus 16C Plaque
S. anginosus 19C Plaque
S. anginosus 43C Tongue
Table 3 .1 . Identity and source of the SAG isolates used in this study.
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3.2.2 Preparation of source materials -  Small leucine-rich 
proteoglycans
Chapter 2 described the isolation, purification and characterisation of 
tissue-derived SLRPs and recombinant SLRPs. The PGs were subjected to 
two purification procedures and underwent numerous characterisation 
procedures, in order to determine the exact nature o f the PG core proteins 
and constituent GAG chains. The alveolar bone and gingival preparations 
contained a mixture of decorin and biglycan substituted with chondroitin 
sulphate and dermatan sulphate GAGs, respectively. Both the recombinant 
PGs (decorin or biglycan) contained chondroitin sulphate. Samples of the 
intact PGs were digested with chondroitinase ABC and subjected to a 
further purification step in order to obtain the core proteins alone.
3.2.3 Surface Plasmon Resonance analysis
The interactions between mixed SLRP preparations from ovine tissues and 
recombinant decorin and biglycan with the SAG isolates were investigated 
by real-time biomolecular interaction analysis (BIA), using surface 
plasmon resonance technology on a BIAcore® 3000 system (BIAcore, 
Uppsala, Sweden). Real-time BIA monitors the formation and dissociation 
of biomolecular complexes on a sensor surface as the interactions occur. A 
direct binding assay was performed whereby the SLRPs (ligands) were 
immobilised on a sensor surface and a solution containing the bacteria 
(analyte) were passed over the surface. The signal was produced in 
resonance units (RU). The SPR signal obtained in each binding cycle was 
recorded as a sensogram, which is a real-time pattern, plotted in RU versus
time, in seconds. The guidelines of the BIAapplications handbook (1993)
/
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were followed for the preparation of the sensor surfaces, binding 
techniques and interpretation of the sensograms and are described below.
3.2.3.1 Sensor chip
The BIAcore sensor chip is composed of an optically flat glass with a gold 
film deposited on one side, which is covered with a covalently bound 
carboxylated matrix, to which the ligand is bound. A number of chips are 
available, which vary according to the surface capture ligand for 
subsequent covalent binding. A number of chips were tested in the present 
study, such as the CM5, CM3 and Cl chips (BIAcore AB), in order to 
produce appropriate immobilisation levels o f PGs.
Before use, the sealed sensor chip pouch was allowed to equilibrate to 
room temperature for lhr. The sensor chip was then docked into the 
BIAcore® 3000 apparatus and the system was primed with HBS-EP 
buffer. Variations in reflectance characteristics between sensor chips may 
affect the SPR signal, therefore 500pl of BIAnormalisation solution (70% 
w/w glycerol in water) (BIAcore AB) was passed through the system and 
used to create a standardised total reflection.
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3.23.2 Immobilisation conditions of proteoglycan ligands
Immobilisation typically shows a pH optimum at a value that is dependent 
on the nature of the ligand. Uncharged amino groups on the ligand are 
required for the coupling reaction. Due to the high isoelectric points of the 
intact ligands (recombinant decorin, pi = 8.87; recombinant biglycan, pi = 
6.63 (Sugars, 2001), they were diluted to a concentration of 150pg/ml in 
lOmM phosphate buffer, pH 7.1 (0.05% monosodium phosphate, 0.17% 
disodium phosphate), for the immobilisation process.
For immobilisation of deglycosylated PGs, 150pg/ml of deglycosylated 
PGs (following chondroitinase ABC digestion) were diluted in lOmM 
sodium acetate buffer (BIAcore AB) at various coupling pH’s (pH 4.5, 5 
and 5.5), in order to find the best pH to achieve preferred immobilisation 
levels. In addition, the coupling buffer 2M GuCl2 with sodium acetate 
buffers (pH 4.5-5.5) (Zhang et al., 2002) were also tested.
The sensogram was initiated and 20pl of the diluted PG sample was run 
over the flow cell surface at lOpl/min. The level of immobilisation suited 
for SMG-PG interaction purposes was achieved through amine coupling.
3.2.3.3 Amine coupling immobilisation
Ligands (PGs) were immobilised on the sensor chip surface using amino 
coupling. The surface preparation ‘wizard’ was utilised to couple the ovine 
decorin and biglycan preparations, recombinant decorin and biglycan, and 
their corresponding core proteins, onto the chip surface. The surface was
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first eluted with lOpl/min continuous flow of HBS-EP buffer, and the flow 
rate was maintained at lOjxl throughout the immobilisation procedure.
Flow cell 1 was used as an in-line reference for flow cell 2, where the 
blank surface was activated by injecting 70pl of 400mM N-ethyl-N’- (3- 
diethylaminoprophyl) carbodiimide (EDC) and lOOmM N- 
hydroxysuccinimide (NHS) solution, in equal quantities. After activation, 
35pl of 150pg/ml of ligand, in appropriate buffer, was applied to the 
surface. The system was washed through with HBS-EP buffer to remove 
any loosely associated ligand. Finally, residual NHS esters were then 
inactivated with 70pl of 1M ethanolamine hydrochloride, pH8.5.
3.2.3.4 Suitable surface regeneration conditions
Regeneration conditions were established to maintain the activity of the 
ligand whilst ensuring the removal of all the interacted material. To test 
the surface, the SAG isolates ( O D 5 5 0  = 0.5) were injected across the chip at 
20pl/min and an interaction with the ligands was observed in the 
sensogram. A number of regeneration solutions were investigated to 
dissociate the interactions between the bacteria and PGs. These included 
lOOmM NaOH, pH 9.5, 1M NaCl, pH 6.5, and 4M GdnHCl, pH 5. The 
injection period was for lmin and the flow rate maintained at 20pl/min.
3.2.3.5 SPR measurement conditions
Preliminary studies showed binding parameters of SAG interactions with 
PGs were affected by flow rates above 20pl/min. Therefore, the flow rate
/
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of the sensogram was maintained at 20pl/min with HBS-EP buffer. 
Following a steady sensogram baseline, bacteria were injected at 20jnl/min 
for 3 minutes, at 25°C.
In this study, the term adherence was taken as the entire process of 
attachment and accumulation i.e. both initial cell-to-surface adherence and 
the subsequent cell-to-cell adherence, of bacterial cells (Eifuku-Koreeda et 
al., 1991). Therefore, the amount of adherence was observed as the 
difference in RU value from before injection of cells (binding response at 
baseline) to the end of injection. After the binding cycle, a dissociation 
phase of 5min was permitted to enable the sensogram to return to baseline 
(running buffer only was allowed to flow over the sensor surface). If 
bacteria remained bound to the sensor chip, the surface of the chip was 
regenerated by exposure to lOOmM NaOH, pH 9.5, for lmin (as 
determined in section 3.2.3.4). The chip was allowed to re-equilibrate 
between injections by the application of HBS-EP buffer for 5min. Each 
isolate was analysed in triplicate, in a randomised order.
3.2.4 SPR control -  fibronectin
The SAG are known to bind to fibronectin (Willcox et al., 1995), therefore 
fibronectin was used as a control. 150pg/ml fibronectin was immobilised to 
the sensor surface (as in section 3.2.3.3) following pH scouting (see section 
3.2.3.2) with sodium acetate buffers. SPR measurement conditions for the 
interaction with SAG were as those in section 3.2.3.5.
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3.2.5 Statistical analysis
The RU data obtained was assessed by analysis of variance (ANOVA) 
using SPSS 12. The data was evaluated both in terms of inter-species and 
inter-strain differences, for each substrate studied. Differences were 
considered significant at p<0.05 and data expressed as the average value of 
triplicate assays + SD.
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3.3 Results
3.3.1 Surface plasmon resonance
A total of 9 clinical SAG isolates and 8 oral isolates from healthy 
individuals were tested for their in vitro adherence to ECM PGs commonly 
present throughout the gingival and alveolar bone tissues. The adherence 
profiles were determined using a surface plasmon resonance biosensor, 
within the BIAcore® 3000 system, allowing interactions to be monitored 
between unlabelled reactants.
3.3.2.1 Immobilisation levels
The Cl chip was preferred for immobilisation of PGs following 
preliminary studies to establish which sensor chip would be appropriate for 
SAG interactions with PGs. The Cl chip has a carboxymethylated surface 
without a dextran matrix and is useful when studying interactions where 
the interaction partner (analyte) is large, such as bacteria. The CM5 and 
CM3 chips also have carboxymethylated surfaces with varying lengths of 
dextran chains attached, which in this study, appeared to interfere with the 
interaction.
PGs were immobilised onto the Cl sensor chip using amine coupling as 
seen in figure 3.2. Following a stable baseline with HBS-EP buffer, the 
immobilisation process started with the injection of EDC/NHS solution, to 
convert the carboxymethyl groups on the sensor chip surface to active 
esters. The intact PGs were injected in phosphate buffer (pH 7.1). For 
deglycosylated PGs, the most appropriate immobilisation levels were
obtained using sodium acetate coupling buffer pH 5.5, compared to other 
buffers (data not shown). The free (uncharged) amino groups of the PG 
sample formed covalent bonds with the active esters, and the residual 
esters were subsequently blocked (deactivated) with ethanolamine.
The amount of immobilisation was represented as an increase in RU 
between the start and end of the immobilisation process. A response of 
1000RU corresponds to a shift of 0.1° in the resonance angle, which 
represents a change in surface protein concentration of about lng/mm2. 
Table 3.2 shows the immobilisation levels obtained for intact ovine and 
recombinant PGs and their core proteins, indicating apparent binding to 
the chip surface. Immobilisation levels were between 302-350 RU, 
corresponding to 0.3 -  0.35ng/mm .
The fibronectin control produced a larger RU level when immobilised 
probably due to this ligand being less negatively charged than the test PG 
ligands. 4515RU corresponds to approximately 4.5ng/ml.
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Figure 3.2. An example o f a typical immobilisation procedure (intact gingival proteoglycans approx. 308RU). The sensor 
surface was immobilised with intact PG or its corresponding core protein. A sensogram is a plot o f continuous real-time 
biniding o f captured molecules (RU) vs. time (s).
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Figure 3.3. Immobilisation o f fibronectin.
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Table 3.2. Immobilisation levels of the intact proteoglycans 
and their corresponding core proteins to the Cl sensor chip.
Ligand Immobilisation level (RU)
Intact
Recombinant decorin 317
Recombinant biglycan 313
Gingiva 308
Alveolar bone 302
Dealvcosvlated (core protein):
Recombinant decorin 350
Recombinant biglycan 327
Gingiva 318
Alveolar bone 337
Fibronectin 4515
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3.3.2.2 Establishment of regeneration conditions
An important detail to enable repeated analysis was the determination of 
the regeneration conditions following the interaction of SAG with the 
immobilised PGs. Large amounts of SAG remained on the chip surface 
following regeneration with 1M NaCl, pH 6.5, whereas regeneration with 
4M GdnHCl, pH5, resulted in a RU value that had decreased below the 
original baseline, suggesting removal of all bacteria but also of some 
ligand. However, subsequent re-binding of SAG to the chip achieved 
similar RU levels to previously obtained levels, thereby proposing that the 
surface chip had not been damaged (data not shown). Regeneration of the 
chip with lOOmM NaOH, pH 9, for lmin resulted in the majority of SAG 
being removed. If there was any residual bacteria, the chip was subjected 
to a second exposure with lOOmM NaOH, pH 9, for lmin.
3.3.2.3 Interaction of SAG with proteoglycans
SAG solutions (OD = 0.5), in their stationary phase following incubation 
for 18hr, were injected onto the sensor chip immobilised with PGs. Figure
3.3 shows an overlay of typical sensograms obtained from SAG isolates 
interacting with intact PGs (gingival PGs). The sensogram records specific 
interactions, recorded as the difference between the start and end of 
injection. During SAG interactions with PGs, ‘spiking’ was a common 
occurrence, with many peaks visible throughout the course of the assay. 
This phenomenon may be due to noise, as the size of the immobilised
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ligand is small (~ 45kDa) (Huber et al., 2004), but it is more likely to be 
due to cell-cell interactions of the SAG strain, which build up on the PG 
chip surface and subsequently become removed in ‘clumps’ with the 
running buffer. This clumping effect is a common occurrence in 
streptococci, and may be a biological determinant of infection with SAG 
(Willcox et al., 1988). The mean RU (±SD) for triplicate interactions are 
shown in table 3.3 and figure 3.4 (a-d).
With the BIAcore 3000 system, it is relatively simple to measure binding 
responses with a maximum of less than 50RU (BIA handbook), therefore 
most of the responses in these studies are sufficient to show host-microbial 
interactions are taking place. However, for the purpose of this study, low 
binding was considered for strains exhibiting RU values of 50 or less, 
moderate binding was considered as 51-200RU, and RU values over 200 
were considered as high binding strains.
For S. anginosus strains exhibited low binding RU values (4 - 16RU) or no 
binding to intact recombinant decorin and biglycan. All S. anginosus 
strains bound to intact gingival proteoglycans ranging from 39-206 RU. 
3/6 strains (two commensal - 19C and 16C and one pathogen - 39/2/14A) 
bound to alveolar bone PGs ranging from 4 - 3 2  RU.
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All S. constellatus strains bound to intact recombinant decorin (4.2 -  775.6 
RU) and gingival PGs (53.2 -  439.5RU), with strain 322/95 (dentoalveolar 
abscess) exhibiting statistically significant binding to recombinant decorin 
(775.6RU), compared to strains within the same species and with strains 
from the other SMG species. For intact recombinant biglycan and alveolar 
bone, 4/5 and 3/5 strains bound, respectively, with no statistically 
significant binding.
S. intermedius strains demonstrated the most significant binding to intact 
PGs. For recombinant decorin, 5/6 strains bound, with 30C (tongue) and 
127/95 (dentoalveolar abscess) exhibiting statistically significant binding 
(p<0.05) compared to strains within the S. intermedius spp. S. intermedius 
strains produced 100% binding to intact recombinant biglycan and 
gingival PGs. Statistically significant binding was shown by 30C to intact 
recombinant biglycan (1378.1 RU), and 30C and 84C (plaque) exhibited 
significant binding to gingival PGs (1532.2 and 1133.7 RU, respectively). 
This significant binding was in comparison with other S. intermedius 
strains and between S. anginosus and S. constellatus strains to the same 
PGs. For alveolar bone PGs, 4/6 S. intermedius strains bound, producing 
values ranging from 6 4 -  155 RU. Of these, 84C demonstrated significant 
binding (155 RU) when compared to strains from within the S. intermedius 
species interacting with alveolar bone PGs.
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Figure.3.4. A typical sensogram o f the response differences in resonance units (RU) between the two flow channels (Fc2- 
F cl) when various SMG isolates were injected randomly over intact gingival PGs ( 19C; _ F436; 322/95; 48C; _
3 9/2/14 A).
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Table 3.3 Average binding (in RU), for three independent assays (± SD), o f commensal and pathogenic strains o f S. 
anginosus, S. constellatus and S. intermedius to recombinant proteoglycans, ovine proteoglycan preparations, and their 
corresponding core proteins.
Recombinant decorin
1
Recombinaiit biglycan Gin giva Alv eoiar bone
Strain Intact Core protein Intact Core protein Intact Core protein Intact Core protein
S. anginosus
19C NBD NBD NBD NBD 41.7 + 25.1 NBD 32.9 ±20.2 NBD
16C NBD NBD NBD NBD 95.8 ±45.8 NBD 4.7 ±1.4 NBD
43C 9.2+ 4.9 NBD 9.6+ 2.9 NBD 39.9 ±3.4 NBD NBD NBD
43586/96 16.9+1.2 NBD 4.6+ 1.5 NBD 145.7 ±59.7 NBD NBD NBD
670/95 NBD NBD 9.0 ±5.5 NBD 206.2 ±79.0 NBD NBD NBD
39/2/14 A NBD NBD NBD NBD 60.5 ±23.1 NBD 27.9 ±1.9 NBD
S. constellatus
48C 11.9 + 3.9 NBD NBD NBD 119.5 ±66.1 NBD NBD NBD
34C 38.4 ±21.2 NBD 28.5 ± 11.8 NBD 54.8 ±25.8 NBD NBD NBD
350/96 19.4 ±5.8 NBD 40.6 ±13.7 NBD 204.4 ±135.9 NBD 26.6 ± 13.4 NBD
F436 4.2 ±1.1 NBD 7.7+ 4.9 NBD 53.2 ±23.3 NBD 11.2 ± 3.1 NBD
322/95 775.6 + 90.1* NBD 72.4 + 24.9 NBD 439.5 ± 148.7 NBD 16.9 + 5.1 NBD
S. intermedius
11C 134.4 + 67.1 NBD 102.9 ±37.7 NBD 139.8 + 72.9 NBD 31.9 ± 15.9 NBD
30C 136 ±17.2* NBD 1378.1± 284.7* NBD 1532.2 ±114.0* 74.3 ± 58.9 112.4 ±50.1 NBD
84C 130.5 + 40.2 NBD 266+ 114.7 NBD 1133.7+115.7* NBD 155 + 8.1* NBD
127/95 168.1 ±23.8* NBD 219.5 ± 91.5 NBD 258.1 ±66.0 42.4 ±3.9 NBD NBD
HW13 23.6 ±14.9 NBD 29.8 ±17.3 NBD 147.3 ±63.3 25.0 ±5 64.0+13.1 NBD
447/95 NBD NBD 19.1 + 8.9 NBD 184.6 + 44.6 NBD NBD NBD
* p <0.05 Commensal isolates NBD = No binding detected
Figure 3.5 Bar charts illustrating SAG binding, in resonance 
units (RU), to (a) recombinant decorin, (b) recombinant biglycan, 
(c) alveolar bone proteoglycans, and (d) gingival proteoglycans. 
Each bar represents the mean o f three independent binding assays 
±_SD; * <p=0.05
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Overall, 59% of the SAG strains, including commensal and pathogenic 
isolates, bound to alveolar bone PGs, 70% of strains bound to intact 
recombinant decorin, 76% bound to recombinant biglycan, 100% o f the 
SMG bound to intact gingival PGs. However, increased standard 
deviations within triplicate assays for the SAG isolates with PGs causes 
some isolates to appear insignificant. These high deviations maybe due to 
a decreased activity in the ligand because of the time course of the assay 
and moderately harsh regeneration conditions. Important to note is the 
majority of strains that bound to intact PGs did not dissociate immediately 
from the immobilised sensor chip following the end of injection (see figure 
3.3). However, subsequent regeneration with NaOH (one or two 
regeneration cycles) removed the bound bacteria and the sensor chip 
surface was returned to baseline.
There was a severe lack of bacterial binding when the chip was 
immobilised with the core proteins of recombinant decorin, biglycan and 
ovine alveolar bone and gingival PGs (see table 3.3). There was no binding 
of S. anginosus and S. constellatus strains to any of the core proteins. For 
S. intermedius strains, there was no binding to recombinant PG core 
proteins or alveolar bone core proteins. However, several S. intermedius 
strains bound to gingival PG  core proteins; 30C (74RU), 127/95 (42RU), 
and HW13 (25RU). The lack of binding to core protein alone suggests that 
the GAG chain is an important factor in PG-SAG interaction analysis.
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Figure 3.6 Interaction o f SAG with fibronectin.
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Table 3.4 Average binding (in RU), for three independent assays (± SD), 
of commensal and pathogenic strains o f  S. anginosus, S. constellatus and 
S. intermedius to fibronectin.
S. constellatus RU+SD S. intermedius RU+SD S. anginosus RU±SD
34C 82.6±5.2 11C 109.5±17.2 16C 2170.2±245.3
48C 104±26.3 30C 1270.8+115 19C 289±23.4
F436 60.4+13.1 84C 158.9±23.5 43C 32.8±15.2
350/96 75.1+14.6 127/95 452±48.2 39/2/14A 32.9±12.4
322/95 283±46.1 HW13 251±32.1 43586/96 56.2±5.7
447/95 180.5±23.1 670/95 45.8+26.3
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3.3.2.4 Interaction of SAG with fibronectin control
Fibronectin was used as a control for SAG binding as interactions between 
this group of bacteria to this extracellular glycoprotein are already 
established (Willcox, 1995). All SAG isolates in this study bound to 
fibronectin albeit in varying amounts from 32 -  2170 RU. Of particular 
interest, S. anginosus commensal isolate 16C was most significant with 
2170RU, other significant binding was S. intermedius 30C (1250RU). This 
control study suggests that SAG binding interactions with intact SLRPs 
are relatively specific.
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3.4 Discussion
Adhesion of microbes to host components is a critical initial step in the 
establishment of bacteria as commensals or in the initiation of infection. 
An increasing number of microbes have been shown to depend upon 
extracellular matrix components for adhesion to host cells and tissues 
(Rostand and Esko, 1997; Wadstrom and Ljungh, 1999; Menozzi et al.,
2002). Therefore, the interactions between isolates of the SAG, from a 
range of sources, with intact and deglycosylated PGs were investigated.
This study has established suitable conditions for the successful analysis of 
host-SAG interactions utilising SPR technology within a BIAcore system. 
This technique allows for analysis of many aspects of the host-microbial 
interaction process, in particular early interactions between bacteria and 
surfaces in a range of seconds, without the use of labelling interactants. It 
was clear from the results that there is a difference in the binding abilities 
of the different species of the SAG. Generally, S. anginosus strains 
exhibited low binding to intact PGs (below 50RU) compared to S. 
constellatus and S. intermedius strains. S. constellatus strains exhibited 
low binding to intact alveolar bone PGs, moderate binding to gingival 
PGs, and low to moderate binding to intact recombinant PGs, however, 
strain 322/95 did produce statistically significant binding to intact 
recombinant decorin. For S. intermedius, the majority of strains produced 
moderate to high binding to all intact PGs, with strains 127/95, 30C and
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84C producing statistically significant interactions. Interestingly, 30C also 
exhibited significant binding to the fibronectin control. All of the SAG 
strains bound to gingival PGs, with an average of 75% binding to 
recombinant PGs and just over half of strains (59%) binding alveolar bone 
PGs. In considering the binding patterns of the SAG, it is recognized that 
different species of the SAG are associated with different clinical 
manifestations (Clarridge et al., 2001), which may govern their binding 
characteristics.
The reason for the significant differential binding characteristics between 
commensal and pathogenic strains of S. intermedius is unknown, but it 
may indicate an adaptation of commensal isolates to become better 
pathogens. Whiley et al. (1990) examined 157 strains of SAG in relation to 
disease. Of the 58 strains originating from supra-gingival plaque of healthy 
individuals, 66% were S. intermedius, 24% were S. constellatus and 10% 
were S. anginosus. Of the 6 strains isolated from sub-ginigival plaque, 5 
strains were S. constellatus and one was S. anginosus. The ability of these 
strains to interact with the ECM of the oral tissues is paramount for the 
survival of these bacteria to initiate infection. There are numerous studies 
that have observed commensal interactions. Allen et al. (2002) examined 
the ability of 55 clinical blood and 21 oral viridans streptococci (VS), 
which included S. anginosus and S. intermedius isolates, to adhere to 
individual purified ECM including laminin, fibronectin and collagen type I
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and IV. This study reported ECM adherence is a common trait among all 
VS, whether isolated from the bloodstream or from the healthy oral cavity. 
Also, Okayama et al. (2005) examined the abscess-forming ability of 
native dental plaque in mice and anti-phagocytic properties of microbial 
isolates following injections of supra-gingival dental plaque. From the 
thirteen microorganisms detected from pus samples, the majority of 
isolates belonged to the SAG, suggesting plaque itself is a source of 
infectious pathogens that cause abscess formation.
One of the fundamental parameters of using SPR technology is the purity 
of the investigated (immobilised) compound. In this study, highly purified 
PGs were used to examine their role as potential binding sites that mediate 
adhesion of oral bacteria. As well as single protein species of recombinant 
decorin and recombinant biglycan, this study also investigated the 
interaction of SAG with a mixed decorin and biglycan population present 
within the gingival and alveolar bone matrices.
SLRPs are renowned for their binding abilities to numerous components of 
the ECM and growth factors, providing the migration and signals for 
governing cell function (Yamaguchi et al., 1990; Schonherr et al., 1995; 
Kinsella et al., 2004), and also being involved in the nlaintenance and 
healing of periodontal tissues, following infection by periodontopathogens. 
These interactions involve defined regions within the SLRP protein core
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and their GAG chains. Potential binding to these areas by SAG could 
mediate adherence and colonisation to the host tissues, and might modulate 
or trap the functional interactions of SLRPs within the ECM.
Some bacterial adhesins exhibit differential binding for matrix proteins in 
soluble versus immobilised states, presumably due to phase related 
conformational change of ligands. Thus, the solid phase ECM adherence 
assay may mimic conditions present within tissue more closely than the 
soluble phase (Allen et al., 2002). Within BIAcore analysis, cell-surface 
multivalent ligands such as, highly glycosylated PGs, are often tethered by 
a single attachment point. In vitro, it is difficult to immobilise multivalent 
ligands at a single site due to their heterogeneity. Thus, it is unknown 
whether the binding site on the PG is ‘hidden’ or shielded away from the 
bacterial (analyte) receptor. Therefore, random covalent coupling was 
utilised in these studies to immobilise the PGs. This method yields a 
surface displaying an ensemble of multivalent ligand orientations 
(Gestwicki et al., 2002). The low immobilisation levels obtained in this 
study were probably related to the use of a C l sensor chip devoid of a 
dextran matrix. Therefore, the surface has a lower hydrophilic character 
and has a much lower immobilisation capacity than CM dextran chips. 
Dextran matrix chips were utilised in pilot studies but the matrix appeared 
to interfere with the interaction. However, the use of the Cl chip was 
preferable since mass transport, steric hindrance, surface crowding,
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aggregation and rebinding events were minimised. Zhang et al. (2002) 
covalently immobilised heparin and the structurally related heparan 
sulphate, the most acidic polysaccharides in the human body, on the Cl 
bio-chip. They achieved immobilisation levels of approximately 300RU 
due to the addition of 2M guanidine to the sodium acetate buffer (pH 4), 
which provided sufficient charge shielding. However, the addition of 2M 
guanidine in this study did not result in higher immobilisation levels to 
those successfully achieved without 2M guanidine.
Some of the interactions observed for the SAG with PGs appear to show 
moderate to high binding values, but they do not appear statistically 
significant due to the high standard deviations incurred. This maybe due to 
the regeneration of the chip resulting in possible loss of ligand function 
after many binding cycles (50-100 times). Also, as binding is not as 
specific in some interactions, other tissue matrix proteins such as 
fibronectin, fibrin, laminin and collagen may well provide alternative 
colonisation sites and involve other binding proteins on the bacterial 
surface. The SaG are known to bind fibronectin (Wilcox et al, 1995a), 
thereby promoting indirect cell adhesion. While this interaction may be 
relevant for adhesion to host cells surroundings where this ligand is 
nearby, it seems probable that these bacteria could also possess a 
mechanism whereby adhesion can occur in the absence of this circulating 
ligand. The data from this study suggests that one such mechanism of SAG
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binding to ECM components, in particular decorin and biglycan, could be 
via the GAG chain, as within this study there was only binding of several 
S. intermedius strains to deglycosylated PGs.
GAGs are renowned for their functions as attachment sites for cellular 
adhesion molecules and matrix molecules, stabilising tissue structure and 
surrounding structures such as matrices. Beside these endogenous 
functions, invading microorganisms, such as parasites, bacteria and viruses 
also utilise GAGs for invasion. They serve as primary attachment sites for 
these microbes or their effector molecules before they eventually enter the 
cells. It is assumed that binding of bacteria to various GAGs depends on 
electrostatic interactions between the negatively charged sulphate groups 
of the GAG chains and positively charged regions of the ligand (Rostand 
and Esko, 1997). Leong et a l (1998) found that the recognition of GAG 
chains by the spirochete Borrelia burgdorferi, previously shown to bind to 
heparin, HS, and DS, as well as decorin, depended upon both charge and 
chain length of the GAG (Guo et al., 1995; Leong et al., 1995). Parveen et 
al (1999) reported charge was not the sole determinant for binding of B. 
burgdorferi, as it did not recognise all GAG chains, and the spectrum of 
GAGs that were efficiently bound varied among different strains. Thereby 
suggesting GAG binding by this particular bacterium displays an element 
of specificity (Leong et al., 1998). Therefore, the SMG-PG interactions 
within this study may be dependent not only on electrostatic attractions,
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but also on specificity due to the presence of iduronic acid residues in the 
DS-GAG chain.
This investigation proposes that the SAG have significantly increased 
binding to DS containing PGs from the gingival tissues, compared to CS 
GAG chains in the decorin and biglycan mixture from alveolar bone and 
recombinant PGs. CS and DS differ mainly in the epimerisation of uronic 
acid. The CS GAG chain is composed of a linear polysaccharide assembled 
as disaccharide units containing A-acetyl-galactosamine and hexuronic acid 
that are linked together by p-glycosidic ((31,4 or p i ,3) linkages. DS is 
structurally related to CS, however the uronic acid of DS is iduronic acid, 
whilst CS contains glucuronic acid. Iduronic acid is also present in 
significant amounts in heparin and HS. The presence of iduronic acid 
causes an increase in the flexibility of these GAG chains, a property that 
has been shown to be important for GAG interactions with other proteins 
(Casu et al., 1988). S. pyogenes was found to bind more to DS than CS, 
which was mediated through surface associated M proteins (Frick et al.,
2003). Also, Srinoulprasert et al. (2006) demonstrated Penicillium 
marneffei conidia adherence to DS and heparin but not to C4S, C6S or HA. 
This study suggested that binding was via the iduronic acid of the 
polysaccharide chains, as the conidia were unable to adhere to HA 
confirming that glucuronic acid is not involved in adhesion.
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In conclusion, this study has shown that certain commensal and disease 
isolates of the SAG are more capable than other commensal and disease 
SAG strains in binding to the GAG chain attached to the SLRPs, decorin 
and biglycan, found within gingival and alveolar bone tissues. This is a 
potential novel pathogenic mechanism of the SAG that is likely exploited 
during very early stages of colonisation, and maybe a pathogenic 
determinant in the production of abscess formation and other infections 
caused by this group of bacteria. Characterisation of these interactions 
between matrix proteins and their corresponding SMG binding proteins 
would be important in understanding the mechanism of SMG colonisation 
with a view to preventing or controlling infection.
/
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CHAPTER FOUR
Chapter 4
Periodontal ligament cellular response to Streptococcus anginosus 
group bacterial supernatants
4.1 Introduction
Dentoalveolar infections are pus-producing infections that result from 
infection around the apicies of teeth. Bacteria gain access to this site either 
from the pulp, secondary to dental caries or via the periodontal route 
between the gingivae and the teeth (Samaranayake, 2001). Bacteria 
frequently isolated from dentoalveolar abscesses include the 
microaerophilic streptococci, the SAG and the presence of this group of 
bacteria in the root canal system is well documented (Sundqvist, 1992; 
Ozaki et al., 1994; Fouad et al., 2003). The root canal space is in open 
communication with the periapical tissues (PDL, cement and alveolar 
bone) via the apical foramen. Bacterial metabolites and toxic products 
arising from bacteria present within the root canal diffuse into the 
periapical tissues and evoke inflammatory responses (Love and Jenkinson, 
2002). The SAG are frequently encountered within supra- and sub-gingival 
plaque (Whiley and Beighton, 1991; Rawlinson et al., 1993; Okayama et 
al., 2005), and entry into gingival tissues with subsequent colonisation and 
infection, often result in exposure of PDL cells to microbial products as 
well as to proinflammatory cytokines liberated from neighbouring tissue 
(Agarwal et al., 1998).
The PDL is a complex, vascular, and highly cellular soft tissue. It is a 
physically small but functionally important tissue, particularly in terms of
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tooth support, proprioception and regulation o f alveolar bone volume 
(McCulloch et al., 2000). The PDL contains a wide range of cells 
including cementoblasts, osteoblasts, fibroblasts, myofibroblasts, 
endothelial cells, nerve cells and epithelial cells. Fibroblasts are abundant 
and are responsible for maintaining PDL integrity and for the regeneration 
of the periodontium, via the metabolism of ECM components (McCulloch 
et al., 2000). Fibroblasts attach to the substratum of the ECM via surface 
receptors for structural matrix components such as, collagen and 
fibronectin. This attachment is essential for cell migration and organisation 
of the extracellular fibrillar matrix (Cho and Garant, 2000).
The SLRPs play an important role in the maintenance and fundamental 
integrity of the PDL. As discussed in chapters 1 and 2, both decorin and 
biglycan have a role in connective tissue matrix formation, growth 
regulation, and they also bind certain growth factors (Ruoslahti, 1989). 
Many studies have identified the presence of PGs, including SLRPs, 
within the ECM of healthy PDL. Laijava et al. (1992) carried out a 
biochemical analysis of newly synthesised PGs by PDL cells obtained 
from Wealthy human periodontium and studied the distribution of PGs in 
different culture compartments (medium, cell membranes and ECM). They 
found that human PDL cells express a number of PGs, including decorin, 
which were predominant in the culture medium. Hakinnen et al. (2000), 
through immunohistochemical analysis, reported that decorin is 
consistently expressed throughout the PDL during development, and Qian 
et al. (2004) demonstrated biglycan and decorin expression in healthy rat 
periodontium. Matheson et al. (2005) showed co-expression of decorin,
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biglycan, fibromodulin and lumican in human and mouse gingival and 
PDL connective tissues where they colocalized with collagen fibril 
bundles. The predominant GAG constituent within PDL appears to be DS 
(Laijava et al., 1992), with others including HA and CS (in an over- 
sulphated form).
Generally, bacteria and their constituents (i.e. lipopolysaccharide, 
lipoteichoic acid, enzymes) have been proposed to be responsible for the 
destruction of periodontal attachment and bone (Lamont and Jenkinson, 
1998). PDL cells are capable of responding directly to oral microbial 
challenges or indirectly, following activation of the host immune response. 
They can alter the composition of connective tissue in several ways, 
namely, synthesis of inflammatory mediators, their receptors and 
antagonists; fibroblast proliferation; collagen synthesis; and synthesis of 
proteolytic enzymes, including MMPs and their corresponding inhibitors 
(Havemose-Poulsen and Holmstrup, 1997).
Alterations in the ECM components are reported at sites of periodontal 
disease. Several periodontopathic bacteria, including P. gingivalis and 
Treponema denticola, have been reported to suppress tissue regeneration 
in vivo not only by activating host defence mechanisms but also directly 
via a suppression of growth and differentiation of human PDL fibroblasts 
and a reduction in ECM collagen (Marquez-San Miguel et al., 2003). The 
expression of type I collagen mRNA has been demonstrated to be reduced 
within both gingival and PDL tissues during periodontal disease (Laijava
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et al., 1989). Other immunochemical studies have demonstrated the 
appearance of CS-decorin and CS-biglycan metabolites in gingival 
crevicular fluid associated with advanced with periodontal disease, which 
has been further shown to arise as a consequence o f alveolar bone 
destruction (Waddington et al., 1998).
Surprisingly, little is known about the direct influence of the SAG bacteria 
on the biological activity of PDL cells. This chapter aims to investigate the 
effects of SAG supernatants on PDL cell growth, differentiation and ECM 
synthesis, as the nature of these interactions are likely to have a major 
influence on the progression of disease. More specifically, this chapter was 
initiated with a view to determining the possible roles of decorin and 
biglycan PGs within the PDL during infection with the SMG. The specific 
aims were, therefore, to examine PG expression from cultured PDL cells 
in the absence and presence of SMG supernatants. These PGs were 
examined at both the mRNA level and through the identification at the 
protein level of the parent species and metabolites extracted from the 
surrounding medium compartment. These observations will provide a 
better understanding of the exact functions of PGs during PDL cell 
response in the presence of pathogenic agents associated with periapical 
abscess formation.
4.2 Materials and methods
4.2.1 Bacterial culture and supernatant preparation
SAG strains showing high levels of adherence in the previous chapter were 
selected for further studies. These were S. constellatus strains 322/95 and 
34C, S. intermedius isolates 127/95 and 30C, and S. anginosus isolates 
43586 and 43C (see table 3.1 for source). Bacteria were grown on 5% 
blood agar anaerobically for 18hr, and subsequently sub-cultured into 
10ml Brain Heart Infusion (BHI) broth. Broth cultures were incubated to 
an OD (550nm) = 0.5 under anaerobic conditions at 37°C. 5ml of bacterial 
suspension was added to 45ml of fresh BHI broth and incubated
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anaerobically until stationary phase (approximately 8hrs) ( 1 x 1 0  cfu/ml).
Bacteria were pelleted at 3, 500g for 10 min. The supernatants were 
filtered with a 0.2pm filter, and the concentration of the supernatant 
adjusted to lOng/ml -  lpg/ml, with culture media, using the BCA protein 
assay kit (section 2.2.6) and stored at -70°C until required.
4.2.2 Preparation of periodontal ligament-like cells
4.2.2.1 Source of cells
Periodontal ligament-like cells were obtained by enzymatic digestion of 
soft tissue adherent to alveolar bone dissected from 28 day-old male 
Wistar rats. Incisions were made at both comers of the mouth, cutting 
through skin and muscle. The front molars were forced apart using a sharp 
scalpel and the muscle and other soft tissue around the jawbone was
excised. The molars and incisors were carefully removed leaving the bone. 
Alveolar bone lining the teeth was removed, detaching any remaining 
gingiva then dissected into 1mm2 pieces.
Rat bone chips were incubated in a 1:1 mixture of 1 mg/ml collagenase 
(Type IV, Sigma Chemical Co.) and 4.5U/ml elastase (Type IV, Sigma 
Chemical Co.), for 2 hours at 37°C with vigorous agitation every 15 min to 
release the PDL. The enzyme mixture, containing the released cells was 
removed, 2ml of serum-containing media (Dulbecco’s modified Eagle’s 
medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum 
(FBS) and antibiotics mixture (100 units/ml penicillin G, 10 mg/ml 
streptomycin sulphate, 25mg/ml amphotericin B) (Sigma Chemical Co.), 
was added to inhibit the collagenase and elastase activity, and cells were 
pelleted by centrifugation at lOOOg for 5min.
The supernatant was discarded and another 2ml of serum-containing media 
was added to wash the cells, which were gently pelleted again by 
centrifugation at lOOOg for 5min. The cells were aseptically transferred to 
a T-75 tissue culture flask, incubated at 37°C, in a humidified atmosphere 
of 5% CO2. After 24hr, the media was changed to remove any dead cells, 
after which the media was changed every 2 days.
4.2.2.2 Cell culture conditions
On reaching confluence, PDL-like cells were treated with trypsin to obtain 
a homogeneous ceil suspension for secondary cultures. The existing media
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was removed and the cells washed twice in PBS followed by the addition 
of 2ml 0.01% trypsin (Invitrogen Ltd.), which was incubated at 37°C in 
5% CO2 for 10 min. An equal volume of media was added to neutralise the 
action of the enzyme and the mixture centrifuged at lOOOg for 5min. The 
supernatant was decanted and the pellet re-suspended in 1ml of serum- 
containing media.
PDL-like cells were counted using a haemocytometer and reseeded at a 1 x 
104 cells/cm2 in a T-75 flask and incubated at 37°C in 5% CO2. Both 
serum-containing media with and without 50pg/ml ascorbic acid were 
used, in order to establish the most favourable growth conditions, 
according to an MTT assay (as described in 4.2.3.1).
4.2.3 Characterisation of periodontal ligament-like cells
To determine the characteristics of the PDL-like cells and to establish the 
number of times cells could be successfully passaged for experimental use 
following trypsinisation, MTT (as described in 4.2.3.1) and alkaline 
phosphatase (ALPase) activity (described in section 4.2.3.2) were 
measured at every passage.
4.2.3.1 Cell growth
PDL-like cell growth was assessed following the uptake of MTT formazan 
by viable cells. The MTT assay is a colorimetric, short-term suspension 
culture assay, which functions by measuring the metabolic activity of 
living cells. The tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyl-tetrazolium bromide (MTT), is taken up into cells and reduced by
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a mitochondrial dehydrogenase enzyme to yield a purple formazan product 
which is largely impermeable to cell membranes, thus resulting in its 
accumulation within healthy cells. Solubilisation of the cells results in the 
liberation of the product, which can readily be detected using a simple 
colorimetric assay. The intracellular reduction of MTT is thus indicative of 
the normal functional biochemistry of energy-requiring mitochondrial 
enzyme reactions and, more broadly, provides a means to estimate the 
number of viable cells.
PDL-like cells from passage 1 to 5 were seeded into 6 well culture dishes 
at 1 x 104 cells/cm2, and incubated with 2ml of DMEM containing 10% 
FBS and antibiotics for 24h. On day 0, media was removed and replaced 
with fresh media and every 24hr after day 0, 500|Jl of media was removed 
and 500|Jl 5mg/ml MTT (Sigma Chemical Co.), in PBS, was added and 
incubated for 4h at 37°C in 5% CO2. The media was removed and replaced 
with 500pl lysing buffer (0.5M NN Dimethylformamide, 20% SDS; Sigma 
Chemical Co.), and incubated for 3h at 37°C, after which, the colour was 
released from the cells by mixing thoroughly, by pippetting. 100|Jl of 
sample was subsequently transferred to a 96 well plate (in triplicate) and 
the absorbance read at 540nm (Microplate Autoreader; Bio-Tek 
instruments). This procedure was repeated on days 2, 3, 4, and 5, to 
monitor the expansion of cell numbers with time in the culture media.
4.2.3.2 Alkaline phosphatase activity
Alkaline phosphatase enzymes are a specialised group of glycoproteins 
usually associated with bone matrix, detected in mineralised matrices and
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linked with the external membranes of osteoblasts (Robey, 1993). No 
specific marker is available at present, however, many studies have used 
ALPase as an effective marker since it is thought that PDL-like cells are 
osteogenic in nature (Lekic et al., 200; Saito et al., 2002). Therefore, 
ALPase activity was utilised in the present study to characterise the 
extracted PDL-like cells.
PDL-like cells were cultured as described above, trypsinised and reseeded 
at lx l0 4cells/cm2 in 24-well plates, and incubated with 1ml of serum- 
containing media. Cells were allowed to settle for 24h, after which (day 0), 
the media was changed every 24h.
Following re-seeding of the cells (passage numbers 1-5), on days 2, 5, 7, 
10, and 13, the media was removed from three of the wells in the culture 
plates and the remaining adherent cells were treated with 2.5ml 0.1% 
Triton X-100, 50mM Tris-HCl buffer, pH 7.2, for 15min at 37°C. The 
PDL-like cellular supernatants, containing solubilised cell components, 
were removed and buffer-exchanged using PD-10 columns (Amersham 
Life Sciences, Buckinghamshire, U.K.). PD-10 columns are pre-packed, 
disposable columns containing Sephadex® G-25 (bed volume 9.1ml) for 
rapid desalting and buffer exchange. Manufacturers’ instructions suggest 
protein yields are greater than 95%, with salt contamination less than 4%. 
The columns were equilibrated with 25ml elution buffer (1M 
diethanolamine, 0.5mM magnesium chloride, pH 9.8). Once equilibrated,
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the 2.5ml samples were allowed to run into the column and protein 
fractions were eluted with 3.5ml of elution buffer.
The alkaline phosphatase assay is based on that of Walter and Schutt 
(1974), in which p-nitrophenyl phosphate is dephosphorylated by alkaline 
phosphatase to generate jp-nitrophenol, detected by an increase in 
absorbance at 405nm.
p-Nitrophenyl phosphate Alkaline phosphatase P'Nitrophenol
+  > +
H2O phosphate
The reaction was performed as a continuous spectrophotometric rate 
determination, with the increase in absorbance determined over 5 min. To 
90pl of eluted sample, 10j.il of freshly prepared 150mM /7-nitrophenyl 
phosphate (Sigma Chemical Co.) solution was added. The activity of 
alkaline phosphatase present was calculated by applying the mean 
absorbance readings to the following equation:
ALP activity (units) = Abs/min x TV
18.45 x L P x S V
TV = Total volume (ml)
SV = Sample volume (ml)
18.45 = Millimolar absorptivity of p-nitrophenol at 405nm 
LP = Lightpath (1 -cm)
The assay was performed in triplicate and the mean activity of alkaline 
phosphatase (activity units/104 cells) for each time point was calculated.
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4.2.4 Periodontal ligament cellular response to S. anginosus group 
supernatants
4.2.4.1 Viable cell count
The possible cytotoxic effect on PDL-like cells at a range of SAG 
supernatant concentrations was assessed by trypan blue staining. This dye 
is taken up by all cells, but only viable cells are able to pump the dye out. 
Therefore, this dye is only present within non-viable cells.
PDL-like cells were seeded in 24 well plates at a concentration of 1 x 104 
cells/ml with 1ml media and incubated at 37°C in a humidified atmosphere 
of 5% CO2 for 24hr. 500pl media was removed and 500pl of fresh media 
containing bacterial supernatants were added at various concentrations (20, 
50, 100, 500ng/ml, 1, 10, 50, 100, 200, 500|Jg/ml). BHI broth was also 
used as a control. After 24 and 48hr incubation, the cells were washed 
three times with PBS and subsequently incubated with 1ml 0.4% trypan 
blue stain for lmin. The stain was removed and cells washed once with 
PBS. The amount of blue stained cells and non-stained cells were 
immediately counted under an inverted microscope with viability greater 
than 95% deemed to be acceptable.
4.2.4.2 Effect of S. anginosus group supernatants on periodontal 
ligament cell growth
The influence of SAG supernatants on PDL-like cell growth was assessed 
by MTT assay (see section 4.2.3.1). Following determination of viability 
counts for PDL-like cells with a range of supernatant concentrations, there 
was a survival rate of less than 95% for cells cultured with supernatant
i
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concentrations above 50ng/ml. Therefore, for the MTT assay, PDL-like 
cells were cultured with Ong/ml or 20ng/ml of SAG supernatants from day 
0, and every 24h thereafter, for 5 days.
4.2.4.3 Effect of S. anginosus group supernatants on periodontal 
ligament cell alkaline phosphatase activity
PDL-like cells were prepared as in section 4.2.3.2, with the addition of 
Ong/ml or 20ng/ml of SAG supernatants on day 0. The assay was carried 
out on days 2, 5, 7, 10 and 13.
4.2.4.4 Effect of S. anginosus group supernatants on mRNA 
expressions of decorin and biglycan by periodontal ligament cells
PDL-like cells were examined for decorin and biglycan mRNA expression 
in the presence and absence of 20ng/ml of each SAG supernatant. Cells 
were seeded at 1 x 104 cells/cm2 in 6-well plates with media and at day 0, 
the cells were cultured in serum containing media supplemented with or 
without the supernatant, and changed every 24h. On days 2, 5, 7, 10, and 
13, the media was removed and the cells washed three times in PBS, ready 
for subsequent extraction.
4.2.4.4.1 RNA extraction
Isolation of total RNA from PDL cells was carried out using a Qiagen 
RNeasy Mini kit (Qiagen Ltd, West Sussex, UK). The extraction steps 
were carried out according to the manufacturers’ instructions. All steps 
were performed quickly, at room temperature, to minimise RNA
degradation. Contamination with genomic DNA was eliminated using a 
DNA-free kit (Promega, UK), according to the manufacturers’ 
instructions.
4.2.4.4.2 Quantification of total RNA by UV spectrophotometry
2pl of total RNA was diluted in 98pl of RNase-free water (Qiagen Ltd), 
and the absorbance read on a GeneQuant II ‘DNA calculator’ (Amersham 
Biosciences). RNase free water was used to provide a blank reading and 
the absorbance value of each RNA sample was read at wavelengths of 
260nm (E260) and 280nm (E280). The concentration of RNA (pg/ml) was 
determined using:
[RNA pg/ml] = Absorbance (E260) x 40 (RNA factor) x 50 (dilution factor)
The ratio of E260 divided by E280 gave an indication of the purity of the 
RNA obtained, with a ratio of approximately 1.8 suggesting highly pure 
RNA. Values between 1.6 and 2.1 were considered normal; samples above 
or below these values were discarded.
4.2.4.4.3 Reverse-transcription of total RNA
500ng (equivalent volume in pi) of total RNA starting material or water 
control was placed into a 0.2ml thin-walled eppendorf. To each sample 
was added 5 pi x 10 thermophilic DNA polymerase buffer (lOOmM Tris- 
HC1, 500mM KC1 and 1% Triton®X-100), 5pl lOmM dNTPs, lOpl 25mM 
magnesium chloride, lp l 40U/pl RNase inhibitor, 2.5pi 500ng/ml random
hexamers, and 1 pi 200U/pl reverse transcriptase (Promega, Southampton, 
UK). The final volume was made up to 50pl with nuclease-free DEPC 
(diethylpyrocarbonate, Sigma Chemical Co.) treated water. Addition of 
nuclease-free water in replacing the constituents described above provided 
a non-RT control.
All samples were vortexed, centrifuged for lmin at 8, OOOg and incubated 
at 25°C for 10 min, 42°C for 60 min and 95°C for 5 min, for 37 cycles, to 
generate cDNA. The samples were subsequently cooled to 4°C and stored 
at -20°C until required for PCR.
4.2.4.4.4 Polymerase chain reaction (PCR)
PCR was performed to amplify gene sequences relating to decorin and 
biglycan. Levels were compared to the housekeeping gene glyceraldehyde- 
3-phosphate (GAPDH). Primer sequences, optimal magnesium 
concentrations and annealing temperatures are displayed in table 4.1.
The RT products (cDNA), water and non-RT (RNA) control samples were 
added to a PCR mixture containing corresponding sense and antisense 
primers in order to amplify a specific part of the gene of interest. PCR 
mixtures were prepared on ice by adding lp l 0.2mM dNTPs, 2.5|il 1pm 
sense primer, 2.5pi 1pm antisense primer, 5pi x l thermophilic DNA 
polymerase buffer (lOOmM Tris-HCl, 500mM KC1 and 1% Triton®X- 
100), 0.5pl 2.5U Taq DNA polymerase, 3pi magnesium chloride 2pl 
cDNA / non-RT (RNA) / water control, making the final volume up to
50|il with nuclease-free water. All samples were vortexed, then 
centrifuged for lmin at 8, OOOg. Cycling parameters were 94°C for 3 min, 
35 cycles at 94°C for 1 min, 58°C for 1 min and 72°C for 5 min. Samples 
were cooled to 4°C and stored at -20°C until required.
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Table 4.1 Oligonucleotide primer sequences and specific conditions for PDL PCR (Roberts, 2004).
Primer sequence Magnesium
concentration
Annealing
temperature
GAPDH forward primer 
GAPDH reverse primer
5' - TCCCTCAAGATTGTCAGCAA - 3’ 
5' - AGATCCACAACGGATACATT - 3' 
307 bp product
2mM 58°C
Biglycan forward primer 
Biglycan reverse primer
5' - CCTCCAGCACCTCTATGCTC - 3' 
5’ - ACTTTGAGGATACGGTTGTC - 3' 
204 bp product
3mM 58°C
Decorin forward primer 
Decorin reverse primer
5' - CAATAGCATCACCGTTGTGG - 3' 
5' - CCGGACAGGGTTGCTATAAA - 3' 
262 bp product
3mM 58°C
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4.2.4.4.5 Detection of PCR products by agarose gel electrophoresis
PCR products were examined by agarose gel electrophoresis containing 
ethidium bromide, which is a fluorescent chemical that binds nucleic acids 
between base pairs in a double-stranded DNA molecule.
5x TBE buffer was prepared by adding one sachet of TBE (Sigma 
Chemical Co.) to 1 litre of ddH20 and autoclaved. 2% agarose gels were 
prepared by mixing lg  of general-purpose agarose (Bioloine Ltd, London, 
UK) to 10ml 5-x TBE and 40ml ddlUO. The gels were heated until the 
agarose had completely dissolved and cooled to approximately 56°C. 5pi 
of ethidium bromide (500pg/ml) (Sigma Chemical Co.) was added to the 
gel, mixed thoroughly and poured into a gel-casting tray and allowed to set 
for lOmin.
A 100 base-pair marker (Promega) was prepared by mixing lOpl of marker 
with 2pl o f 6 x loading buffer (Promega). lOpl samples were added to 2pl 
of x 6 loading buffer (Promega), then molecular weight marker and 
samples were loaded onto gels and run at 75V for 40 min in 0.5 x TBE 
electrophoresis running buffer. The gels were subsequently visualised 
under UV light and the gel images captured and semi-quantified using 
Bio-Rad Quantity One (Bio-Rad Lab., Hertfordshire, UK).
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4.2.4.5 Extraction and identification of proteoglycans from 
conditioned cell culture medium
PDL cells were re-seeded at 1 x 104 cells/cm2 and cultured in the presence 
and absence of 20ng/ml SMG supernatant. PDL cell culture media (in T25 
flasks) was removed on days 2, 5, 7, 10 and 13 and dialysed, as described 
in section 2.2.2, against ddH20. The fully dialysed extracts were 
lyophilised and stored at -20°C until needed.
4.2.4.6 Immuno-detection of small leucine-rich repeat proteoglycans
PGs present within the tissue culture media from PDL-like cells, cultured 
in the absence and presence of 20ng/ml of SAG supernatants, were 
characterised on the basis of their immuno-reactivity to the polyclonal 
antibodies, anti-decorin (LF113) and anti-biglycan (LF106), by Western 
blot analysis (see section 22.1.2)
4.2.4.7 Glycosaminoglycan detection by cellulose acetate 
electrophoresis
The PDL-like media samples, supplemented with or without 20ng/ml of 
SAG supernatant, were examined for the presence of GAG chains using 
cellulose acetate electrophoresis (section 2.2.13).
4.2.4.8 Immunolocalisation of collagen type I
Due to the well-established presence of collagen type I within the PDL 
ECM, and the literature of evidence demonstrating the influence of decorin 
on collagen fibrillogenesis, the effects of SMG supernatants upon collagen 
type I within the PDL ECM were examined.
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PDL-like cells were reseeded in 6 well plates at 1 x 104 cells/cm2 and 
cultured in serum-containing media at 37°C in 5% CO2 for 24h. The media 
was changed at day 0, after which the media (with and without 
supernatant) was changed every 24h. On days 2, 5, 7, 10, and 13, the 
media was removed and the slide fixed in 2% formaldehyde for 30min 
then stored in PBS at 4°C until sampling was complete.
Prior to staining, the slides were washed in PBS. Normal horse serum 
(Sigma Chemical Co.) was placed in each well and left for lOmin to block 
background staining. This was removed and the cells incubated with 
mouse monoclonal anti-collagen type I (Sigma Chemical Co.), at 1:2,000 
in 0.5% horse serum in PBS for lhr at room temperature. The wells were 
then washed with 0.5% Tween-20 PBS, three times for 5min. Cells were 
incubated with rabbit anti-mouse IgG FITC conjugate secondary antibody 
at 1:100 (Sigma Chemical Co.) for 30min at room temperature. Slides 
were observed directly under a fluorescent microscope (at x40 objective).
4.2.5 Statistical analysis
The Student impaired two-tail T-test (Instat Package, Graph Pad software) 
was performed to obtain /7-values for analysis of differences between cells 
cultured with and without SMG supernatants. /?<0.05 was determined as 
statistically significant.
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4.3 Results
4.3.1 Optimisation of cell culture conditions
To establish the optimal culture conditions for PDL-like cells, culture 
media with and without ascorbic acid was examined. Figure 4.1 illustrates 
the unfavourable effects of ascorbic acid on PDL-like cells. Therefore, 
subsequent analysis of PDL-like cells were carried out without ascorbic 
acid in the growth media.
4.3.2 Passage effects on cell growth and alkaline phosphatase activity
In order to establish the optimal number of times PDL-like cells could be 
passaged until they lost their initial characteristics, PDL-like cells were 
subjected to an MTT and ALPase activity assay. Figure 4.2 shows the 
effects of passaging on PDL-like cells. Average MTT values (absorbance 
at 540nm) over five days in culture were taken from sets of cells from 
passages 1-5. These average MTT absorbance values were subsequently 
compared to average MTT assay results (over a five-day culture period) of 
PDL-like cells from passage 1. It appeared that, on average, PDL-like cells 
became less viable after passage 4. Therefore, PDL-like cells for 
subsequent assays were taken from passages 2-4. ALPase activity (data not 
shown) was also decreased in PDL-like cells from passage 5 compared to 
the activity of those cells from earlier passages.
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Figure 4.1. The effects o f  ascorbic acid (50pg/ml) in serum-containing 
culture media for PDL-like cells. * Significant difference (p<0.05)
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Figure 4.2. The effects o f  passaging on PDL-like cell growth. * 
Significant difference (p<0.05)
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4.3.3 Viable cell count
Following culture o f PDL-like cells with 0 - 500pg/ml o f SAG 
supernatants (one commensal and one pathogen from S. constellatus, S. 
intermedius and S. anginosus), the cells were stained with trypan blue to 
obtain cell viability counts. 100 cells were viewed and the percentage of 
non-viable cells (blue stained) and viable cells (unstained) were counted. 
The percentage of viable cells for each supernatant were calculated from 
the cell count, where a cell viability count greater than 95% was 
acceptable. The cells cultured in the presence o f  Ong/ml and 20ng/ml of all 
SMG supernatants demonstrated a viability o f  95-98%. Cells incubated 
with 50ng/ml had a viability count of 90%, cells cultured with lOOng/ml or 
more of SAG supernatants had viabilities o f 80% and less. Also noted at 
concentrations above 20ng/ml of bacterial supernatant were a number of 
cytoxic effects, appearing appreciably different from control cells, 
including rounding up of cells (data not shown). Therefore, 20ng/ml was 
used in further studies.
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Figure 4.3 The influence o f  SAG supernatants on PDL-like cell 
growth. * Significant difference (p<0.05) between cells co­
cultured with Ong/ml and 20ng/ml o f  supernatant
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4.3.4 The effects of S. anginosus group supernatants on periodontal 
ligament cell growth
The influence of SAG supernatants at a concentration of 20ng/ml on viable 
cell numbers was investigated using the MTT assay (figure 4.3). This 
assay revealed all commensal and pathogenic SAG strains demonstrated 
the same behaviour toward PDL-like cell growth, by increasing PDL cell 
growth in comparison to those PDL-like cells cultured without SAG 
supernatants. For all strains, there was an increase in PDL-like cell growth 
from day 1 to day 5, with statistically significant PDL-like cell growth on 
day 4 (p<0.05), with 10-20% increases, and on day 5 (p<0.05), with up to 
15% increases compared to PDL-like cells cultured without SAG 
supernatants.
4.3.5 The effects of S. anginosus group supernatants on periodontal 
ligament cell alkaline phosphatase activity
Figure 4.4 illustrates the effect SAG supernatants have upon membrane- 
bound alkaline phosphatase activity. The PDL-like cells were cultured at 
day 0 in the absence or presence of individual supernatants and were 
subsequently assessed for ALPase activity at different intervals for 13 
days. PDL cells cultured in the presence of S. intermedius commensal 
(30C) and pathogenic (127/95) supernatants showed a significant increase 
(25%) in ALP activity on day 5 in comparison to PDL-like cells cultured 
without supemtants. However, this initial increase in activity did not 
continue and by day 13 the activity was less than the activity produced by 
PDL-like cells without supernatant.
For S. constellatus supernatants (34C and 322/95), there was a statistically 
significant increase in ALPase activity on day 5 compared to the activity 
of PDL-like cells without supernatant. However, on days 7 and 10 this 
activity began to decrease compared to cells without supernatant. On day 
13 of culture, the ALP activity in PDL-like cells incubated with S. 
constellatus supernatants were statistically significantly decreased 
(p<0.05) compared to PDL-like cells without supernatant.
Both S. anginosus supernatants produced statistically significant decreases 
in ALPase of PDL-like cells on days 5 (-30%  decrease) compared to those 
cells cultured without supernatant. Further statistically significant 
decreases were also observed for the S. anginosus commensal strain (43 C) 
on days 10 and 13 (approximately 35% decrease). The pathogenic strain 
(43586/96) had no significant difference on the ALPase activity of PDL- 
like cells in the later stages of culture.
/
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Figure 4.4 The influence o f  SAG supernatants on PDL alkaline 
phosphatase activity. * Significant difference (p<0.05) between 
cells co-cultured with Ong/ml and 20ng/ml o f  supernatant
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(a)
Figure 4.5. Typical effects o f  SAG supernatants on mRNA  
expressions for biglycan and decorin, standardised against 
GAPDH (example shown is S. constellatus 322/95).
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Figure 4.6. The effects o f  (a) S. intermedius (b) S. 
constellatus and (c) S. anginosus supernatants on mRNA 
expression o f  biglycan and decorin. * Significant difference 
(p<0.05) between PDL-like cells cultured in the absence 
and presence o f  20ng/ml SAG supernatant.
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4.3.6 The effects of S. anginosus group supernatants on biglycan and 
decorin expression by periodontal ligament cells
Figure 4.5 demonstrates the mRNA expressions for biglycan (204bp) and 
decorin (262bp) by PDL cells cultured in absence and presence of SAG 
supernatants. These expressions were normalised against GAPDH and the 
relative mRNA expressions for these SLRPs are illustrated in figure 4.6 (a- 
c).
Figure 4.6 (a) shows the relative mRNA expression of biglycan and 
decorin by PDL-like cells following co-culture with or without S. 
intermedius isolates. In the absence of supernatant, biglycan mRNA 
expression was detected at a steady rate throughout culture. Following 
exposure of PDL-like cells to either commensal or pathogenic S. 
intermedius supernatants, biglycan expression of PDL-like cells appeared 
to produce statistically significant increases from as early as day 2 and 
continued to increase biglycan (compared to cells without supernatants) 
throughout culture until day 13. The increase in biglycan expression by 
PDL-like cells appeared to be of a similar trend for each of the commensal 
and disease isolates of S. constellatus shown in figure 4.6 (b) and S. 
anginosus shown in figure 4.6 (c).
Figure 4.6 (a-c) also show the relative decorin mRNA expression by PDL- 
like cells cultured in the absence and presence of SAG supernatants. 
Decorin expression appeared to increase throughout culture in the absence 
of supernatants. However, on exposure to commensal or pathogenic strains
of S. intermedius, S. constellatus and S. anginosus, the relative mRNA 
expression of decorin decreased in comparison to PDL-like cells cultured 
in the absence of supernatant. For both S. intermedius supernatants, there 
were statistically significant (p<0.05) decreases in decorin levels on days 
10 and 13 (35% and 50% decrease, respectively). Both commensal and 
pathogenic strains of S. constellatus produced the same effect on PDL 
decorin expression, showing significant decreases (p<0.05) on days 7, 10 
and 13 (10-, 15- and 45%, respectively), in comparison to the relative 
amount of decorin mRNA expression by PDL-like cells cultured without 
these supernatants. Also, the commensal and pathogenic strain of S. 
anginosus acted in the same manner as S. constellatus strains, by 
producing significantly less decorin mRNA on days 7, 10 and 13 when 
compared to PDL-like cells cultured without supernatants.
4.3.7 Immimo-identification of small leucine-rich repeat proteoglycans
Following sample digestion with chondroitinase ABC, typical Western 
blots identifying the PG species present within media extracts of PDL-like 
cells, subsequent to culture in the absence and presence of SAG 
supernatants are shown in figure 4.7 (a), and figure 4.7 (b) respectively.
In the absence of SAG supernatant, LF 106, which detects a sequence in 
the terminal of biglycan, produced an intense immuno-response from day 
2 which continued throughout culture until day 13, with a band 
recognisable at approximately 45kDa. Other observable bands were 
present including a strong band at about 98kDa, and a range of bands 
between 45-28kDa.
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The immuno-detection of decorin within PDL-like cells was carried out by 
utilising LF-113, which has an epitope to the sequence in the N-terminal of 
the decorin core protein. In the absence of SAG supernatants, this antibody 
produced intensely stained bands at approximately 38- and 45kDa from 
day 2 through to day 13, with other bands detected at 28- and 17kDa.
Following co-culture with supernatants, immuno-detection for biglycan 
showed a band was evident at approximately 45kDa throughout culture, 
with other bands detectable from approximately 28- to 6kDa. Decorin 
immuno-detection for PDL-like cells cultured with SAG supernatants 
produced visible bands at approximately 45kDa, however, there was less 
intense staining when compared to decorin detection from cells without 
supernatants. Staining at 45kDa appeared to decrease from day 7, in the 
presence of SMG supernatant, until it was undetectable at day 13. Other 
bands at 28- to 6kDa were visible and did not decrease in reactivity 
throughout culture.
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Figure 4.7. Typical Western blot analysis, following chondroitinase ABC 
digest, for the immuno-identification o f  biglycan and decorin synthesised 
into the media by PDL-like cells (a) without SAG supernatant (b) with 
20ng/ml SMG (322/95) supernatant.
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Figure 4.8. Typical glycosaminoglycan profiles produced 
by PDL-like cells with (a) no supernatant (b) S. constellatus 
or S. intermedius isolates, and (c) S. anginosus isolates.
(a) Ong/ml SAG supernatant 
Day
2
5
Std HA DS C4SC6S
7
10
13
(b) 20ng/ml S. constellatus / S. intermedius supernatants 
Day
2 1  1
5
Std HA
7
10
13
Std = Standard
170
(c) 20ng/ml S. anginosus supernatants
Day
2
Std HA DS C4S C6S
10
13
171
4.3.8 The effects of S. anginosus group supernatants on periodontal 
ligament cell glycosaminoglycan synthesis
The GAG chains were released from the PG media samples by protease 
digestion and analysed by cellulose acetate electrophoresis. Identification 
was judged on the distance of sample GAG migration compared to the 
GAG standard mixture.
A typical GAG separation profile from PDL-like cells cultured without 
SAG supernatants is shown in figure 4.8 (a). Cellulose acetate 
electrophoresis revealed the predominant presence of HA, DS and CS 
throughout culture in the absence of SAG supernatants, with an average of 
35%, 32% and 33% of the total GAG content, respectively.
GAG analysis of PDL-like cell media following co-culture with 
commensal and pathogenic strains of S. constellatus and S. intermedius 
showed a similar pattern, illustrated in figure 4.8 (b). There was a gradual 
decrease in DS and CS from day 2 to day 13, with average decreases of 
32% down to 21%. However, the intensity of HA increased when PDL- 
like cells were exposed to S. constellatus and S. intermedius supernatants. 
This increase in HA from day 2 through to day 13, averaged from 36% of 
the total GAG content to 47%.
Figure 4.8 (c) illustrates that, in the presence of commensal and pathogenic 
S. anginosus supernatants, HA was present from day 2 to day 7, after
which it appeared to decrease in intensity. CS and DS levels also
/
172
decreased over the culture period with an average presence of 33% on day 
2 to 29% on day 13 for both GAGs.
In order to confirm the identification of the iduronic acid-containing 
GAGs, specific enzyme digestion with chondroitinase AC was carried out 
(data not shown). There was apparent DS detection for PDL-like cells on 
days 2, 5, 7, 10 and 13 when co-cultured with all SAG supernatants albeit, 
decreasing in proportions as the time course progressed. Digestion with 
chondroitinase ABC (data not shown), which depolymerises both 
glucuronic acid and iduronic acid containing GAGs, demonstrated no 
identifiable GAG, thus indicating the presence o f HA, DS and CS in all 
samples.
4.3.9 The effects of the S. anginosus group supernatants upon collagen 
within the periodontal ligament cell extracellular matrix
The PDL cells were immuno-stained for collagen type I, in order to 
observe the effects of SAG on ECM formation. Figure 4.9 demonstrates 
the presence of collagen type I within the normal matrix (Ong/ml) and the 
typical effects of supernatant upon collagen type I within the PDL matrix. 
In the absence of SAG supernatant, there is an increase in collagen from 
day 2 until day 13. However, in the presence of SAG supernatant there 
was a decrease in immuno-staining from day 2 until day 7, after which 
there was no staining of collagen. All supernatants from commensal and 
pathogenic strains of SAG appeared to behave in the same manner.
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Figure 4.9. Typical immuno-localisation o f collagen within periodontal ligament cells extracellular 
matrix following culture in the absence (Ong/ml) and presence (20ng/ml) o f SAG supernatant 
(example shown is S. constellatus 34C).
4.4 Discussion
The present study has investigated the effect of commensal and pathogenic 
supernatants of S. constellatus, S. intermedius and S. anginosus on PDL- 
like cells, with regards to cell growth, differentiation and matrix synthesis. 
By analysing gene expression and identification of the corresponding 
protein secreted by the cells, the results firmly indicate a differing pattern 
of expression for decorin and biglycan by PDL-like cells when exposed to 
SAG, with potential effects upon collagen within the matrix. The results 
obtained from this study provide strong evidence to suggest that SAG are 
potentially capable o f damaging the ECM of the PDL.
Initial culture conditions for PDL-like cells were determined by assessing 
cell viability in the presence or absence of ascorbic acid. Ascorbic acid is a 
known co-factor and anti-oxidant that stimulates the transcription, 
translation and post-translational processing of collagen in connective 
tissue cells (Francesshi, 1992). In the present study, the addition of 
ascorbic acid failed to show any benefits as the PDL cells were more 
viable in the absence of ascorbic acid. Also, PDL cells cultured without 
ascorbic acid did not fail to produce a collagenous matrix, as demonstrated 
by later collagen immuno-detection studies. There are previous studies that 
have used ascorbic acid in t|ie conditioned culture media of PDL cells and 
there are studies that have not used ascorbic acid. Most notably, ascorbic 
acid has been added to PDL culture media in numerous studies in order to 
demonstrate the potential osteogenic potential of these cells (Marquez-San 
Miguel et al., 2003; Shiga et al., 2003; Ishikawa et al., 2004).
Crude bacterial supernatants were used as a representative of a 
combination of factors released by the bacterial cells. Bacterial 
supernatants have been utilised in a number of studies to observe effects 
upon host cells, as secreted toxins play an important role in bacterial 
pathogenesis. Sukeno et al. (2005) used S. intermedius supernatants to 
observe the effects of secreted toxins upon liver cells. This group also 
demonstrated culture supernatants of S. intermedius mirrored the results 
obtained using live bacteria with regard to the effects on hepatic cells. 
Other studies include Zhang and Maddox (2000) who used crude 
supernatants of coagulase negative staphylococci to study cytoxic activity 
in bovine mastitis and Ohkusa et al. (2003) induced experimental 
ulcerative colitis by Fusobacterium varium by exposing Vero cells to 
culture supernatants.
The MTT assay has previously been used to establish the effect of oral 
bacteria on cell growth and proliferation o f periodontal cells (Yamasaki et 
al., 1998; Roberts, 2004). Within this study, the cell growth of PDL-like 
cells appeared to increase when co-cultured with 20ng/ml of all SAG 
supernatants, particularly from days 3 to 5. A possible explanation for the 
increase compared to PDL-like cells cultured without SAG supernatant is 
the initiation of an inflammatory response. The increase in this study is in 
agreement with a number of studies that have detected an increase in cell 
growth when certain cells are in contact with bacterial extracts/products. 
Through histopathology and immuno-staining analysis, it was reported that
infection with the bacterium Citrobacter rodentium increased epithelial 
cell proliferation (Newman et al., 2001) as does Helicobacter pylori in 
mucosal cells (Lynch et al., 1999), with both of these bacteria being linked 
to colonic and gastric cancer. Roberts (2004) demonstrated an increase in 
rat alveolar bone-like cell growth and proliferation, via the MTT assay, 
when these cells were co-cultured with P. gingivalis lipopolysaccharide, 
compared to cells cultured without this bacterial product. Also, Belibasakis 
et al. (2002) found Actinobacillus actinomycetemcomitans, which 
possesses a cytolethal distending toxin (cdt), inhibited proliferation of 
gingival fibroblasts and PDL cells without affecting their viability, with no 
evidence of lysis or apoptosis detected. Total protein synthesis remained 
unaffected, and cells exhibited an elongated and distended cell body, 
suggesting cdt may compromise tissue homeostasis in the periodontium.
SAG had a profound effect upon the ALPase activity of PDL-like cells, 
with an overall decrease in ALPase activity by all SAG supernatants 
compared to cells cultured without supernatants. The marked decrease in 
ALPase activity following culture with SAG suggests that this group of 
bacteria could target the osteoblast-like cell type or their progenitor cell 
within the heterogeneous cell population of the PDL. Marquez-San 
Miguel et a l (2003) showed that extracts from a range of periodontopathic 
bacteria, such as P. gingivalis and T. denticola, caused the suppression of 
ALP activity and reduced the collagen content of human periodontal 
fibroblasts. Marquez et al. suggested the extracts from these Gram 
negative bacteria contain not only soluble proteins, but also butyric acid,
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propionic acid and collagenases that may have a direct influence on 
periodontal fibroblasts. Murata et a l  (1997) studied the effects of various 
oral-related bacteria, including P. gingivalis, A. actinomycetemcomitans, 
and Streptococcus spp. on bone formation of MC3T3-E1 cells (immature 
embryonic cells with osteoblast-like activity). P. gingivalis and A. 
actinomycetemcomitans decreased the ALPase activity in a dose- 
dependent manner, whereas Streptococcus spp., including S. milleri, did 
not influence the ALPase activity in of MC3T3-E1 cells. In the current 
study, the relative inhibition of ALPase activity o f PDL-like cells 
following bacterial application suggests that products present within the 
SAG supernatants could target mature osteoblast-like cells within the 
heterogeneous population of PDL cells, rather than immature cells of this 
type.
The relative mRNA expression of biglycan and decorin from PDL-like 
cells co-cultured with SAG supernatants showed an increase in biglycan 
and a decrease in decorin compared to the relative mRNA expressions of 
these SLRPs from PDL-like cells cultured without SAG supernatants. 
These results were supported by immuno-detection of the SLRPs. The 
detection of protein at approximately 45kDa, in both experimental 
conditions correspond to the core protein o f both SLRPs. Other detectable 
proteins larger or smaller than 45kDa may represent a combination of the 
intact PG and PG metabolites, formed in the process of catabolism and/or 
remodelling of the PDL matrix.
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Differences seen in expression between decorin and biglycan maybe due to 
the different roles they play within the matrix and their being located 
differently. Biglycan has a pericellular location while decorin is bound to 
the collagen network (Bianco et al., 1990). In the presence of SAG 
supernatant, biglycan expression significantly increases from day 2 
through to day 13 compared to those PDL-like cells cultured in the 
absence o f supernatants. This strong detection of biglycan could indicate a 
number o f roles for this PG, emphasising a function in cell signalling, 
possible related to cellular growth (Chen et al., 2002). Waddington et al. 
(2003) identified periods of decorin and biglycan expression within a 
primary rat bone cell culture model. Analysis of biglycan mRNA levels 
revealed expression during phases related to cell proliferation. Biglycan 
has also been implicated as a pro-inflammatory factor, by acting as an 
endogenous ligand of TLR4 and TLR2, which mediate innate immunity 
and increase TNF-a (Schaefer et al., 2005).
There are a number of studies that suggest SLRPs, particularly decorin, 
can directly or indirectly influence cell growth, via epidermal growth 
factor receptor (EGFR) or TGF-6. In transformed cells, such as A431 
squamous carcinoma cells, decorin elicits growth suppression by binding 
to EGFR. This interaction induces phosphorylation of the EGFR, which 
leads to activation of the mitogen-activated protein kinase (MAPK) 
pathway, up-regulation of p21 cyclin-dependent kinase inhibitor 
expression (leading to cell cycle arrest), and an increase in the intracellular 
Ca2+ level (De Luca et al., 1996; Santra et al, 1997; Moscatello et al, 1998;
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Iozzo, 1999). However, within PDL cells, blocking of the EGFR tyrosine 
kinase activity did not prevent decorin-induced growth inhibition and p21 
expression, suggesting an alternative or additional signal transduction 
pathway within these cells, which are heterogeneous in nature (Hakkinen 
et al., 2000). Biglycan is not capable of activating the EGFR (Moscatello 
etal., 1998).
The ability o f decorin and biglycan to complex with TGF-B isoforms 
suggests another mechanism via which these SLRPs influence cell growth. 
Altered patterns of expression of SLRPs in the presence of SAG 
supernatants is likely to involve TGF- B, although this can only be 
hypothesised at the present time.
A change in production of PGs and/or their side-chains may influence the 
fibroblast, either directly or indirectly, through modulating growth factor 
and cytokine activity. An important example of this is the abrogation of 
the activity of TGF-P by decorin (Hildebrand et al., 1994). Another 
possible explanation for the observed increase of biglycan and decrease in 
decorin following exposure to SAG supernatants could be through the 
ability o f these SLRPs to bind TNF-a, (Tufvesson and Westergren- 
Thorsson, 2002). One possibility is that decorin can function as a reservoir 
for sequestering TNF-a out in the ECM. In inflammation, there is an 
increase in TNF-a expression, as well as a decrease in decorin, that 
reduces this resevoir, resulting in an additional release o f TNF-a. Partial 
proteolysis of decorin due to the action of MMPs could be an explanation
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for releasing immobilised TNF-a. Furthermore, the up-regulation of 
biglycan, which at its pericellular location binds TNF-a, could augment a 
higher concentration of TNF-a closer to the cell, promoting association of 
the cytokine to its cell surface receptors (TufVesson and Westergren- 
Thorsson, 2002). Overall, the observations of SLRPs within the current 
study support the hypothesis that there are different roles for SLRPs within 
the inflamed PDL and that SAG supernatants may have consequences 
upon cell growth through modulation of SLRPs.
Immuno-localisation studies in the present chapter demonstrated an 
increase in collagen content in a time-dependent manner for those PDL- 
like cells cultured without SAG supernatants. However, for PDL-like cells 
cultured with SAG supernatants, there was a marked decrease in collagen 
content throughout the culture period. The ability of SLRPs to interact 
with collagen and facilitate collagen fibril formation have been proposed 
as having important roles in the requirement of a collagenous framework, 
associating with fibrillar collagens and regulating collagen fibrillogenesis 
(Vogel and Trotter, 1987; Sugars et al., 2003). Structural organisation of 
collagen may also be important for the defence against periodontal disease, 
because in certain conditions abnormal collagen fibrils associate with 
increased susceptibility to periodontal disease. Matheson et al. (2005) 
studied the role of SLRPs to regulate collagen fibril and fibril bundle 
formation in periodontal tissues. To assess the function o f SLRPs they 
studied periodontal tissues of mice harboring targeted deletions of decorin, 
fibromodulin or lumican genes and lumican and fibromodulin double
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knockout mice using histological and electron microscopic methods. They 
demonstrated SLRPs were co-expressed in human and mouse gingival and 
periodontal ligament connective tissues where they co-localized with 
collagen fibril bundles. Teeth in the knockout animals were fully erupted 
and showed normal gross morphology. Targeted deletion o f decorin, 
fibromodulin, and lumican resulted in abnormal collagen fibril and fibril 
bundle morphology that was most evident in the periodontal ligament. 
This indicated that decorin, fibromodulin and lumican co-ordinately 
regulate the fibrillar and suprafibrillar organisation of collagen in the 
periodontal ligament. In periodontal disease, the breakdown of the 
collagen-rich connective tissue matrix parallels a decrease in the level of 
decorin in inflamed connective tissue (Oksala et al., 1997). The immuno- 
localisation results obtained in this study along with the observed decrease 
in decorin expression suggests that SMG supernatants have an 
unfavourable effect on matrix formation and assembly. It is possible that 
abnormal collagen organisation, because of decorin deficiency, may lead 
to increased susceptibility to periodontal disease (Hakkinen et al, 2000) 
and undermine periapical integrity. However, it is also known that the 
SAG secrete collagenases, therefore the decreasing effect observed with 
decorin could be a secondary event following bacterial degradation of 
collagenase. Overall, aberrant ECM expression may enhance inflammatory 
tissue breakdown and encourage perapical abscess formation.
With regard to the GAG moiety, PDL-like cells cultured in the absence of 
SAG supernatants showed a constant production in HA, CS and DS,
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suggesting these GAGs encourage cell development and matrix formation. 
GAGs are important in regulating assembly o f collagen fibrils. Small PGs 
substituted with CS isolated from cartilage were reported to promote 
fibrillogenesis (Vogel and Trotter, 1987). Studies using recombinant 
decorin substituted with CS chains have also shown that both the core 
protein and GAG chain are capable o f promoting collagen fibrillogenesis 
(Sugars et al., 2003). Following co-culture with SAG supernatants, the 
nature of the GAG moiety o f PDL cells appeared to be affected. For S. 
constellatus and S. intermedius supernatants, there was an increase in HA 
proportions whereas there was a decrease in CS and DS proportions. 
However, S. anginosus supernatants did not appear to effect HA as the 
other supernatants, but S. anginosus isolates did decrease CS and DS 
proportions. The altered GAG expression may suggest that matrix 
remodelling is being inhibited, hence delaying favourable conditions for 
tissue repair.
The decreasing proportions of CS and DS may be due to the observed 
decrease in decorin within the PDL matrix, particularly for the decrease 
observed in DS proportions. Although biglycan is increased within this 
study it may not be glycosylated, as various forms of this SLRP have 
previously been reported (Hocking et al., 1996; Tufvesson et al., 2002). 
However, bacterial degradation of GAGs cannot be discounted at this time, 
as the hydrolytic enzyme production o f SMG is well established. 
Chondroitin sulfatase activity has been observed within the SMG, 
particularly S. intermedius and S. constellatus (Homer et al., 1993; Jacobs
183
and Stobberingh, 1995), which provides a plausible explanation for the 
decrease in CS proportions observed in PDL-like cells cultured with SAG 
supernatants. In addition, the decrease in CS within cells co-cultured with 
supernatants observed in this study supports the independent effects of 
SAG supernatants on ALP-positive cells, as osteoblast-like cells are likely 
to carry the CS GAG chain. Although there was a clear decrease in the 
total GAG content o f CS following culture with SAG supernatants, CS 
presence did not disappear completely. This is possibly due to the presence 
of larger PGs, such as versican, abundantly expressed by PDL cells 
(Laijava et al., 1992), however, the detection o f this large CSPG was not 
conducted in this study. The presence o f versican in PDL is well- 
established and roles in other tissues in the initial formation o f the ECM 
have been proposed (Zimmerman and Ruoslahti, 1989). Therefore, the 
reduction in CS by PDL-like cells in the present study may suggest a 
reduction in versican synthesis, which in turn may effect matrix formation.
The data presented within this chapter suggests that the SAG may alter 
ECM components and their synthesis directly via a suppression of PDL 
differentiation or via a reduction or destruction of the ECM. It is of interest 
to note that SAG supernatants can potentially modulate various functions 
of PDL-like cells, including those o f decorin and biglycan, present in host 
tissues. However, it is only possible to hypothesise the consequence of 
altered PG levels at this time.
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CHAPTER FIVE
Chapter 5
Endothelial cellular response to Streptococcus anginosus group
supernatants
5.1 Introduction
Dentoalveolar infections, including dentoalveolar abscesses, can develop 
by the extension o f the initial carious lesion into dentine, and spread of 
bacteria to the pulp via the dentinal tubules. They can also develop via the 
perapical tissues (PDL, cementum and alveolar bone) due to open 
communication of these tissues to the root canal space and vice versa 
(Love and Jenkinson, 2002).
The pulp and surrounding periodontal tissues are extremely vascularised. 
Blood vessels are fundamentally composed of endothelial cells, which 
inter-connect to form the tubes that direct and maintain blood flow and 
tissue perfusion (Hanahan and Folkman, 1996). They are vital for the 
proper functioning o f blood vessels by aiding in the regulation of blood 
flow, inhibition o f smooth muscle cell growth, and resisting thrombosis 
(Bermophl et al., 2005).
The functional state of endothelial cells (quiescent or angiogenic) is 
regulated by a number of growth factors and cytokines (Roberts and 
Spom, 1989). However, and of relevance to this thesis, the functional state 
of endothelial cells appears to correlate with the expression of specific 
SLRPs (Schonherr et al., 2001). Resting endothelial cells in vivo as well as
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confluent cells in vitro constitutively express biglycan, which becomes up- 
regulated when endothelial cell migration is stimulated (Jarvelainen et al., 
1991; Kinsella et al., 1997). Nelimarkka et al. (1997) made similar 
observations using a cell line derived from human umbilical vein 
endothelial cells. This group demonstrated that, when forming monolayer 
cultures typical o f macrovascular endothelial cells, this cell line expresses 
and synthesise detectable amounts o f biglycan, but not decorin. However, 
it has been demonstrated that decorin is expressed in human capillary 
endothelial cells during inflammation when angiogenesis occurs 
(Schonherr et al., 1999).
As well as constitutively expressing SLRPs, endothelial cells synthesise 
HSPGs, including perlecan (Saku and Furthmayr, 1988), members of the 
cell surface associated PGs, syndecan and glypican (Mertens et al., 1992). 
Growth factors and cytokines can regulate PG synthesis in endothelial 
cells, particularly TGF-p. This process appears to be cell density- 
dependent; TGF- p promotes the synthesis of both perlecan and biglycan 
when the cell density is high whereas only biglycan synthesis is stimulated 
when the cell density is low. Furthermore, GAG chains in biglycan are 
longer at a high cell density (Kaji et al., 2000).
When challenged by bacteria, the endothelium responds by presenting a 
thrombotic surface and increasing vessel permeability, thereby allowing 
local adherence, activation and extravasation of inflammatory cells. 
Angiogenesis and vascular remodelling are important features of many
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chronic inflammatory diseases. Angiogenesis can be initiated in 
pathological circumstances in order to repair vessels and preserve tissue 
structure and function. However, it can also contribute to the pathology of 
diseases such as periodontal and pulpal disease, by exacerbating the 
inflammatory conditions (Ezaki et al., 2001). Rajashekhar et al. (2006) 
reported endothelial expression of a transmembrane form of the pro- 
inflammatory cytokine TNFa activated the endothelium, enhancing sprout 
formation independently of angiogenic growth factors.
In view of the importance of endothelial cell response to bacterial 
challenge, the aim of this chapter was to observe the response of a human 
aortic endothelial cell line to SAG supernatants. More specifically, the 
objective was to determine the role of SAG in endothelial cellular growth, 
the effect on migratory properties, and the expression of decorin and 
biglycan PGs within endothelial cells.
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5.2 Materials and methods
5.2.1 Endothelial cell culture conditions
EA.hy926 cells were generated by immortalisation of human umbilical 
vein endothelial cells (HUVECs) (Edgell et al., 1983). HUVECs were 
fused with the immortalised human lung epithelial carcinoma cell line 
A549 and retained the signalling characteristics of HUVECs. In this study 
EA.hy926 cells (a kind gift from Dr Elke Schonherr/Loma Fiedler) were 
grown in MCDB 131 media (Difco) supplemented with 10% fetal bovine 
serum (FBS) (Difco), glutamine (Difco), antibiotics mixture (100 units/ml 
penicillin G, 10 mg/ml streptomycin sulphate, 25mg/ml amphotericin B) 
(Sigma Chemical Co.) and 1 x hypoxanthin/aminopterin/thymidine (HAT) 
(Invitrogen).
5.2.2 Bacterial strains
The bacterial strains used in this study were the same as those used in 
chapter 4: S. constellatus 322/95 and 34C; S. intermedius 127/95 and 30C; 
S. anginosus 43586/96 and 43C (for original sources see table 3.1). The 
supernatants were prepared as in section 4.2.1.
5.2.3 Endothelial cellular response to S. anginosus group supernatants
5.2.3.1 Viable cell count
Similar to section 4.2.4, EA.hy926 cells were seeded as a monolayer, at a 
concentration of 1 x 105 cells/ml in 24 well plates with 1ml media and 
incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2 for
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24h. 500p.l media was removed and 500(4.1 of fresh media containing 
bacterial supernatants were added at various concentrations (10, 50, 100, 
500ng/ml, 1,10, 50, 100, 200, 500(1g/ml, 1 mg/ml -  determined using the 
BCA protein assay as described in section 2.2.6) and diluted with working 
media. BHI broth was used in place of the bacterial supernatant, as a 
control. After 24 and 48 hr of incubation, cell growth was determined by 
trypan blue dye exclusion. The assay was carried out in triplicate and the 
highest concentration at which all the cells exhibited cytopathic effects 
was recorded as the cytotoxic level.
5.2.3.2 Effects of S. anginosus group supernatants on endothelial cell 
growth
The influence of SAG supernatants on endothelial cell growth was 
assessed by MTT assay (as described in section 4.2.3.1). Following 
determination of viability counts for endothelial cells with a range of 
supernatant concentrations, there was a survival rate of less than 95% for 
cells cultured with supernatant concentrations above 500ng/ml. Therefore, 
for the MTT assay, endothelial cells were cultured with Ong/ml or 
lOOng/ml of SAG supernatants from day 0, and every 24h thereafter, for 5 
days.
5.2.3.3 Effects of S. anginosus group supernatants on endothelial cell 
migration
A migration assay was performed using endothelial cell cultured as 
spheroids according to Korff and Augustin (1998) and Loma Feidler
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(personal communication). EA.hy926 cells (lOOO/lOOpl), were suspended 
in Waymaouth medium supplemented with 5% heat-inactivated FCS, and 
30% methyl cellulose (Sigma). Cells were seeded at lOOpl/well of a 96- 
well round bottom hydrphobic plate (Griener Bio-One Ltd, UK), and 
incubated for 48h at 37°C, 5% CO2. After incubation, all suspended cells 
associated to form a single spheroid per well, of equal size and shape. 
Using cut-off 1ml pipette tips, each spheroid was removed, transferred to 
individual 15ml tubes (Greiner Bio-one, Gloucestershire, UK), and 
pelleted by centrifugation at lOOOrpm for 2 min. The medium was 
exchanged for Waymouth medium supplemented with 0.5% heat- 
inactivated FCS, without (control) and with lOOng/ml of SAG supernatant, 
a final volume was maintained at approximately lOOpl per spheroid. lOOpl 
of each spheroid and culture media (with or without lOOng/ml SAG 
supernatants) was transferred to one well of a flat bottomed 96-well 
hydrophilic plate (Cellstar, Griener), with a minimum of 12 wells for each 
supernatant. Images were captured at 6-72h at 40x magnification using an 
Olympus CK2 microscope using a Nikon E995 digital camera. Spheroid 
height and width at the indicated time-points were measured on Adobe 
Photoshop (Adobe Systems Incorporated), using the ruler tool and the 
average and standard deviation for each variable and time-point was 
calculated. Spheroids cultured with lOOng/ml SAG supernatants were 
statistically compared to spheroids cultured without supernatants (see 
section 5.2.4).
190
§.2.3.4 Effects o f S• anginosus group supernatants on decorin and 
biglycan mRNA expressions of endothelial cells
EA.hy926 cells, cultured as monolayers, were examined for decorin and 
biglycan mRNA expression in the presence and absence of lOOng/ml of 
each SAG supernatant. At day 0 the cells were seeded at 1 x 105 cells/ml 
cultured in MCDB 131 serum containing media supplemented with or 
without the supernatants and continued to be cultured as in section 5.2.1.
On days 1, 3, 5, and 7, the media was removed and the cells washed three 
times in PBS. RNA was subsequently extracted as in section 4.2.4.4.I. The 
total RNA was quantified by UV spectrophotometry as described in 
section 4.2.4.4.2. Total RNA was reverse-transcribed (see section 
4.2.4.4.3), followed by PCR (see section 4.2.4.4.4). For EA.hy926 
endothelial cells, the primer sequences for decorin, biglycan and the 
housekeeping gene glyceraldehyde-3-phosphate (GAPDH) are displayed 
in table 5.1 along with the optimal magnesium concentration and 
annealing temperatures. The detection of PCR products was performed by 
agarose gel electrophoresis as described in section 4.2.4.4.5.
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Table 5.1. Oligonucleotide primer sequences and specific conditions for EAhy.926 PCR.
Magnesium
concentration
Annealing
temperature
GAPDH forward primer 
GAPDH reverse primer
5' -  GTCAGTGGTGGACTGACC - 3'
5' -  ACCTGGTGCTCAGTGTAGCC - 3'
123 bp product (Strazynski et al., 2004)
2mM 51°C
Biglycan forward primer 
Biglycan reverse primer
5' -  CCCTCTCCAGGTCCATCCGC - 3’
5' -  GAGCTGGGTAGGTTGGGCGGG - 3' 
480 bp product (Chen et al., 2002)
2mM 63°C
Decorin forward primer 
Decorin reverse primer
5' -  AGCTGAAGGAATTGCCAGAA - 3'
5' -  TGGTGCCCAGTTCTATGACA - 3'
132 bp product (Strazynski et al., 2004)
2mM 51 °C
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5.2.3.5 Extraction and identification of proteoglycans from 
conditioned cell medium
EA.hy926 cells were seeded at a density of 1 x 105 cells/ml in T25 flasks 
(Griener), in MCDB 131 serum containing media supplemented with or 
without lOOng/ml SMG supernatants. Culture medium was removed and 
collected on days 1, 3, 5, and 7 and dialysed against ddFkO, as in section 
2.2.2. The dialysed media samples were lyophilised and stored at -20°C 
until required. For the immuno-detection of SLRPs, the tissue culture 
media from EA.hy926 cells were characterised on the basis of their 
immuno-reactivity to the polyclonal antibodies, anti-decorin (LF113) and 
anti-biglycan (LF106), by Western blot analysis (as described in section 
2 2 .12 )
5.2.3.6 Glycosaminoglycan detection by cellulose acetate 
electrophoresis
The EA.hy926 media samples, supplemented with or without lOOng/ml of 
SAG supernatant, were examined for the presence of GAG chains using 
cellulose acetate electrophoresis (see section 2.2.13).
5.2.4 Statistical analysis
The Student unpaired two-tail T-test (Instat Package, Graph Pad software) 
was performed to obtain ^ -values for analysis of differences between cells 
cultured with and without SMG supernatants. p<0.05 was determined as 
statistically significant.
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5.3 Results
5.3.1 Viable cell count
Following culture of EA.hy926 cells with 0-1 mg/ml of SAG supernatants 
(one commensal and one pathogen from each of the three species; S. 
constellatus, S. intermedius and S. anginosus), the cells were stained with 
trypan blue to obtain cell viability counts. 100 cells were viewed and the 
percentage of non-viable cells (blue stained) and viable cells (unstained) 
were counted. The percentage of viable cells for each supernatant was 
calculated from the cell count, a cell viability count greater than 95% was 
acceptable. The cells cultured in the presence of Ong/ml and lOOng/ml, of 
all SMG supernatants, demonstrated a viability of 95-98%. Cells incubated 
with over 500ng/ml had viability counts of less than 80%. Therefore, 
lOOng/ml of bacterial supernatant was used in further studies.
5.3.2 Effects of S. anginosus group supernatants on endothelial cell 
growth
The influence of SAG supernatants at a concentration of lOOng/ml on 
viable endothelial cell numbers was investigated using the MTT assay. All 
strains of SAG species exhibited the same behaviour, namely, the growth 
of endothelial cells increased following culture with lOOng/ml SAG 
supernatants (figure 5.1). Statistically significant differences were 
observed on days 3 and 4 with average growth increases of 30% in 
comparison to cells cultured without supernatant. The largest stimulatory 
effects were observed on day 5 (average 40-50% increases).
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Figure 5.1. Effects o f SAG supernatants on EA.hy 926 cell 
growth. * Significant difference (p<0.05) between cells co­
cultured with Ong/ml and lOOng/ml o f supernatant.
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5.3.3 Effects of S. anginosus group supernatants on endothelial cell 
migration
Figure 5.2 illustrates the effects of SAG supernatants on the migration 
properties o f endothelial cells. The cells showed statistically significant 
migration (2- to 3-fold higher) in the absence o f SAG supernatants from 6h 
through to 72h, compared to cells cultured with supernatants. At 6h, the 
migratory distances o f cells cultured without supernatant were, on average, 
28% more than those cells co-cultured with SAG supernatants. At 24h, the 
migratory distance rose to a 40% increase compared to cells co-cultured 
with SAG supernatants, and at 48h there were increases between 30 and 
60% for the migration o f cells without supernatants.
There appeared to be a difference between commensal and disease SAG 
isolates. For supernatants derived from disease strains (43586/96 and 
127/95), cell migration appeared to be less compared to commensal 
supernatants assayed. However, this was deemed not to be statistical 
significant within our sample population.
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Figure 5.3 (a) Biglycan and decorin mRNA expression 
from EA.hy926 cells (example shown is S. intermedius 
127/95)
Ong/ml supernatant lOOng/ml supernatant
Day 1 3 5 7 1 3 5 7
GAPDH
BGN
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Figure 5.3 (b-d) Relative biglycan mRNA expression. * 
Significant difference (p<0.05) between cells co-cultured 
with Ong/ml and lOOng/ml o f  supernatant
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5.3.4 Effects of S. anginosus group supernatants on biglycan and 
decorin expression by endothelial cells
Figures 5.3 (a-d) show the mRNA expressions for biglycan and decorin by 
endothelial cells cultured in the presence and absence o f lOOng/ml SAG 
supernatants. In the absence o f bacterial supernatants, biglycan mRNA 
expression was detected as early as day 1, with a band identifiable at 
204bp. This detection remained constant throughout culture until day 7. 
However, in the presence o f SAG supernatants, the expression o f biglycan 
was strong on day 1 but detection subsequently decreased. On days 5 and 
7 significantly reduced (p<0.05) levels o f biglycan mRNA were evident 
compared to cells cultured without supernatants, demonstrating an average 
decrease o f 20% on day 5, and 30% on day 7. Decorin mRNA expression 
was not apparent in endothelial cells cultured in the absence or presence of 
SAG supernatants.
53 .5  Immuno-identification of small leucine-rich proteoglycans
Western blot analyses identifying the PG species produced by EA.hy926 
cells, without and with SMG supernatant (322/95) are shown in figure 5.4 
(a) (anti-biglycan) and figure 5.3 (b) (anti-decorin).
In the absence o f supernatant, LF 106, which detects a sequence located in 
the N-terminal o f  biglycan, demonstrated immuno-reactivity from day 1. A 
positive reactivity using this antibody continued throughout culture, until 
day 7. A number o f bands were revealed from 200kDa down to 17kDa. 
Sharp bands were visible at 98kDa and a doublet at approximately 45kDa,
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which became much more intensive following the action o f chondroitinase 
ABC. Other bands were visible below 38kDa, and were regarded as 
degradation products of biglycan.
In the presence o f SAG supernatants, biglycan detection was also detected 
at day 1 and continued throughout co-culture until day 7, thus biglycan 
expression appeared to be the same as for biglycan expression by cells 
cultured without supernatant. As with immuno-reactivity for cells cultured 
without supernatants, there was strong detection at 98kDa and a doublet at 
approximately 45kDa. There were also bands detected below 38kDa, again 
regarded as degradation products. There were no evident differences in 
biglycan immuno-detection between strains o f the SAG.
Immuno-detection for decorin with LF-113, whose recognition site rests in 
a sequence in the N-terminal o f decorin, did not produce an immune- 
reactive response in cells cultured in the presence or absence o f SAG 
supernatant. This result is in accordance with the mRNA results observed 
within this study.
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Figure 5.4 Western blot analysis o f  (a) biglycan and (b) 
decorin by EA.hy926 cells in the absence and presence o f  
SAG supernatants (example shown is S. constellatus 
322/95).
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5.3.6 Effects of S. anginosus group supernatants on endothelial cell 
glycosaminoglycan composition
The GAG chains were released from the PG samples by protease digestion 
and analysed by cellulose acetate electrophoresis (figure 5.5). GAGs were 
judged by distance of migration compared to the standard GAG mixture. 
Cellulose acetate electrophoresis detected CS as the exclusive GAG, on 
each day in culture for EA.hy926 cells in the absence and presence o f SAG 
supernatants. GAG presence was quantified by measuring staining 
intensities (Bio-Rad Quantity One).
For cells in the absence o f SAG supernatants, there was a steady increase 
in the level o f CS from day 1 to day 7. For those cells co-cultured in the 
presence o f SAG supernatant, CS was detectable at day 1 until day 7, but 
appeared to decrease throughout culture in comparison to cells cultured 
without supernatant. The differences in CS presence between cells with 
and without SAG supernatants increased from 30% on day 3 upto 80% on 
day 7. All SAG supernatants behaved in the same manner toward CS 
proportions.
Following specific enzymatic digestions with chondroitinase AC and 
chondroitinase ABC (data not shown), there were no identifiable GAGs 
present, thereby verifying the presence o f CS and the absence of DS and 
HS in all samples.
203
Figure 5.5 Cellulose acetate electrophoresis o f  
glycoaminoglycans produced by EA.hy926 cells in the 
absence and presence o f  lOOng/ml o f  SAG supernatants 
(example shown is S. cmginosus 43C)
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5.4 Discussion
The present study investigated the effect o f  SAG supernatants on the 
temporary appearance o f PGs, decorin and biglycan, and GAGs 
synthesised by EA.hy926 endothelial cells, relating their expression in the 
presence or absence o f an inflammatory pathological condition, such as a 
dental abscess or periapical disease. By observing gene expression and the 
detection o f  the corresponding protein secreted by these cells, the results 
assist in ascribing roles for these PGs during the development o f normal 
and aberrant endothelial cell matrix formation, and describe potential 
mechanisms via which SAG could potentially orchestrate tissue 
destruction during inflammatory disease.
Within the current study, it appeared there was an increase in EA.hy926 
endothelial cell growth when cells were cultured in the presence o f SAG 
supernatant. Angiogenesis and vascular remodelling are features o f many 
chronic inflammatory diseases (Ezaki et al., 2001). Proliferation and 
migration o f  endothelial cells and the subsequent establishment o f a stable 
monolayer are critical events in the repair o f  injured vessels and in 
angiogenesis and vasculogenesis, and tissue repair (Kinsella et al., 1997). 
Ezaki et al. (2001) reported that the rate o f  tracheal endothelial cell 
proliferation and the size o f blood vessels increased rapidly in C3H mice 
following injection with Mycoplasma pulmonis, which ultimately lead to 
chronic inflammatory airway disease. Cell proliferation peaked at 5 days, 
at a level 18 times the pathogen-free value, declined sharply until day 9, 
but remained at approximately 3 times the pathogen-free value for at least
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28 days. Although cell growth was increased in the current study following 
culture with SAG supernatants the migration assay demonstrated that the 
migratory properties o f cells cultured in the absence o f SAG supernatants 
exhibited greater migration, compared to cells cultured in the presence of 
SMG supernatants. Cell proliferation and migration are controlled by 
multiple factors, such as fibroblast growth factor (FGF), TGF-p, and cell 
adhesive interactions mediated by integrins. Therefore, initiation of cell 
migration may involve a change in cell-matrix remodelling and altered 
matrix receptor expression, which are processes directed in part by growth 
factors (Kinsella et a l., 1997).
W ithin the current study, there was detection at both the mRNA and 
protein level for biglycan, but not decorin, from EA.hy926 cells cultured in 
the absence o f  SAG supernatants, which is in agreement with other studies 
(Jarvelainen et a l., 1991; Kinsella et al., 1997; Nelimarkka et al., 1997). 
For cells cultured in the presence o f SAG supernatants, biglycan mRNA 
expression appeared to decrease at days 5 and 7 compared to cells cultured 
without supernatants. However, the Western blot analysis investigating the 
corresponding protein produced under the same conditions, showed strong 
immuno-detection o f biglycan throughout the culture period. Although this 
finding cannot be fully explained, it may give an indication o f the turnover 
and persistence o f the intact biglycan molecule and its metabolites. For 
both conditions, the band observed at 45kDa is in accordance with the core 
protein molecular weight o f biglycan from endothelial cells (Kinsella et 
al., 1997). The doublet observed may be due to differences in
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glycosylation, as this has been observed for decorin, with glycoforms 
containing two and three AMinked oligosaccharides (Hocking et al., 1996; 
Seo et al., 2005). Also, biglycan isoforms with differences in 
polysaccharide substitution and core protein have been identified in human 
lung fibroblasts (Tufvesson et al., 2002), and Jarvelainen et al. (1991) 
reported two forms o f biglycan produced by bovine endothelial cells. The 
band at 98kDa may be a biglycan dimer (Scott et al., 2006). The detection 
o f biglycan at molecular weights greater or lower than 38kDa through 
Western blot analysis may represent a combination o f the intact PG and 
PG metabolites, formed in the process o f catabolism or remodelling o f the 
matrix.
Many studies have reported the production o f SLRPs from endothelial 
cells, including EA.hy926 cells. As mentioned, the functional state of 
endothelial cells (quiescent or angiogenic) correlates with the expression 
o f specific SLRPs (Schonherr et al., 2001). Resting endothelial cells in 
vivo as well as confluent cells in vitro constitutively express biglycan 
(Jarvelainen et al., 1991). Biglycan is a major PG o f the ECM, the 
functions o f which are only beginning to be understood. EA.hy926 cells 
express and synthesise detectable amounts o f biglycan, but not decorin, 
when forming monolayer cultures, typical o f macrovascular endothelial 
cells in vivo (Nelimarkka et al., 1997).
When diseases evolve slowly, as may be the case in the gradual initiation 
o f infection o f  the SAG, the accompanying changes in the 
microvasculature would seem to be similarly gradual (Ezaki et al., 2001),
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which could explain the difference between the levels o f biglycan at the 
mRNA and protein levels. Decreases in biglycan levels were observed by 
Nelimarkka et al. (1997). This group reported the net synthesis o f biglycan 
was markedly decreased following endothelial cell culture with TNF-a. 
Several other growth factors and cytokines, including interferon-gamma 
and IL-1B, did not modulate biglycan expression o f EA.hy926 cells. 
However, Kinsella et al. (1997) reported an increase in both biglycan core 
protein synthesis and biglycan proteolytic processing, resulting in the 
accumulation o f a 20kDa N-terminal biglycan fragment in the medium of 
wounded cultures through SDS-PAGE. This group also reported that 
biglycan RNA steady-state levels selectively increased 2- to 3-fold after 
wounding.
It is also apparent that biglycan has different effects depending on the cell 
type, and these effects are varied depending upon cell conditions. Shimizu- 
Hirota et al. (2004) produced mice which constitutively over-expressed 
biglycan in the vascular smooth muscle, to examine the effects on vascular 
pathology. They reported enhanced vascular smooth muscle cell 
proliferation and migration due to biglycan. However, it was noted that the 
proliferative effects o f  biglycan appeared to depend on cell type, as 
biglycan caused a decrease in proliferation in cultured endothelial cells in 
contrast to the effects on vascular smooth muscle cells (VSMC). Similarly, 
biglycan increased migration in VSMCs but not in endothelial cells. 
Concerning other cells, biglycan has been suggested to stimulate growth 
and differentiation o f brain microglial cells, whereas in pancreatic cancer
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cells biglycan suppressed proliferation (Kikuchi et al., 2000; Weber et al., 
2001).
It has been demonstrated, by Northern blot analysis, that decorin is 
expressed in human capillary endothelial cells during inflammation when 
angiogenesis occurs (Schonherr et al., 1999). The apparent lack o f decorin 
detection within cells at both the mRNA and protein level for cells 
cultured with SAG supernatants illustrates the complexity of decorin 
expression and suggests that the cells are not under going angiogenesis, 
which would diminish the repair mechanisms following disease 
(Jarvelainen et al., 1991).
The decrease in CS-GAG detection is parallel with the decrease in mRNA 
expression for biglycan but it is not in accordance with the continuous 
detection o f  biglycan at the protein level, suggesting that the SAG 
supernatants could degrade the GAG chain within the endothelial cell 
matrix before affecting the core protein. GAG degradation is quite likely 
due to the hydrolytic enzyme production o f SAG. More specifically, the 
decreasing proportions o f CS correspond to CSase activity produced by 
SAG, particularly S. intermedius and S. constellatus (Homer et al., 1993; 
Jacobs and Stobberingh, 1995).
The effects o f  oral streptococci upon the endothelium have been studied in 
some detail due to their association with infective endocarditis. However, 
these studies have focused on the adherence and invasion o f endothelial
209
cells (Parham et al., 2003; Stinson et al., 2003). Under normal conditions, 
a controlled cellular response to bacterial products protects the host from 
infection. Important in determining the consequences o f bacterial 
colonisation and occurring early in the interactive process, is the induction 
o f pro- or anti-inflammatory cytokines in response to bacterial products. 
Gram-positive bacteria may act as cyto-stimulating cell components. Ag 
I/II o f  SAG may mediate their ability to stimulate IL8 production in 
epithelial cells and o f IL8 and IL6 in endothelial cells (Vernier et al., 
1996).
The data from the present study demonstrates that SAG supernatant 
modulates a number o f functions o f the endothelial cell line EA.hy926, 
most notably cell migration and ECM synthesis. Considering the proposed 
roles for SLRPs, such as those in migration, these changes may have 
important consequences on the pathogenesis o f  disease caused by the 
SAG, including formation o f periapical abscesses and subsequent systemic 
spread o f SAG.
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CHAPTER SIX
Chapter 6
Streptococcus anginosus group virulence factor induction due to 
periodontal ligament extracellular matrix proteins
6.1 Introduction
The mechanism by which the SAG change from harmless commensals to 
virulent pathogens is unclear but likely to be complex. Successful infection 
requires that the bacteria gain access to, persist in, and replicate in normally 
privileged sites within the host. Moreover, they must produce certain factors 
that result in a level o f host damage that perturbs homeostasis (Boyce et al., 
2004).
SAG appears to produce an array of glycoprotein- and glycosaminoglycan- 
degrading enzymes, which may contribute to the virulence of this species. It 
has been suggested that glycosidase production may play a nutritional role for 
the SAG. The release o f carbohydrates from host glycoproteins is essential 
for SAG proliferation (Beighton et al., 1994). Among the other potential SAG 
virulence factors are the glycosaminoglycan-degrading enzymes, including 
hyaluronidase (HAase) and chondroitin sulphate depolymerase (CSase), 
which cleave the hexosaminyl-hexuronyl linkages o f hyaluronic acid (HA) 
and chondroitin 4 and 6 sulphates. The resulting tissue destruction may 
subsequently facilitate the spread of bacteria through tissues (Homer et al., 
1993; Jacobs and Stobberingh, 1995). Homer et al. (1993) reported that strains 
o f S. intermedius and S. constellatus degraded HA, whilst only strains of S.
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intermedius produced CSase. These results were confirmed by Jacobs and 
Stobberingh (1995), although they also observed CSase activity in S. 
constellatus. Sialidases hydrolyse the release o f sialic acid from a variety of 
glycoconjugates and play significant roles in the pathogenesis of a number of 
important diseases. Beighton and Whiley (1990) demonstrated sialidase 
activity in S. intermedins but not in S. anginosus or S. constellatus.
O f the SAG, S. intermedius, often highlighted the most important pathogen 
due its predilections for defined body sites and the fact that it is an early 
coloniser o f  the oral biofilm, and as such regarded as a commensal. But it is 
also a serious pathogen associated with deep-seated purulent infections 
including abscesses in the liver and brain (Whiley et al., 1992). S. intermedius 
has been implicated as an occasional causative agent o f infective endocarditis, 
which secretes a human-specific pore-forming cytolysin, intermedilysin (ILY) 
(Nagamune et al., 1996). It has been shown that ILY directly causes cell 
membrane damage in erythrocytes and in cell lines derived from major organs 
involved in deep-seated infections associated with S. intermedius (Nagamune 
et al., 1996), and may represent an important virulence factor of this species 
(Nagamune et al., 1996; Jacobs et al., 2000). It has been shown that the 
production of this cytotoxin in isolates from deep-seated abscesses is 6.2-10.2- 
fold higher than in strains considered to be commensals, for example, isolated 
from dental plaque. However, no differences in the production levels of other
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potential virulence factors such as hyaluronidase were found (Nagamune et 
al„ 2000).
Under certain growth conditions, certain streptococci have been shown to 
regulate the expression o f adhesion and virulence associated genes at the 
transcriptional level (Jenkinson and Lamont, 1997). Previous studies have 
established that certain growth conditions can enhance bacterial virulence 
factors. Fibronectin binding protein, prtF 1, in group A streptococci is up- 
regulated by atmospheric oxygen, while its M protein levels decrease (Fogg et 
al., 1994). Also, the presence of collagen in growth medium up-regulates the 
expression o f cell surface platelet aggregation-associated protein in S. sanguis 
(Erickson and Herzberg, 1995). Therefore, bacteria that experience dramatic 
environmental changes often regulate gene expression in order to maintain 
optimal phenotypic properties (Jenkinson and Lamont, 1997).
The aim o f this chapter was to determine the range o f degradative enzyme 
activities produced by a selected group of the SAG, and whether this profile 
was affected following contact with host ECM components. As S. intermedius 
appears to have exceptional virulence factors, an additional aim was to 
investigate the production of ILY production from commensal and disease 
strains o f S. intermedius, before and after contact with host ECM proteins.
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6.2 Materials and methods.
6.2.1 P reparation  of periodontal ligament extracellular m atrix proteins 
PDL-like cells were obtained as in section 4.2.2 and 4.2.3. Briefly, PDL-like 
cells from 28 day old male Wistar rats were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) (Gibco) supplemented with 10% fetal bovine 
serum (FBS) and antibiotics (100 units/ml penicillin G, 10 mg/ml 
streptomycin sulphate, 25mg/ml amphotericin B) (Sigma Chemical Co.). On 
reaching 95% confluence, cell culture media was exchanged for media as 
above but with 0.2% FBS. PDL-like cells were cultured under these 
conditions for 48h, the media was subsequently removed, dialysed (as in 
section 2.2.1.1) and lyophilised. Samples were stored at -20°C until required. 
The amount o f protein within the PDL-like ECM preparation was determined 
using the BCA assay (see* section 2.2.6).
6.2.2 Bacterial growth and incubation with periodontal ligament 
extracellular m atrix proteins
The bacterial strains utilised within this study were S. anginosus National 
Type Culture Collection (NCTC) 10713 and S. constellatus NCTC 11325, S. 
constelltus 322/95 and 34C, S. intermedius 127/95 and 30C, and S. anginosus 
43586/96 and 43C (original source in table 3.1). S. intermedius strains 11C, 
30C, 84C, 127/95, 447/95, HW13 (see table 3.1), were utilised in further 
studies of virulence factors.
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Each bacterial isolate was grown on blood agar at 37°C, in an anaerobic 
cabinet (10% v/v CO2, 20% v/v H2, 70% v/v N2) (Don Whitley Scientific Ltd., 
Shipley, UK), until purity was confirmed. Bacteria were inoculated into BH1 
broth at ODssomn = 0.2 and cultured anaerobically for 18h. 1ml of broth was 
removed from the overnight culture and subsequently added to 9ml of fresh 
BH1 broth. The fresh culture broth was subsequently grown, under anaerobic 
conditions, until mid-log phase (approximately 4h). Following these initial 
growth conditions, the bacteria were incubated for a further 4h, anaerobically, 
with or without 250pg/ml o f protein collected in the media from serum- 
starved (2% FBS) PDL cells. This procedure was carried out in duplicate and 
lml aliquots o f bacterial suspensions were utilised for subsequent analysis of 
virulence factors.
6.2.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
lOpg o f each bacterial suspension, cultured with or without 250pg/ml of 
protein, was separated by SDS-PAGE (see section 2.2.4.3), and stained with 
Coomassie brilliant blue solution (50% methanol, 0.05% Coomassie brilliant 
blue, 10% acetic acid, and 40% ddH20 )  for lh. The gel was subsequently 
destained (50% methanol, 10% acetic acid, 40% ddH20 ), until visualisation of 
the molecular weight marker was evident.
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6.2.4 API-ZYM
API ZYM (bioMerieux, Marcy-l’Etoile, France) is a semi-quantitative micro­
method designed for the identification o f enzymatic activities. The technique 
is applicable to microorganisms. It allows the systematic and rapid study of 19 
enzymatic reactions using very small quantities. The system consists of a strip 
with 20 cupules, the base o f which contains the enzymatic substrate and its 
buffer (see table 6.1). This base allows contact between the enzyme and both 
soluble and insoluble substrate. API ZYM permits the detection of enzymatic 
activities in a complex, non-purified sample, from which more precise 
spectrophotometric or electrophoretic methods would be unsuitable. The test 
provides a semi-quantitative estimate of enzymatic production.
lml o f bacterial suspension, cultured with and without 250pg/ml ECM 
proteins was diluted with distilled water to equate to 5-6 MacFariand. The 
enzyme strip was assembled as per Manufacturers’ instructions. Briefly, 65pl 
o f bacterial suspension was added to each cupule, and incubated for 4hr at 
37°C. Following incubation, 1 drop of ZYM A and 1 drop of ZYM B reagents 
(supplied in kit) were added to each cupule, and the colour left to develop for 
7-10min.Using the reading table provided (table 6.1), a value ranging from 0- 
5 was assigned, corresponding to the colours developed: 0 corresponding to a 
negative reaction, 5 to a maximum intensity. Due to subjectivity, two 
individual readers were used.
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Table 6.1. API ZYM reading table
No. Enzyme assayed for Result
Positive Negative
1 Control Colourless 
of the
or colour of 
sample
2 Alkaline phosphatase Violet
3 Esterase (C4) Violet
4 Esterase lipase (C8) Violet
5 Lipase (C14) Violet
6 Leucine arylamidase Orange
7 Valine arylamidase Orange
8 Cysteine arylamidase Orange
9 Trypsin Orange Colourless
10 a-chymotrypsin Orange or very pale
11 Acid phosphatase Violet yellow
12 Napthol-AS-BI-phosphohydrolase Blue
13 a-galactosidase Violet
14 (3-galactosidase Violet
15 {3-glucuronidase Blue
16 a-glucosidase Violet
17 p-glucosidase Violet
18 N-acetyl-{3-glucosaminidase Brown
19 a -mannosidase Violet
20 a -fucosidase Violet
6.2.5 Determ ination of chondroitinase and hyaluronidase activity 
Methods were taken from Tipler and Embery (1985). Autoclaved BHI broth 
(Gibco) was supplemented with of chondroitin-4-sulphate (Whale cartilage, 
type A, Sigma Chem. Co.) and hyaluronic acid (Bovine umbilical cord, grade 
1, Sigma Chem. Co.) to give a final concentration of 400pg/ml. Chondroitin- 
4-sulphate was readily soluble, whereas the hyaluronic acid required constant
217
agitation for 2h at room temperature. Both GAG were sterilised using 0.45^m 
pore size filters.
The inoculum used for each test was the growth harvested at mid-log phase, 
lml o f bacterial suspension, with and without ECM, was added to 4ml of HA- 
C4S-medium, in duplicate. The broth was incubated under anaerobic 
conditions for 7 days. After incubation, the broth was removed from the 
cabinet and lml o f each broth subjected to centrifugation at 3000g for 10 min. 
20pl o f each supernatant were added to 4ml o f distilled water and the UV 
absorbance o f each diluted sample was read at 232nm against non-inoculated 
broth (negative controls). Those samples showing U.V. absorption at 232nm, 
which is the characteristic U.V. absorbance o f the unsaturated bond formed 
following the elimination reaction of HA and CS, were considered positive for 
the hyaluronidase and chondroitin sulphatase.
6.2.6 Isolation of bacterial total RNA followed by RT-PCR
Isolation o f total RNA from bacterial cells was carried out using a Qiagen 
RNeasy Mini kit (Qiagen Ltd, West Sussex, UK). The extraction steps were 
carried out according to the manufacturers’ instructions. All steps were 
performed quickly, at room temperature, to minimise RNA degradation. Total 
RNA was quantified as described in section 4.2.8.2. The protocol used for RT- 
PCR of bacterial total RNA was the same as that used for PDL cells (see 
section 4.2.8.3).
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6.2.7 Quantification of intermediiysin production by S. intermedius
6.2.7.1 Intermediiysin polymerase chain reaction
PCR o f the ILY gene was carried out according to the method of Nagamune et 
al. (2000). The reaction volume of 50pl contained lp l of bacterial DNA, 
0.25mM deoxyribonucleoside triphosphate (Promega), 1U Taq DNA 
polymerase (Promega), 20pmol of ILY forward primer (5’- 
AACACCTACCAAACCAAAAGCAGC-3’), 20pmol o f ILY reverse primer 
(5 ’-ACTGTGG ATG A AGGGTTGTTCCCC-3’), 50mM KC1, lOmM Tris-HCl 
and 1.5mM MgCh. The PCR program was as follows; initial denaturation at 
95°C for 5min, followed by 30 cycles of a denaturation step at 95°C for lmin, 
an annealing step at 55°C for lmin, and an extension step at 72°C for 2min. 
The expected amplified fragment size was l,463bp. S. anginosus (43586/96) 
was used as a negative control.
6.2.7.2 16S rRNA polymerase chain reaction
The 16S rRNA gene o f S. intermedius isolates were amplified in order to 
quantify the amount o f ILY expression. PCR amplification of 16S rRNA 
genes was performed in a reaction volume o f 50 pi, consisting of 0.2 mM each 
dNTP, 2.0 mM MgCb, 1.5 U Taq DNA polymerase, 5 pi lOx PCR buffer (all 
reagents from Promega), 5 pi (between 50 fg and 50 ng) of extracted DNA as 
template, and 0.5 pM each primer. The primer pair used was 27F (5’- 
GTGCTGC AG AG AGTTTG ATCCTGGCTCAG-3 ’) and 1492R (5’-
C ACGG ATCCT ACGGGT ACCTT GTT ACG ACTT-3 ’), specific for the
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domain (Dymock et al., 1996; synthesized by Invitrogen).
A touchdown protocol was used whereby, in the first cycle, denaturation was 
performed at 94#C for 6 min, primer annealing was performed at 65°C for 1 
min, and extension was performed at 72°C for 2 min. In subsequent cycles 
denaturation was performed for 1 min and the annealing temperature was 
decreased by 2#C each cycle for 11 cycles, after which 25 cycles were carried 
out under the same conditions. In the final cycle, extension was performed for 
12 min.
6.2.7.3 Detection of PCR products by agarose gel electrophoresis
PCR products resulting from amplification o f the ILY gene within S. 
intermedins commensal and disease strains were separated as in section 
4.2.8.5.
6.2.8 Statistical analysis
The Student unpaired two-tail T-test (Instat Package, Graph Pad software) 
was performed to obtain /7-values for analysis of differences between cells 
cultured with and without SMG supernatants. A p  value of <0.05 was deemed 
as significant.
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6.3 Results
6.3.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis of S. 
anginosus group supernatants following exposure to m atrix proteins 
SDS-PAGE followed by Coomassie blue staining o f bacterial supernatants
cultured in the absence or presence of ECM proteins from PDL cells revealed
a number o f bands ranging from 200kDa to 28kDa (see figure 6.1). For each
isolate cultured with the ECM proteins, there was an extra intense band at
approximately 55kDa, which was not present in the ECM alone (no bacteria
added) control. Both commensal and disease isolates appeared to produce a
double band at approximately 188kDa, following incubation with the ECM
proteins.
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Figure 6.1. SDS-PAGE followed by Coomassie blue staining o f  bacterial 
supernatants cultured in the absence and presence o f ECM proteins
BHI ECM 34C 322/95 30C 127/95 43C 43586
(controls) - + - + -  + - + - + - +
BHI = Brain heart infusion broth (no bacteria)
ECM = Extracellular matrix components (250pg/ml) (no bacteria) 
-/+ = without / with 250pg/ml ECM
Table 6.2 (a) API ZYM of SAG isolates co-cultured without extracellular matrix components
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
ECM (alone)
+ + + + + + + +
NCTC 11325 (S. constellatus) - w - - - (5) - - - (1) (3) - - (2) (2) - -
+ + + + + + + + + + +
322/95  (S. constellatus) - w 0 ) - - (5) (2) (3) (2) (1) (5) (3) - - (2) (2) - - -
+ + + + + + + + + +
34C (S. constellatus) - (5) (1) - - - (2) - - (2) w - - -
+ + + + + + + + + + + + +
127/95 (S. intermedius) - . 5 ) - - - ( 5 ) *3 ; (2) (3) (5) (3) (3) - (2) (2) (2) (2) -
+ + + + + + + + + +
30C (S. intermedius) - (1) - - - (2) (2) - - (2) (2) (1) - - (1) (3) -
+ + + + + + + + + + + + + +
NCTC 10713 {S.anginosus) - (5) (2) - - (5) (2) w (2) (3) (2) (3) (2) - (3) (3) - (2) -
+ + + + + + + + + + +
43586 /96  (S. anginosus) - (3) - - - (5) w (3) (1) (2) (5) (2) (1) - - (1) (1) - - -
+ + + + + +
43C  (S. anginosus) - (1) - - - w - - - (1) m (3) - - - (2) - - - -
1 = Control 5 = Lipase (C14) 9 = Trypsin 13 = a-galactosidase 17 = B-glucosidase
2 = Alkaline phoshatase 6 = Leucine arylamidase 10 = a-chymotrypsin 14 = B-galactosidase 18 = N-acetyl- B-glucosaminidase
3 = Esterase (C4) 7 = Valine arylamidase 11 = Acid phosphatase 15 = B-glucuronidase 19 = a-mannosidase
4 = Esterase lipase (C8) 8 = Cysteine arylamidase 12 = Napthol-AS-BI-phosphohydrolase 16 = a-glucosidase 20 = a-fucosidase
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Table 6.2 (b) API ZYM of SAG isolates co-cultured with extracellular matrix components
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
ECM
▼ A
NCTC 11325 (S. constellatus)
+
(2) T
+
(4)
+ A
0 )
+
(3)
+
(3)4 + A(3)
+
(2) (2)
322/95  (S. constellatus)
+
(4)
+
d )
+
(5)
+
(2)
+
(3)
+ A
(2)
+
(3)
+
(5) (5)A
+
(4) (3)
34C (S. constellatus)
+
(5)
+
(5)
+
(3)
+
(3)
+
(3)
+
(3)
+
(5)
+
(5) <4>*
+
(5 )
A A
127/95 (S. intermedius)
+ A
(5)
+ A
(5)
+
(3)
+
(4)
+ A
(2)
+ A
(3)
+ A
(5) (4)A
+ A
(4) (4)*
+ A
(3) (5)A
+
(4)
30C (S. intermedius)
+
(4)
+
(5)
+
(3)
+
(2)
+
(2)
+
(3)
+
(5) (4V
+
(4)
+
(3)
+
(3)
+
(5)
+
(4)
NCTC 10713 (S. anginosus)
+ A
(4)
+ +
(5)
+ +
(3)
+
(2)
+ A
(3)
+
(5)A + A(3)
+
(3)
+ A
(3)
+ A
(2)
+ A
(2)
43586/96 (S. anginosus) (5 )A
+
(5)
+
(4)
+
(4)
+
(2)
+
(4)T
+
(4)
+
(4)
+
(3) ( V
+
(3)
A
+
(3)
43C (S. anginosus)
+
(3)
+
(4) -
+
(2)
+
(4) <1+) m
+
(4)
+
(3)
a  increase in enzyme production in SAG isolates following co-culture with ECM components
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6.3,2 Production of enzymes by the S. anginosus group in the absence 
and presence of extracellular matrix proteins
Table 6.1(a) and (b) indicate the enzymes produced by SAG, using the API 
ZYM assay, following incubation in the absence (table 6.1 a) and presence 
(table 6.1 b) of PDL ECM proteins.
The three species within the SAG differed in their abilities to produce an 
array of enzymes. All strains were negative for the control (number 1), 
showing the strip in use was producing valid results. All strains produced 
alkaline phosphatase activity (enzyme no. 2), under both growth conditions, 
with S. intermedius 30C, S. anginosus 43586/96 and 43C showing large 
increases in activity after exposure to ECM proteins. There was negligible 
activity for esterase (no. 3) and no activity of esterase lipase (no.4) or lipase 
(no. 5) for any strain. Disease and commensal strains of each SAG species 
produced all arylamidase enzymes (no. 6, 7, and 8), in the absence and 
presence of ECM proteins, except for 43C, which produced only leucine 
arylamidase. Also, there was an increase in trypsin (no. 9) activity 
following co-culture with ECM proteins for 34C (S. constellatus) and 30C 
(S. intermedius).
Numerous glycosidases were produced by the under both conditions. 
However, following co-culture with the ECM proteins, there were notable 
increases in certain glycosidase production for a number of the isolates 
compared to the non co-cultured condition. These isolates included both S. 
anginosus strains (43586 and 43C) for a-galactosidase (no. 13), and S.
225
intermedius (127/95 and 30C) for p-galactosidase (no. 14). For a- 
glucosidases (no. 16), there were increases in all strains, and there were 
increases for all strains except 43C for p-glucosidase (no. 17). 127/95, 30C 
and 43C each showed increases for N-acetyl-p-glucosaminidase (no. 18), 
and for a-mannosidase (no. 19) activity there were increases in 127/95, 
30C and 43586. No activity was observed for a-fucosidase in any isolate.
6 3 .3  Degradation of hyaluronic acid and chondroitin-4-sulphate by the 
S, anginosus group
Figure 6.2 illustrates a typical peak at 232nm, showing the breakdown of 
hyaluronic acid and chondrotin-4-sulphate. Table 6.3 shows the production 
of HAase and CSase from the SAG. HAase activity was restricted to S. 
constellatus and S. intermedius strains. This activity was observed in both 
the absence and presence of ECM proteins. CSase activity was 
demonstrated in both disease and commensal isolates for S. constellatus 
and S. intermedius, but not in either disease or commensal isolates of S. 
anginosus. However, the peak produced by S. constellatus and S. 
intermedius for CSase was less pronounced than the peak produced for 
HAase.
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Figure 6.2. Typical spectra produced by the SAG enzymes acting on GAG substrates
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Table 6.3. Hyaluronidase and chondroitin sulphate depolymerase activity 
o f  SAG isolates
Hyaluronidase Chondroitin -  4 - sulphate
without ECM with ECM without ECM with ECM
(S. anginosus) 
NCTC 10713
(S. constellatus)
NCTC 11325 + + + +
(S. constellatus) 
322/95 + + + +
{S. constellatus)
34C + + + +
(S. intermedius) 
127/95 + + + +
(S. intermedius) 
30C + + + +
(5. anginosus) 
43586/96
(S. anginosus) 
43C - - - -
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6.3.4 mRNA expression of ILY from S. intermedius co-cultured with 
and without periodontal ligament ECM proteins
Figures 6.3 and 6.4 shows the expression o f ILY mRNA within S.
intermedius strains when cultured without or with ECM proteins, 
normalised against the bacterial 16S mRNA gene. For commensal strains 
11C, 30C and 84C, ILY expression is less in the absence o f ECM proteins 
compared to ILY expression in the presence o f ECM proteins (p <0.05).
ILY is present in disease isolates 127/95 and HW13 when cultured with 
and without ECM proteins in similar amounts, whereas 447/95 did not 
produce ILY in either culture condition situation.
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Figure 6.3. ILY expression by S. intermedius isolates in the absence and 
presence o f  extracellular matrix components
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Figure 6.4. Relative expression o f  intermedilysin by S. intermedius 
isolates cultured in the absence and presence o f  extracellular matrix 
proteins, normalised to the expression o f  the 16S rRNA gene
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6.4 Discussion
Following attachment to specific sites within tissues, the SAG would need 
to be able to grow and divide successfully. The ECM is rich in nutrients in 
the form o f glycoproteins and other components, which, if  the bacteria can 
degrade them, are potential sources o f both amino acids and sugars 
(Willcox et al., 1995b). It has been shown that members o f the SAG 
produce proteolytic activity and glycosidases (Homer et al., 1990; Whiley 
et a l., 1990; Willcox et al., 1995b) which may be important in ECM 
degradation.
Utilising a panel o f  well-established biochemical tests, this study evaluated 
the differences in the potential virulence factors of the SAG strains 
following exposure to PDL-like ECM proteins. In this study, SDS-PAGE 
o f the SAG supernatants allowed for a rapid comparison o f proteins 
produced by isolates cultured with and without ECM proteins without the 
expense required for more specialised techniques (Sacilik et al., 2000). 
SDS-PAGE, followed by Coomassie blue staining, o f total extracellular 
proteins within the bacterial supernatants, revealed a range o f molecular 
bands under both culture conditions. However, in the presence o f ECM 
proteins, a number o f extra bands were present for all SAG isolates, in 
particular an intense band at approximately 55kDa, which was not present 
in controls. A number o f potential virulence factors have already been 
reported within the SMG. These include: L-cysteine desulfhydrase 
(44kDa); fibronectin binding protein (14kDa); amylase binding protein 
(12.5kDa); intermedilysin (54kDa); antigen I/II (160kDa); hyaluronidase
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(~120kDa) and dipeptidyl peptidase (84kDa) (Willcox et a l., 1995a; 
Nagamune et al., 2000; Petersen et a l ,  2001; Yoshida et al., 2002; Takao, 
2003; Fujimnra et al., 2005). The protein observed within this study may 
be derived as part o f a transport system for ECM proteins or as the 
consequence o f release upon cell death and disintegration (Willcox et a l,  
1995).
The API-ZYM assay demonstrated that a number o f enzymes produced by 
commensal and disease strains of the SAG increased following culture 
with host ECM proteins. Overall, marked increases were observed in 
alkaline phosphatase activity, as well as trypsin, a-glucosidase and N- 
acetyl-fi-glucosaminidase. The SAG strains utilised in the current study 
showed similar enzyme production to SAG isolates in previous studies. 
However, the current study also showed that the activity o f many enzymes 
were increased following SAG exposure to the host ECM, which may have 
potential pathogenic implications in vivo.
Glycosidase activity is o f great value for invading bacteria. Within the 
current study, numerous glycosidase activities appeared to increase 
following bacterial co-culture with ECM proteins, particularly a -  and P- 
glucosidase. Willcox et al. (1995b) studied the degradative enzymes 
produced by oral streptococci, in particular, the S. sanguis group and the 
SMG. They reported that S. anginosus, S. intermedius and the majority of 
S. constellatus isolates produce p-glucosidase, whereas only S. constellatus 
and S. anginosus produce a-glucosidase. They also reported a -
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galactosidase activity was restricted to S. anginosus and the majority o f S'. 
anginosus and all o f the S  intermedius isolates produced p-galactosidase. 
Willcox et al. (1995b) also reported that all isolates o f the SAG they tested 
produced lysine arylamidase activity. S. constellatus produced activity 
against Val-Pro-Arg-7-Amido-4-methyl-coumarin (AMC; a synthetic 
substrate for thrombin-like activity), and S. anginosus and S. constellatus 
produced activity against Ile-Glu-Gly-Arg-AMC (for factor Xa activity). 
The expression o f trypsin-like proteolytic activity is considered a plausible 
potential virulence factor and has been reported in other 
periodontopathogens, such as Porphyromonas gingivalis (Wyss, 1992).
The production o f a-mannosidase within the current study appeared to 
increase in both S. intermedius isolates and was induced in S. anginosus 
(strain 43586/96) following co-culture with ECM proteins. Homer et al. 
(2001) assayed the production o f mannosidase activity by all currently 
recognised species o f human viridans group streptococci, in which 
bacterial growth was dependent on the degradation o f RNase B and 
subsequent utilisation o f released mannose. They reported that 
mannosidase activity was produced by S. intermedius and, in addition to 
its a - ( l —>3), a - ( l—>6), and P-(l->4) mannosidase activities, this isolate 
also produced Af-acetylglucosaminidase activity. Both S. intermedius and 
S. anginosus showed P-mannosidase activity when synthetic substrates 
were used.
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It is generally accepted that bacteria catabolise GAGs by an eliminase 
enzyme reaction leading to the formation o f unsaturated products, whereas 
mammalian systems are unable to manufacture such enzymes and rely on a 
hydrolytic cleavage. Within the current study, HAse and CSase production 
by commensal and disease SAG strains following exposure to ECM 
proteins was no different to the enzyme production o f the SAG strains 
exposed to the substrate medium only. However, this study demonstrates 
that the enzyme is induced following initial contact with HA and CS and 
continuously produced, which would have profound effects upon the host.
The 232-nm assay has been proved sensitive compared to the commonly 
used plate method (Tipler & Embery, 1985). The production of 
hyaluronidase by S. constellatus and S. intermedius strains in this 
investigation is in accordance with other studies (Homer et a l., 1993; 
Jacobs and Stobberingh, 1995). HAase production may enable cells to gain 
entry into the body by breaking the epithelial /cell matrix integrity 
(Willcox et a l., 1995), then subsequently to breakdown the matrix when 
inside the host. As mentioned, HAase is able to breakdown HA, however, 
some o f  these enzymes are also able to cleave CS, albeit at a slower rate 
(Kreil, 1995). Important to note in this study, there was CSase activity in 
commensal and pathogenic isolates o f S. constellatus and S. intermedius. 
Previous studies have also shown CSase activity for S. constellatus and S. 
intermedius (Homer et a l., 1993; Jacobs and Stobberingh, 1995; Shain et 
al., 1996), however, Jacobs and Stobberingh (1995) reported CSase 
activity tended to be more associated with infection-related strains.
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Therefore, it is difficult to establish the action o f bacterial HAase and 
CSase on the tissues o f the periodontium. These GAGs are prominent in 
both the non-mineralised tissues and mineralised tissues o f the 
periodontium. It must also been bome in mind that GAGs, such as CS, are 
also found as part o f PGs, which subsequently interact with collagen to 
form a supporting fibrous network common to all types o f connective 
tissues. The structural integrity o f periodontal tissues is lost during 
infection, as such events have detrimental effects upon the ECM 
components o f the underlying periodontal tissues, including collagen, PGs 
and HA (Tipler & Embery, 1985).
SAG enzymatic activity, in particular glycosidase activity, may not only 
change the function o f the ECM components o f the host, but they could 
also release products, such as carbohydrates, which would play a role in 
the persistence o f the SAG at infection sites. Whether SAG enzymatic 
activity is the same in vivo is yet to be determined, and further biochemical 
characterisation o f enzyme activity and the substrate specificity o f the 
enzyme will be required to elucidate the mechanism by which degradation 
is achieved.
The detection o f commensal and disease strains o f S. intermedius ILY 
mRNA levels within the current study is o f  particular interest. Following 
co-culture with the ECM protein preparation, the commensal isolates 
increased ILY production significantly. ILY was present in 2 o f 3 disease 
isolates (127/95 and HW13) when cultured in the absence and presence of
234
ECM proteins; and expression was slightly increased following co-culture 
with ECM. The failure to detect ILY in S. intermedius isolate 447/95 is not 
unprecedented given that Nagamune et al. (2000) detected the gene in all 
strains o f  S. intermedius except for two that were phenotypically and 
genetically atypical.
ILY was previously found to be produced by an S. intermedius strain from 
a human liver abscess (Nagamune et al., 1996). More recently, Nagamune 
et al. (2000) revealed that the toxin exists only in S. intermedius and no 
homologue to the toxin gene is distributed in other members o f the SAG. 
Moreover, isolates from deep sites, such as brain and liver abscesses, 
produce ILY at levels much higher than that of strains from dental plaque 
or peripheral-site infections. However, there was a lack o f significant 
correlation in this respect for other enzymatic activities (CSase, HAase, 
and sialidase). This indirectly highlights the importance o f ILY, perhaps as 
a primary, or triggering, pathogenic factor, to ultimately cause deep-seated 
infections (Nagamune et al., 2000). Although there is no clear view of the 
regulation mechanism for ILY expression there may be two types of 
strains: weak (or poorly inducible) or strong (or potentially strongly 
inducible) within S. intermedius. It has been postulated if  an individual 
carrying a strongly ILY-producing strain in their dental plaque experiences 
trauma within their oral cavity, the strain may enter their bloodstream and 
more readily cause a deep-seated infection (Nagamune et al., 2000). In 
studies with PMN cells, which are important components o f the innate 
immune system, Macey et al. (2001) demonstrated that ILY appears not to
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act as a chemotactic agent but can modulate PMN functions, such as 
stimulation o f phagocytosis and can cause PMN cell death. Sukeno et a l 
(2005) observed that ILY is essential for S. intermedius invasion o f human 
hepatoma HepG2 cells, and that secretion o f ILY within host cells is 
essential for subsequent host cell death. It has been suggested that when a 
strain o f  S. intermedius, producing ILY, enters the bloodstream from its 
normal habitat possibly due to oral injury, it can evade killing by PMNs 
due to the activity o f its secreted ILY, and can thereby reach remote 
infection sites. Subsequently, surviving bacterial cells are bound to host 
cells at these sites (e.g. brain or liver), and are able to invade the host cells 
and spread to neighbouring cells in the tissue through ILY action, and 
other virulent enzymatic action, which may eventually form a necrotic 
region. Finally, macrophages within the tissue and/or PMNL migrating to 
the site o f  infection result in the formation o f an abscess, within which S. 
intermedius will persist, aided significantly in its defence by ILY activity 
(Sukeno et al.9 2005).
The aim o f chapter 6 was to study a number o f well-known virulent 
enzymes produced by the SAG and to observe whether these enzymes 
were regulated upon contact with host ECM components. ILY is a crucial 
virulent enzyme associated with S. intermedius, an important member of 
the SAG due to its tendency to cause severe abscess formation (as 
mentioned previously). Therefore, ILY was seen as a key enzyme to study 
in the pathogenesis o f these bacteria. Since this study has reported an
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increase in the protein expression o f ILY, further tests can be warranted to 
observe if  the functional activity of these bacteria is also increased.
The data from the present study shows the successful in vitro expression of 
enzyme and toxin production o f the SAG, and it appears that the protein 
expression by SAG may be regulated by the environmental conditions they 
are exposed to. The results confirmed the necessity to compare this 
virulence factor production in normal and diseased states i.e. without and 
with ECM proteins present. The presence o f these potential virulence 
factors is confirmed through API-ZYM analyses, which has supported 
previously determined enzyme characteristics o f the SAG, whilst also 
suggesting other enzyme expressions are increased following exposure to 
host ECM. ILY production by S. intermedins strains has been confirmed 
through PCR analysis, providing evidence for the concept that the 
expression o f this toxin within commensal isolates is up-regulated on 
contact with the ECM. These studies have provided important information 
on possible virulence factors, which may operate during initial SAG-ECM 
interactions, and their subsequent roles throughout infection with this 
group o f bacteria in relation to periapical disease and systemic spread.
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CHAPTER SEVEN
Chapter 7 
General discussion
The aims o f this thesis were to investigate host-microbial interactions 
associated with the Streptococcus anginosus group (SAG) within the 
periapical tissues, the consequence of the interaction on host cells, and to 
observe subsequent effects of the host ECM upon the bacteria. An attempt 
was made to relate these results to our current understanding of periapical 
infection, namely abscess formation, by the SAG and to enhance our 
perception o f SAG mechanisms of ECM destruction.
Purification of both ovine tissue and recombinant PGs was central to the 
biomolecular interaction analysis. A number of well-established 
chromatography and anion exchange purification steps were carried out in 
order to eliminate co-purifying PGs such as collagen and 0.2 HSG (Sugars et 
al., 2003). The denaturant guanidinium chloride was utilised throughout 
purification, which served to disaggregate proteins, without grossly changing 
the structure of the PG (Scott et al., 2006). Following robust characterisation 
of PGs, this study showed the successful purification o f a mixed population of 
decorin and biglycan substituted with CS and DS in alveolar bone and 
gingiva, respectively. We were also able to purify and characterise transfected 
HeLa cells transfected to over-express recombinant decorin or biglycan 
substituted with CS, producing appropriate material for subsequent studies.
238
Both decorin and biglycan, which are ubiquitously expressed within alveolar 
bone and gingival tissues (Bratt et al., 1992; Fisher et al., 1993), are 
implicated in a wide range of functions including collagen fibril formation 
(Vogel and Trotter, 1987; Greve et al., 1990), and have been shown to interact 
with growth factors (Hildebrand et al., 1994; Kinsella et al., 2004). PGs are 
also reported to act as ligands for bacterial attachment (Rostand and Esko, 
1997; Joh et al, 1999), behaving as a ‘foothold* for subsequent propagation. 
The BIAcore® surface plasmon resonance system enabled successful 
immobilisation o f purified PGs, and the establishment of a model protocol for 
the analysis o f specific interactions o f commensal and pathogenic strains of 
the SAG with intact PGs and their corresponding core proteins. The apparent 
lack o f binding to the core protein alone suggested that the SAG mediated 
binding through the GAG chain attached to the PG. There was greater binding 
to intact gingival PGs compared to other intact PGs indicating that, if binding 
is via the GAG chain, then it is likely to be the DS-GAG chain. This result is 
similar to that observed for B. burgdorferi, the causative agent of Lyme 
disease, which also binds to DS (Leong et al., 1998). It is apparent that these 
initial binding studies of the SAG have uncovered numerous areas worthy of 
further investigation. Analysis of more strains from the SAG is necessary in 
order to confirm the results from this study. Other fundamental studies are 
required to understand the biophysical nature o f bacterial attachment to host 
tissue components. Further work could involve competitive-inhibition studies, 
where decorin or biglycan antibodies, or antibodies for the GAG chain present
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on the sensor chip surface, can be added to the analyte solution and passed 
across the ligand. In addition, reversing the current situation by using bacteria 
as the ligand and PGs as the analyte would be useful as a confirmatory 
experiment. Although a consideration in vivo, such an approach would allow 
us to remove factors relating to steric hindrance due to agglutination of 
bacteria, allowing us to look directly at PG-bacteria interactions.
Initial attachment within the host tissues may lead to destruction of 
surrounding periapical tissues, including the PDL. This tissue may be affected 
by bacteria via the dental pulp, due to entry through the dentinal tubules, 
following dental caries. Infection finally reaches the periapex, which is in 
close proximity to the PDL. Work presented in chapter 4 provided information 
on the expression of decorin and biglycan, and the GAG components 
synthesised by the PDL following exposure to the SAG. Collectively, the data 
indicated increased biglycan levels and decreased decorin levels in response to 
bacterial exposure. These results highlight previous suggestions proposing 
different roles for these SLRPs, including inflammatory roles for biglycan 
(Schaefer et al., 2005), and a misassembled collagenous matrix due to 
decreased decorin (Hakkinen et al., 2000). Commensal and pathogenic strains 
of the SAG also had detrimental effects upon the GAG moiety, with 
decreasing proportions of CS and DS. This decrease could possibly be an 
effect of the SAG resulting in a change in PG profile, as a consequence of 
altered post-translational synthesis of the GAG leading to shorter chain length.
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Equally, it could be due to the GAG-depolymerising enzymes produced by 
this group of bacteria. Overall, the changing GAG profile would affect the 
functional integrity of host tissue and tissue remodelling.
The SAG influenced cellular activity o f PDL cells in other ways. Both 
commensal and pathogenic strains o f the SAG increased PDL cell growth 
whilst decreasing their alkaline phosphatase activity, indicating the diverse 
effects these bacteria produce. This would have potential consequences upon 
tissue repair by interfering with cell differentiation. Since this study used 
primary PDL-like cells, it can be considered as being of greater relevance to 
periodontal disease in vivo in possibly paralleling mechanistic avenues 
involved during PDL destruction.
Infections with the SAG are likely to involve interaction with endothelial 
cells, as the periapical tissues are highly vascularised. Evidence provided 
within this study indicated that commensal and pathogenic strains o f the SAG 
had debilitating effects on the ability of endothelial cells to synthesise a stable 
matrix. The SAG affected a number of parameters including increasing cell 
growth, decreasing migration and decreasing biglycan synthesis along with a 
corresponding decrease in CS-GAG detection. The lack o f decorin production 
suggests that the endothelial cells were not undergoing angiogenesis 
(Schonherr et al.y 1995), although the cells were subjected to potential SAG 
infection conditions, thereby stressing the importance o f SLRPs and their
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biological roles within the ECM. Overall, the results would suggest that the 
net endothelial ECM loss observed may be due to both increased destruction 
in combination with a decrease in angiogenic properties.
The combined effects on different cell types reported in chapter 4 and 5 
emphasise the complexity and multifactorial nature of destruction by the 
SAG. It is o f interest to note that SAG supernatants can potentially modulate 
various functions of PDL-like cells, including those of decorin and biglycan, 
present in host tissues. It is possible that cells cultured in the presence of any 
member o f the SAG could be stimulated to secrete cytokines in response to 
pathological products o f this group of bacteria. PDL cells are known to 
express certain pro-inflammatory cytokines during periodontal inflammatory 
conditions (Quintero et al., 1995; Agarwal et al., 1998). Once synthesised, 
these cytokines may amplify the host immune response, exerting 
autocrine/paracrine effects. In furthering our understanding of SAG 
pathogenesis, it would be advantageous to observe if members of the SAG 
could also modulate host immune functions, including those of IL-lp and IL- 
6, and various cytokines, such as TGF-p and TNF-a.
It is well established that the SAG produce a number of degradative enzymes 
(Homer et al., 1993; Jacobs and Stobberingh, 1995; Willcox et al., 1995b). 
Interestingly, data presented within this thesis suggests SAG enzymatic 
virulence factors, such as glycosidases, increase following exposure to ECM
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proteins synthesised by PDL-Iike cells. Other interesting results were 
observed for commensal strains of S. intermedius with regard to 
intermedilysin (ILY) expression. There was a 2- to 3-fold increase in ILY 
expression following exposure to ECM proteins. Other streptococci have been 
shown to regulate expression of virulence-associated genes at the 
transcriptional level following exposure to different environmental conditions 
(Fogg et al., 1994; Erickson and Herzberg, 1995; Jenkinson and Lamont, 
1997). This increased virulence would have dire consequences for the host by 
breaking down the matrix and altering tissue repair.
In conclusion, it is known that one way the SAG (within supra- or subgingival 
plaque) can gain entry into host periapical tissues is via dentinal tubules, 
whenever dentin is exposed in the oral cavity, due to a number of factors 
including carious lesions and dental trauma.
Once the bacteria reach the root canal space they can come into open 
communication with the periapical tissues (including PDL) via the apical 
foramen. If SAG were to persist and invade the host they could become 
established within periapical tissues. Evidence from this thesis suggests the 
SAG recognise ECM components present within the host tissues, which 
would enable the SAG to gain a foothold within the host and stimulate 
bacterial adherence and growth within these tissues.
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Subsequently, SAG metabolites and toxic products, such as hyaluronidase and 
chondroitin sulfatase (as seen in chapter 6), could diffuse throughout the 
periapical tissues evoking a number of inflammatory changes to the host 
ECM, including alteration of host ECM synthesis. In situations where tissues 
have been damaged, observed within the PDL matrix in chapter 4, periapical 
disease can manifest and if host defences are inadequate abscess formation 
can occur.
This thesis has enhanced our knowledge on the host-microbial interactions 
associated with the SAG in relation to periapical disease. It provides new 
potential roles o f initial adhesion, in the establishment of infection. 
Furthermore, data has been presented that may provide additional 
explanations for the subsequent infections the SAG could cause within these 
tissues, such as abscess formation. The importance of such information 
enhances the fundamental knowledge of the SAG, which may lead to novel 
strategies for management and, more importantly, prevention o f disease.
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